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ABSTRACT
Hypertension or high blood pressure has been identified as a major risk factor for
developing cardiovascular disease, stroke and kidney disease. To lower blood
pressure, lifestyle changes such as following a healthy diet, weight loss and exercise
have been recommended. This thesis draws on dietary data from a weight loss trial in
which blood pressure was a secondary outcome.
Previous studies investigating the effect of diet on blood pressure have mainly
focussed on single nutrients such as sodium and potassium. Whilst this has been
informative, food is not consumed as single nutrients but as whole foods, in different
combinations which make up dietary patterns. An understanding of the
interdependence between nutrients, foods and dietary patterns would help in
translating dietary advice in clinical practice especially in food-based
recommendations for blood pressure reduction. The central hypothesis of this thesis
is that dietary patterns, characterised in terms of nutrients and foods, significantly
influence blood pressure in adults.
To assess the current level of evidence on the effect of dietary patterns on blood
pressure, a systematic review and meta-analysis of randomised controlled trials was
conducted. A dietary pattern characterised by high consumption of fruit, vegetables,
whole grains, legumes, seeds, nuts, fish and low-fat dairy and low consumption of
meat, sweets and alcohol resulted in significant reductions in systolic (SBP) and
diastolic (DBP) blood pressure by 4.26 mm Hg and 2.38 mm Hg, respectively.
Whether this would still relate to a clinical sample of overweight adults is an
important question for practice.
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The first stage in the analysis started with the nutrient aspects of the diet-blood
pressure relationship. A secondary analysis of baseline data from a 12 month
lifestyle intervention trial (the HealthTrack study) was conducted. The results
showed that median urinary sodium and sodium-to-potassium ratio significantly
predicted SBP (P < 0.0005). Identifying food sources of sodium and potassium then
enabled translation from the nutrient level of understanding to that of foods. Cereal
based products and dishes; cereal and cereal products; meat, poultry and game
products and dishes; and milk products and dishes were identified as the major
contributors for dietary sodium. Conversely, vegetable products and dishes; meat,
poultry and game products and dishes; and milk products and dishes were the major
contributors for dietary potassium intake. Thus, while relationships could be seen
with nutrient intakes, the consumption of specific foods was also implicated in this
relationship.
The regular consumption of specific foods constitutes a dietary pattern. The next
level of analysis therefore investigated the association between dietary patterns and
blood pressure. Six dietary patterns were derived using principal component
analysis. These included; the “nuts, seeds, fruit and fish”, “milk and meat”, “breads,
cereals and snacks”, “cereal based products, fats and oils”, “alcohol, eggs and
legumes” and “savoury sauces, condiments and meat” dietary patterns. Multiple
regression analysis showed that a dietary pattern characterised by nuts, seeds, fruit
and fish was significantly and inversely associated with SBP (F (7,320) = 15.248, P
< 0.0005; adjusted R2 = 0.234), DBP (F (7,320) = 17.351, P < 0.0005; adjusted R2 =
0.259) and sodium-to-potassium ratio (F (7,320) = 6.210, P < 0.0005; adjusted R2 =
0.100). On the other hand, the association between SBP and DBP with the other
dietary patterns was not significant. Thus a dietary pattern that is dominated by
26

specific foods nuts, seeds, fruit and fish appeared protective. All of these foods are
naturally low in sodium and the plant foods are all high in potassium.
The second stage in the analysis assessed the impact of specific dietary advice on
change in dietary patterns, food and nutrients. Effects on blood pressure after 3
months were assessed. Participants were randomised to one of three groups:
intervention (interdisciplinary intervention with individualised dietary advice),
intervention + walnut (interdisciplinary intervention with individualised dietary
advice plus a supplement of 30 grams of walnuts/day), or control (usual care). SBP
reduced significantly in all groups. The greatest reduction however was observed in
the intervention + walnut group (-7.0 mm Hg, P < 0.001). The change in SBP was
significantly greater in the IW and I groups compared to the control group (P =
0.022 and P = 0.041, respectively). There was no significant difference in change in
SBP between IW and I groups (P = 0.692). Using multiple linear regression, an
increase in urinary potassium and decrease in urinary sodium-to-potassium ratio was
significantly associated with SBP reduction in the intervention + walnut group (P =
0.044 and P = 0.037 respectively). In the intervention + walnut group, an increase in
the consumption of seed and nut products and dishes was significantly associated
with a reduction in SBP (P = 0.034) while increased intake of seafood products and
dishes was significantly associated with decreased DBP (P = 0.024). This confirmed
the associations observed in the cross sectional analysis at baseline.
Lifestyle changes are an important component of the management of hypertension.
Losing weight is a significant strategy, but in addition there is value in emphasizing
dietary strategies that support lower blood pressure. This thesis provided novel
evidence that, in the context of clinical practice for weight loss, specific food choices
and nutrient intakes that align with beneficial dietary patterns may also assist in
27

reducing blood pressure. The evidence is provided by data on (1) intakes of dietary
sodium and potassium, (2) food sources of these nutrients, and (3) overall dietary
patterns. This data was generated in a practice setting incorporating an
interdisciplinary model of care for weight loss. Despite utilising a secondary
analysis of trial data where weight loss was the primary outcome, the results
demonstrated that blood pressure effects can nonetheless be seen in small clinical
samples. In clinical practice, dietary advice based on specific food choices and
attention to sodium and potassium intakes could be helpful in not only addressing
weight-loss but also high blood pressure. Further research to test this hypothesis in
practice would strengthen these findings.
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1.1 Introduction

This chapter provides an overview of blood pressure and the definition of high blood
pressure (hypertension), its aetiology, consequences and management. It further
explains the link between diet and blood pressure by reviewing the body of literature
on the role of nutrients, single foods and dietary patterns while also considering the
implications of behaviour change and the role of primary healthcare and service
delivery models in blood pressure management. This chapter also highlights the gaps
in the literature which will be addressed in subsequent chapters of this thesis.
1.2 Blood pressure

Blood pressure refers to the force exerted on the arterial walls of the large arteries by
the blood circulating in the cardiovascular system [1]. Prolonged raised blood
pressure can lead to serious harm to various parts of the body while low blood
pressure may result in fainting due to reduced blood flow to the brain, hence
maintaining a fairly constant blood pressure is important [2]. Blood pressure
regulation is controlled by the renin-angiotensin system, the sympathetic nervous
system and the kidneys through regulation of the volume of body fluids and
electrolytes [1]. In approximately 95% of cases, raised blood pressure has no
particular identifiable physiological cause, and is known as primary, essential, or
idiopathic hypertension. In the other 5%, an underlying kidney or adrenal disease
resulting in an impaired renin-angiotensin system, increased adrenal medulla
catecholamine secretion or increased adrenal cortex aldosterone secretion may lead
to secondary hypertension [3] [2]. In essential hypertension, there are multiple risk
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factors for raised blood pressure that affect a wide range of population groups
(Figure 1.1).
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Figure 1.1 High blood pressure: risk factors, consequences, and high-risk groups
[1]
Blood pressure within a population does not have a well-defined line between
‘normal’ and ‘abnormal’ blood pressure but it is rather a continuous range of blood
pressures [2].
1.3 Hypertension: Definition and Health Consequences
Hypertension is the clinical diagnosis of measured and agreed level of ‘high blood
pressure’. Hypertension has been identified as a major risk factor for developing
cardiovascular disease, stroke and kidney disease, with 51% of stroke and 45% of
deaths from ischemic heart disease being attributed to high blood pressure [4] [5]. In
2001, high blood pressure was said to cause about 54% of stroke, 47% of ischemic
heart disease, 75% of hypertensive disease, and 25% of other cardiovascular diseases
[6]. While in 1990 high blood pressure (hypertension) was the fourth leading risk
factor for the total burden of disease worldwide, it is currently ranked as the leading
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risk factor for mortality and total burden of disease with an estimated 9.4 million
deaths per year [7]. The effects of high blood pressure on population health have
been experienced both in high and low-income regions such as sub-Saharan Africa
and south Asia [7].
Globally, various guidelines exist regarding the measured blood pressure
classification of hypertension. Generally, most guidelines classify hypertension as
systolic blood pressure (SBP) above 140 mm Hg and/or diastolic blood pressure
(DBP) above 90 mm Hg in patients above 18 years, based on a mean of two or more
measurements taken while seated. This cut-off is based on the existing evidence
which shows that treatment of patients to reduce blood pressure below these values
is beneficial [8]. Due to the high day to day variability of blood pressure, the United
Kingdom National Institute for Health and Clinical Excellence recommends the use
of ambulatory blood pressure monitoring or home blood pressure monitoring to
confirm a diagnosis of hypertension in the case that clinic blood pressure is above
140/90 mm Hg [9]. Table 1.1 and 1.2 are examples of hypertension classification
[10] [11] while Appendix C and Table 1.3 outline management guidelines proposed
by different organizations [5] [8] [10] [12] . The recommendations and blood
pressure targets differ according to population groups and the presence or absence of
other risk factors such as diabetes and chronic kidney disease.
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Table 1.1 Blood pressure classification for adults above 18 years
Classification

SBP (mm Hg)

DBP (mm Hg)

Normal

<120

and

<80

Prehypertension

120-139

or

80-89

Stage 1 hypertension

140-159

or

90-99

Stage 2 hypertension

≥160

or

≥100

Adapted from The Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure report [10]
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Table 1.2 Definition and classification of office blood pressure levels according to
the 2013 ESH/ESC guidelines for the management of arterial hypertension
Category1

Systolic (mm Hg)

Optimal

<120

and

<80

Normal

120-129

and/or

80-84

High normal

130-139

and/or

85-89

Grade 1 hypertension

140-159

and/or

90-99

Grade 2 hypertension

160-179

and/or

100-109

Grade 3 hypertension

≥180

and/or

≥110

Isolated systolic

≥140

and

<90

Diastolic (mm Hg)

hypertension
1

The blood pressure category is defined by the highest level of blood pressure,

whether systolic or diastolic. Isolated systolic hypertension should be graded 1, 2 or
3 according to systolic blood pressure values in the ranges indicated; ESH, European
Society of Hypertension; ESC, European Society of Cardiology.
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Table 1.3 Magnitude of blood pressure reduction associated with adherence to
lifestyle modifications to manage hypertension
Lifestyle modification

Recommendation

Range of average
SBP reduction, mm
Hg

Maintain normal body weight

5 – 20 per 10 kg

(BMI 18.5-24.9 kg/m2)

weight loss

Adopt DASH diet eating

Adopt a diet rich in fruits,

8 – 14

plan

vegetables and low fat dairy and

Weight reduction

low in saturated and total fat
Reduced dietary sodium

Restrict dietary sodium to <100

2–8

mmol/day (2400 mg sodium or
6 g salt)
Increased physical activity Regular aerobic exercise such as

4–9

brisk walking for at least 30
minutes, most days of the week
Moderate alcohol

Consumption of alcohol no

consumption

more than 2 drinks* for men and

2–4

1 drink for women and lighterweight people
Adopted from JNC 7 guidelines [10]; *1 drink = 375 ml mid strength 3.5% alcohol
volume beer, 100 ml wine or 42.5 g 80-proof whiskey; BMI, body mass index;
DASH, Dietary Approaches to Stop Hypertension; SBP, systolic blood pressure.
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In adults over the age of 50, SBP has been shown to better predict cardiovascular
events and renal damage than DBP [8]. In primary care practice, risk scores such as
those developed using the Framingham Heart Study data can be used to predict risk
of developing hypertension [13] or cardiovascular disease [14] [15] taking into
account risk factors such as age, sex, family history, body mass index (BMI), blood
pressure, cholesterol levels and other lifestyle factors. Blood pressure is thus seen in
the context of total cardiovascular disease risk. In Australia, the majority of
individuals have more than one risk factor (including hypertension), for developing
chronic disease with about 50% of adults having two or three risk factors [16]. As a
result, absolute cardiovascular disease risk scores were developed to be used by
general practitioners in primary care setting to assist in the management of multiple
individual risk factors [17].
The prevalence of hypertension is increasing. In 2011, about one billion people
globally were hypertensive [18] with the prevalence of hypertension predicted to
reach 1.56 billion people by 2025 [19]. According to the 2011-2012 Australian
Health Survey, the prevalence of hypertension in Australia is about 31.6%, with
higher prevalence in men (34.1%) compared to women (29.1%) and in older persons
especially those aged above 85 years (87.7%)[20] [20]. Hypertension is therefore an
important public health concern both in Australia and globally.
1.4 Effects of lowering blood pressure

Numerous epidemiological studies and randomised controlled trials have
demonstrated that reducing blood pressure results in various health benefits. In a
meta-analysis of 61 observational studies involving 958,074 participants without any
vascular disease at baseline, a 20 mm Hg difference in SBP was associated with a
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significantly reduced risk of stroke (RR 0.36, 95% CI 0.32-0.40), ischemic heart
disease (RR 0.49, 95% CI 0.45-0.53) and other vascular causes (RR 0.43, 95% CI
0.38-0.48) in adults between 40-49 years, with the risk decreasing with age [21]. In
addition, reducing blood pressure has been shown to reduce the risk of coronary
heart disease, stroke, and major cardiovascular events [22].
In a recent meta-analysis of 123 randomised controlled trials involving 613,815
participants, lowering SBP by 10 mm Hg through the use of hypertensive
medications led to a significant reduction in the risk of stroke (RR 0.73, 95% CI
0.68-0.77), cardiovascular disease events (RR 0.80, 95% CI 0.77-0.83), heart failure
(RR 0.72, 95% CI 0.67-0.78), coronary heart disease (RR 0.83, 95% CI 0.78-0.88)
and all-cause mortality (RR 0.87, 95% CI 0.84-0.91) across different population
subgroups [23]. In the US population, lowering SBP and DBP by 5.0 and 3.0 mm Hg
respectively was estimated to result in a 15% reduction in the incidence of coronary
heart disease and 27% reduction in stroke incidence [24]. In addition, lowering SBP
by 10 mm Hg or DBP by 5 mm Hg through the use of blood pressure lowering
medication has been shown to reduce the incidence of coronary heart disease events
and stroke by 25% and 30% respectively [25]. Conversely, an increase of 20 mm Hg
in SBP and 10 mm Hg in DBP in adults between 40 and 70 years old has been
estimated to double the risk of developing cardiovascular disease [10]. Older and
overweight individuals with prehypertension are more likely to progress to
hypertension thus emphasising the importance of primary preventative interventions
for lowering blood pressure [26].
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1.5 The role of obesity in hypertension aetiology

Given the high burden of hypertension on health care services and individual risk of
disease outcomes, there has been an extensive focus on identifying non
pharmacological strategies to prevent its development. In this regard, the
relationship between obesity and hypertension is well established. Obesity has been
identified as a major risk factor for essential hypertension commonly referred to as
obesity-hypertension [27]. In the World Health Organization MONICA
(MONItoring of trends and determinants in CArdiovascular disease) Project, BMI
was shown to be a significant predictor of SBP accounting for 14% and 32% of
variance in men and women respectively after controlling for age [28]. In an 11 year
prospective population study, an increase in BMI was significantly associated with
an increase in SBP and DBP in 15,971 women and 13,846 men who were not on
blood pressure medications, had no diabetes or cardiovascular disease. Further, each
5% weight gain was correlated with a 20-30% increased risk of developing
hypertension [29]. In addition, in the Framingham Offspring Study, obesity was
identified as a major predictor of hypertension after controlling for baseline blood
pressure after 8 years follow-up of 2,027 men and 2,267 women aged between 20
and 49 years [30]. Risk estimates indicated that about 73% and 56% of hypertension
cases in men and women respectively were attributed to obesity [30].
The precise mechanism that links obesity and hypertension is not well understood.
However, both animal models and human studies have shown that expansion of the
blood volume and increased sodium reabsorption in the kidneys play a major role in
the development of obesity-hypertension [27]. The increased likelihood of
developing hypertension in the obese may be attributed to hyperinsulinemia which
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leads to the activation of the sympathetic nervous system which may increase blood
pressure either through vasoconstriction or increased sodium retention [31]. Serum
leptin, which is elevated in obesity [32], has also been attributed to the development
of obesity-hypertension via increasing renal sympathetic nerve activity and reducing
sensitivity to appetite inhibition [33]. In prospective studies, greater hospitalisations
due to different types of cardiovascular disease have been observed in patients with a
higher BMI [34].
Given the high and increasing prevalence of obesity both in industrialized and
developing countries [35], body weight management is an important target for
hypertension prevention. Approximately 58% of the world’s adult population is
projected to be overweight or obese by 2030 [36]. Identification of strategies to
lower blood pressure in the overweight and obese population is therefore important
in reducing the likelihood of developing hypertension over time.
1.6 Diet and blood pressure

As well as energy imbalance (obesity), other dietary factors are known to influence
blood pressure through inter-related interactions occurring at various levels between
nutrients, foods and dietary patterns. In addition, nutrients, foods and dietary patterns
can be influenced by lifestyle factors such as exercise and access to healthcare
interventions at the primary healthcare level (Figure 1.2).
Nutrients, foods and dietary patterns are all interconnected. Firstly, nutrients are
delivered by foods and are essential for human health, together with other nutritional
compounds whose health benefits are being recognised [37]. Focus on the role of
nutrients in health previously enabled the understanding and prevention of deficiency
diseases [38] which then led to the development of nutrient supplementation
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strategies. However, as it is well known, nutrients are delivered from the diet as
whole foods. This may also result in food synergy –whereby the combination of
nutrients provided through different food matrices may have greater benefits
compared to individual nutrients in individual foods themselves [39]. A combination
of individual foods leads to the aspect of dietary patterns, which is helpful in
enabling easier translation of food based recommendations, such as dietary
guidelines and their application in clinical practice [40].

Healthcare
Lifestyle
Dietary pattern
Food

Pragmatic diet
interventions
Usual diet
Physical activity
Wellbeing
DASH diet vs
Western diet
Vegetables vs
Cured meat

Nutrient

Figure 1.2 Interrelationships between nutrients, foods and dietary patterns
Adapted from: [39] [40] [41] [42].
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Sodium. Potassium

1.7 The impact of single nutrients on blood pressure
1.7.1 Sodium
Dietary sodium or salt was one of the earliest dietary components to be identified as
being associated with blood pressure. In approximately 1700 BC, the Chinese
physician Huang Ti Nei Ching Su Wein stated that “therefore if large amounts of salt
are taken, the pulse will stiffen and harden”, as translated by Wan Ping in AD 762
[43]. Several large epidemiological studies have investigated the relationship
between salt intake and blood pressure. Notably in the INTERSALT study, a large
international epidemiological study involving 10,074 individuals across 52 centres,
higher urinary sodium excretion (difference of 100 mmol) was significantly
associated with higher blood pressure values (approximately 3/0 to 6/3 mm Hg)
especially in middle aged individuals compared to younger adults [44]. In a metaanalysis investigating the effect of long-term reduction of sodium intake, a reduction
to 1,720 mg/day (4.4 g salt/day) resulted in a decrease in blood pressure of 2.0 and
1.0 mm Hg in SBP and DBP respectively in normotensive subjects, with greater
reductions of 5.0 and 3.0 mm Hg in SBP and DBP respectively observed in
hypertensive subjects [45].
It has been suggested that inconsistencies regarding the impact of increases in
sodium intake on the development of hypertension may be the result of differences
in the degree of salt sensitivity between individuals [46]. Salt-sensitivity refers to a
situation whereby blood pressure is elevated during intake of high dietary sodium
and decreases during low sodium intake while in salt-resistant individuals, blood
pressure does not change with restriction of sodium intake [47]. Differences in blood
pressure response to salt intake in salt-sensitive and salt resistant individuals has
been demonstrated in normotensive as well as hypertensive adults [48]. Increased
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salt-sensitivity has been linked to the impaired function of the kidneys in sodium
excretion whereby in salt-sensitive individuals with hypertension, a higher blood
pressure is required to adequately excrete sodium [49]. The application of saltsensitivity has remained in the research domain, because of difficulties in applying
the criteria and a need to hospitalize individuals for the periods of salt restriction or
salt loading. The following groups of patients tend to have increased susceptibility to
salt-sensitive hypertension, and have been suggested to be targeted for intervention
[47]:
• People of African descent
• Elderly people
• Obese persons (not in all studies)
• Patients with type 1 or type 2 diabetes
• Patients treated with calcineurin inhibitors
• Patients with chronic kidney disease
The use of blood pressure as an outcome end-point in studies that investigate the
effect of high salt intakes has been subject to various controversies. For instance, in
recent studies including the observational cohort - Prospective Urban Rural
Epidemiology (PURE) study, using mortality or occurrence of cardiovascular disease
events as definitive outcomes to investigate the effects of sodium intake on health
have shown that both consumption of salt intakes lower than 7 g salt (2,730 mg
sodium) and higher than 14 g salt (5,460 mg sodium) were associated with an
increased risk of death and cardiovascular events [50] [51]. The PURE study had
various limitations including estimating 24- hour sodium and potassium intake from
formula estimate of morning fasting urine samples. In addition, the 2013 Institute of
Medicine (IOM) report [52] pointed out that while higher sodium intakes are
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associated with the risk of cardiovascular disease, the report concluded that there is
insufficient evidence to provide recommendations to lower intakes below 2,300
mg/day. This has raised questions regarding a potential adverse effect of low salt
intakes on long term health outcomes.
However, the IOM report did not assess the association of sodium intake with
intermediate end-points such as blood pressure. The question of the optimal levels
for sodium intake in the general population and in clinical populations, specifically,
therefore remains to be further explored. Furthermore, an American Heart
Association Science Advisory review of 26 cohort studies that examined the
relationship between sodium intake and cardiovascular disease identified various
methodological issues arising in the body of evidence. These included random and
systematic error in assessment of sodium intake, reverse causality, inadequate
follow-up, residual confounding and insufficient power, resulting in inconsistent
findings [53]. According to the World Health Organization, the final consensus to
date on sodium consumption is a recommendation of less than 2,000 mg of sodium
per day (5 g salt) in adults [54].
1.7.2 Potassium
Potassium is another key nutrient which has been shown to play a major role in
blood pressure regulation, with an inverse association demonstrated in randomised
controlled trials. In a meta-analysis of 32 randomised controlled trials, increasing
potassium intake by 780 mg/day without the use of antihypertensive medications
was shown to reduce SBP and DBP by 4.9 mm Hg and 2.7 mm Hg, respectively
[55]. However, despite these findings, research investigating the association between
potassium intake and cardiovascular disease risk factors has provided conflicting
results. A significant inverse association was demonstrated between potassium
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consumption and stroke incidence in a meta-analysis of 11 cohort studies comprising
of 127,038 participants [56]. However in the same study, there was no significant
association between potassium intake and the incidence of cardiovascular disease
and coronary heart disease. Likewise, there was no significant association between
potassium intake and risk of cardiovascular disease events in a prospective
observational cohort study of 7,795 adults majority with albuminuria and no history
of cardiovascular events at baseline after adjustment for lifestyle and dietary factors
[57]. The lack of association in this study may have been due to the high overall
median urinary potassium excretion of 70 mmol/24 h which is equivalent to
potassium intake of approximately 90 mmol/d. Many populations have intakes much
lower than this value, as a result of inadequate fruit and vegetable intakes [58] thus
the results may not have wide generalizability.
1.7.3 Sodium-to-potassium ratio

The role of sodium and potassium in influencing blood pressure may be mediated by
their effect on a number of synergistic mechanisms of the endothelial system that
increase vasodilation, such as production of nitric oxide, endothelium-derived
hyperpolarizing factors and prostaglandins [59]. A high sodium intake has been
linked to impaired endothelial function [60] while, conversely increased potassium
intake enhances endothelial function [61]. In the development of hypertension,
excessive sodium and insufficient potassium intake are both shown to play a role
since they result in vascular smooth muscle cell contraction which leads to increased
peripheral vascular resistance thus causing high blood pressure [62]. A recent review
demonstrated that in various randomised controlled trials the sodium-to-potassium
ratio had a stronger association with blood pressure than sodium or potassium alone
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[63]. The sodium-to-potassium ratio may therefore be a better target for dietary
interventions aimed at lowering blood pressure across various geographical regions
and cultures [64]. According to the World Health Organization sodium and
potassium targets, a sodium-to-potassium molar ratio of 1:1 is implied as optimal
although this has not been specified as such [65]. A low sodium-to-potassium ratio
may reflect high diet quality, while a high ratio may reflect poorer diet quality. For
instance, in 24,807 adults in the United States participating in the National Health
and Nutrition Examination Survey 2001-2010, a high consumption of canned
vegetable and fruit was associated with a significantly lower sodium-to-potassium
ratio of 1.38 compared to a ratio of 1.45 in the low consumption category as assessed
through 24-hour dietary recall interviews. The lower sodium-to-potassium ratio was
also associated with favourable diet quality as measured by the Healthy Eating
Index-2010 [66]. In terms of diet quality and hypertension, a higher diet quality
score as measured using the Dietary Guideline Index and Recommended Food Score
was inversely associated with hypertension in men in a cross-sectional analysis of
the Australian Health Survey 2011-2013 [67].
As a result of the relationship between excessive sodium intake and low potassium
intake with increased risk of hypertension and cardiovascular disease, the World
Health Organization recommends a population intake target of 2,000 mg of sodium
(equivalent to 5 g salt per day) and 3,510 mg of potassium per day [54]. Due to an
increase in salt sensitivity in individuals with the metabolic syndrome [68], the
Australian National Health and Medical Research Council (NHMRC) further
recommends a Suggested Dietary Target of 1,600 mg of sodium for chronic disease
prevention [69]. The Nutrient Reference Values for sodium are currently under
review by the Australian Government Department of Health in partnership with the
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New Zealand Ministry of Health
(http://www.health.gov.au/internet/main/publishing.nsf/Content/nutrient-ref-values).
In the United States, the Dietary Reference Intakes for potassium is 4700 mg/day and
the Upper Limit for sodium is 2300 mg/day which represents a 2:1 ratio [70]. In
addition, the American Heart Association and the American College of Cardiology
recommends a further reduction to 1500 mg/day for those who need blood pressure
lowering [71].
1.7.4 Other nutrients
Other nutrients that may influence blood pressure include dietary fibre [72], calcium
[73] and magnesium [74], though research on the effects of these nutrients is
inconsistent. Furthermore, it is also well known that nutrients have multiple
interactions and may therefore be responsible for blood pressure reduction [24]. For
instance, the blood pressure lowering effect of potassium and calcium may be
mediated by their ability to increase sodium excretion by the kidneys or through the
interactions between sodium and potassium in the sodium-to-potassium ratio [75].
Thus, several nutrients in combination may affect blood pressure rather than a single
nutrient alone.
1.8 The impact of single foods on blood pressure

Nutrients are delivered in foods, which also include other components such as plant
sterols and polyphenols that investigations have shown to be beneficial to human
health [37]. In addition, research into foods and their effect on health has
implications for policy development, notably translation into dietary guidelines. We
do not consume nutrients in isolation, and as such policies such as dietary guidelines
must provide recommendations on consumption of foods, rather than individual
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nutrients [40]. As a result, the effect of individual foods on blood pressure has been
investigated in randomised controlled trials and observational studies. These foods
include fruit and vegetables, dairy foods, nuts, pulses, meat and coffee.
1.8.1 Fruit and vegetables
Fruits and vegetables are rich sources of dietary potassium [76], a nutrient that has
been associated with reduced blood pressure [55]. The effect of fruit and vegetables
consumption on blood pressure has been investigated in several cohort studies. For
example, in the SUpplementation en VItamines et Mine´raux AntioXydants
(SU.VI.MAX) study, consumption of more than 642 g per day of fruit and
vegetables compared to 228 g per day, resulted in a smaller increase in blood
pressure after 5 years of follow-up [77]. The SU.VI.MAX study included 2,341 men
and women aged between 35 and 63 years. These results indicate that consumption
of more fruit and vegetables could ameliorate changes in blood pressure which occur
with age.
A higher fruit and vegetable intake (more than 8 serves of fruit and vegetables per
day) was also associated with a significantly reduced risk of hypertension in a largescale cohort of 28,082 women who were followed up for 12.9 years [78]. However,
the association did not remain significant after adjusting for other lifestyle and
dietary factors such as smoking, alcohol intake, physical activity, whole grains, red
meat, low fat dairy and nuts; highlighting the impact of other lifestyle and dietary
factors on blood pressure. This highlights that blood pressure is not only impacted by
single foods such as fruits and vegetables, but also by other foods that are consumed
in combination.
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1.8.2 Dairy foods
Dairy foods are another food category of interest. The foods are rich in protein and
bioactive peptides, which through mechanisms such as the influence on the
endothelium function, inhibition of angiotensin-I-converting enzyme or effect on
body weight, may influence blood pressure [79]. In addition, nutrients such as
calcium, magnesium and potassium which are found in dairy foods, have been
associated with reduced blood pressure [80] [81].
The association between dairy intake and blood pressure was investigated in a cohort
of 5,880 middle aged men and women free of hypertension, cardiovascular disease,
diabetes and cancer in the 27-month Seguimiento Universidad de Navarra (SUN)
longitudinal prospective study in Spain [82]. Low-fat dairy consumption of more
than 2 serves per day (615 g) was associated with 54% lower risk of developing
hypertension. In addition, the Rotterdam study investigated the association between
dairy intake and hypertension in the Netherlands by following up 2,245 older adults
for 2 to 6 years [79]. In this study, intake of 561 g per day (3.7 serves) of low fat
dairy was associated with 31% lower risk of hypertension after 2 years of follow-up.
After 6 years of follow-up, this association was observed in overweight participants
only.
Likewise, the PREvencio´n con DIeta MEDiterra´nea (PREDIMED) study found an
inverse association between low-fat dairy intake and blood pressure in 2,290 adults
after a 12-month follow-up [83]. In this study, dietary intake was assessed using a
semi-quantitative 137-item food frequency questionnaire. In the highest quartile of
dairy consumers consuming 632 g per day in the PREDIMED study, SBP and DBP
were significantly lower [-4.2 mm Hg (95% CI: -6.9, -1.4) and -1.8 mm Hg (95% CI:
-3.2, -0.4] respectively. However, no significant associations were observed with
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whole-fat dairy consumption. In addition, in the 1946 birth cohort study in Britain,
no association was found between dairy intake, blood pressure and incident of
hypertension after 10 years of follow-up in 1,750 adults [84]. The lack of association
between whole-fat dairy and blood pressure may be explained by the detrimental
effect on the endothelial function asserted by a diet high in saturated fatty acid [85].
Dairy foods are still an important component of diet as they contain nutrients that are
implicated for blood pressure control. However, the current body of evidence
suggests limiting consumption of whole-fat dairy in the diet would be beneficial.
1.8.3 Nuts
The effect of nut consumption on blood pressure has also been investigated in
prospective studies and randomised controlled trials. Nuts contain high amounts of
mono- and polyunsaturated fats, magnesium, potassium and fibre and are low in
sodium and saturated fats and thus may elicit a blood pressure lowering response
[86]. These nutrients and their effects are known but the unique combination and
other factors in the nuts may also exert the effect.
In a meta-analysis of four prospective cohort studies involving 40,102 participants
and 12,814 hypertension cases, consumption of 1 serving of nuts/day was
significantly associated with reduced risk of hypertension (RR: 0.66; 95% CI: 0.44,
1.00; P = 0.006) [87]. In a recent meta-analysis of 21 randomised controlled trials,
increased nut consumption was shown to lower SBP by 1.29 mm Hg in participants
without type 2 diabetes [88]. On the other hand, no association was found between
nut intake and development of hypertension after adjustment for sex, age and other
confounding factors in the SUN prospective cohort of 9,919 adults [89]. In the SUN
study, the effect of nut intake on incidence of hypertension was assessed over a
follow-up period of a median 4.3 years using a food frequency questionnaire with
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four categories of nut intake (rarely/never, 1-3 times per month, once per week, and
2 or more times per week). Previous studies have investigated the effect of
consuming salted or unsalted nuts on blood pressure. For instance, a randomised
controlled crossover trial in which participants were randomised to either 30 g/day of
raw or dry roasted, lightly salted hazelnuts found that both interventions significantly
reduced SBP after 28 days [90]. In most prospective studies, the information on
whether the nuts are salted or unsalted is not usually provided [87], thus becoming a
limitation to the studies. The effect of nut consumption on blood pressure is
therefore not conclusive and it may be influenced by other dietary factors.
1.8.4 Pulses
Blood pressure reductions have also been observed after increasing the consumption
of dietary pulses (dried peas and beans). Dietary pulses are rich sources of plant
protein, dietary fibre and potassium which have been shown to have blood pressure
lowering effects [91]. For instance, in a meta-analysis of eight isocaloric randomised
controlled trials which included 554 participants with and without hypertension,
intake of dietary pulses (average 162 g/day) were found to significantly lower SBP (2.25 mm Hg (95% CI, -4.22 to -0.28), P = 0.03) [92]. Dietary pulses may therefore
have a beneficial effect on lowering blood pressure.
1.8.5 Meat
The effect of meat on blood pressure has been investigated in different studies.
Consumption of meat would be expected to impact negatively on blood pressure due
to the higher amounts of sodium, saturated fat and nitrates that are negatively
associated with blood pressure [93]. In addition, high meat intake might replace
other beneficial foods such as fruit and vegetables, whole grains and pulses. On the
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contrary, meat consumption may have a blood pressure lowering effect due to the
presence of amino acids such as arginine, tryptophan, taurine and tyrosine that
impact on the vascular system. L-arginine and taurine were found to lower blood
pressure in animal models [94]. In addition, L-arginine infusion in patients with
hypertension resulted in reduction of blood pressure through a vasodilatory effect
due to an increase in nitric oxide production [95].
In the Coronary Artery Risk Development in Young Adults (CARDIA) prospective
study, 4,304 participants aged between 18 and 30 years were followed up for 15
years [93]. The results showed that consumption of red and processed meat more
than 1-2 times/day at baseline was positively associated with 20-40% higher risk of
developing elevated blood pressure compared to intake less than 0.6 times/day. On
the other hand, a higher risk of developing hypertension (OR 1.26, 95% CI, 1.001.59) was observed in participants who consumed less meat compared to those who
consumed meat more frequently after 4.6 years of follow-up of 3,486 normotensive
Japanese male workers [96]. Thus, since red meat has been shown to both positively
and negatively impact on blood pressure, its influence may be related to the total
dietary pattern in which it is consumed, rather than as a single food in the diet.
1.8.6 Coffee
The effect of coffee consumption on blood pressure has also been investigated in
various studies. Coffee may impact on blood pressure negatively through caffeineinduced pressor effects whereby antagonism of endogenous adenosine results in
vasoconstriction and raised total peripheral resistance [97]. Increased pressor effects
of caffeine are however observed within the first 3 hours after ingestion and diminish
thereafter [97] which may result in a lack of association between coffee intake and
blood pressure. Coffee is also a good source of antioxidants comparable to red wine
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and green tea [98]. Green coffee bean extract has been shown to have
antihypertensive properties in animal models due to the presence of polyphenols that
influence nitric oxide production [99].
A meta-analysis of 16 randomised controlled trials investigating the effects of coffee
and caffeine on blood pressure found a significant increase of 2.04 mm Hg and 0.73
mm Hg in SBP and DBP respectively [100]. However, when coffee and caffeine
trials were analysed separately, larger increases were observed for caffeine (SBP:
4.16 mm Hg, DBP: 2.41 mm Hg) compared to the coffee trials (SBP: 1.22 mm Hg,
DBP: 0.49 mm Hg). A systematic review and meta-analysis of 10 randomised
controlled trials and five cohort studies did not find a significant effect of coffee
consumption on blood pressure or the risk of hypertension [101]. Likewise, coffee
intake was not associated with incident hypertension in the 12-y prospective cohort
Nurses’ Health Studies I and II comprising of 155,594 women free from physiciandiagnosed hypertension [102]. However in this study, consumption of caffeinated
cola beverages including both sugared and diet cola were found to be positively
associated with hypertension.
Better understanding of diet-blood pressure associations is warranted, and
particularly in at risk groups such as obese and overweight adults. Diets are complex
with multiple nutrient interactions, thus making it difficult to isolate the role of
individual foods or nutrients in relation to specific health and disease outcomes
[103].
1.9 Impact of dietary patterns on blood pressure

While investigating the effect of single nutrients or foods on blood pressure
management may have some positive results, individual foods are not consumed in
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isolation and are included within a whole diet, resulting in nutrient interactions
which may be synergistic [40]. Separating nutrients and foods may therefore not
represent the real picture of the combination of foods that people eat and their
influence on health. Consequently, dietary pattern analysis has been recommended in
nutritional epidemiology as an additional method to better understand relationships
between diet and chronic diseases [104]. It is therefore beneficial to assess the effects
of entire dietary patterns on blood pressure rather than focusing on single nutrients or
single foods.
Perhaps the most well-known study to investigate the impact of dietary patterns on
blood pressure was the Dietary Approaches to Stop Hypertension (DASH) trial [24].
The DASH study was a controlled feeding trial that enrolled 459 adults who were
supplied with the meals from study centres. The participants were randomised to
either the “DASH diet (combination diet)”, “fruit and vegetables diet” or the “control
diet (typical American diet)”. The DASH diet was composed of large amounts of
fruit and vegetables, increased low-fat dairy products, whole grains, nuts, legumes
and seeds and accompanying small amounts of meat and saturated fat. The “fruit and
vegetables diet”, was similar to the control diet, though it had larger amounts of
fruits and vegetables and less sweets and snacks. In comparison to the typical
American control diet, the DASH diet was shown to lower SBP on average by 5.5
mm Hg (-7.4 to -3.7) and DBP by 3.0 mm Hg (-4.3 to -1.6) in all participants.
However, the reduction was greater in subjects with hypertension. In the DASH
study, weight was kept constant and there was no difference between the sodium
content of the three comparator diets. However, the DASH diet led to a reduction of
73 mg in sodium intake compared to a reduction of 232 mg in the fruit and vegetable
diet and an increase of 142 mg in the typical American control diet. This may
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indicate that the overall dietary pattern has more influence on blood pressure
reduction than a single nutrient such as sodium. The effect of reducing sodium was
consequently assessed in the DASH-Sodium cross-over parallel group study
whereby a significant reduction in SBP was found for participants randomised to
both the low sodium (50 mmol sodium/day) and high sodium (150 mmol
sodium/day) DASH diets [105]. The low-sodium DASH diet resulted in significant
reductions in SBP of 8.9 mm Hg (-6.7 to -11.1) while the DASH diet alone resulted
in SBP reduction of 5.5 mm Hg (-7.4 to -3.7) [24], thus showing the additional
benefit of lowering sodium in the DASH diet. The DASH-Sodium study therefore
showed that having a good quality diet with plenty of fruit and vegetables may be as
beneficial as lowering sodium if on a poor American type diet – additive effects of
both were less than expected.
The DASH diet can be tailored to include locally produced foods and also consider
local food habits. This was demonstrated in a low glycaemic index Brazilian diet
whereby the food items were adapted to the local production and dietary habits but
incorporated the DASH principles including salt reduction [106]. After 6 months, the
intervention group had a net reduction of 6.2 mm Hg in DBP compared to the usual
care group. Urinary sodium excretion significantly reduced in the intervention group
by 43.4 mmol/24 hours and there was a significant reduction of 1000 mg in sodium
intake compared to the control group.
The DASH diet has also been modified to the Australian setting (OZDASH) and
investigated in a randomised controlled crossover trial involving 94 community
dwelling adults over 25 years of age, with baseline SBP greater than 120 mm Hg or
DBP greater than 80 mm Hg [107]. The OZDASH was based on the original DASH
diet [24] but had moderate sodium intake (2668 mg per day vs 3000 mg per day in
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the DASH diet). After four weeks of intervention, the OZDASH diet led to a
reduction in SBP by 1.8 ± 0.5 mm Hg compared to the control diet. In the same
study, a low sodium and high potassium diet (1400 mg sodium and 4100 mg
potassium) also led to a reduction in SBP and DBP by 4.4 ± 0.8 mm Hg and 2.0 ±
0.6 mm Hg respectively in comparison to the control diet.
Another dietary pattern that has been identified in various randomised controlled
trials is the Nordic diet. This diet consists of foods of Nordic origin such as whole
grains (rye, barley and oats), rapeseed oil, berries, fruits, vegetables, legumes, fish,
nuts and low-fat dairy products [108]. The Nordic dietary pattern’s effect on
ambulatory blood pressure was examined in a randomised controlled trial. The
control diet was based on mean nutrient intake in Nordic countries and comprised
wheat products, dairy fat-based spreads such as butter, and low intake of fruits,
vegetables and fish. The Nordic diet significantly reduced 24-hour ambulatory DBP
by 4.4 mm Hg in the intervention group compared to the control group. In another
study, the effect of a healthy Nordic diet, eaten ad libitum, on blood pressure was
assessed in 88 subjects with mild hypercholesterolemia and with blood pressure less
than 145/85 mmHg [109]. The Nordic diet lowered SBP by 6.55 mm Hg after 6
weeks. However, the change did not remain significant after adjusting for weight
loss. Likewise, in comparison to an average Danish diet the Nordic diet was shown
to have significant reduction in SBP after 26-weeks by 5.13 mm Hg in 181 adults
with metabolic syndrome [110]. The Danish diet was composed of refined grains,
meat, dairy and cheese, sweets and was low in vegetables and imported fruits.
The Mediterranean dietary pattern is another combination of foods that has been
shown to have a beneficial role in blood pressure reduction. The traditional
Mediterranean diet is generally characterized by high intake of plant foods such as
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fresh fruits, vegetables, legumes, nuts and seeds, unrefined cereals, fish and is low in
meat, [111] [112]. It may include moderate amounts of dairy foods, fish and poultry
and low amounts of red meat but there may be some variation in food composition
between regions. In general though, olive oil is the major source of fat and wine is
consumed moderately with meals. The PREDIMED study, a 4-year randomised
controlled trial showed that Mediterranean diet supplemented with extra virgin olive
oil, and with a daily supplement of 30 g mixed nuts led to significant reductions in
DBP by 1.53 mm Hg and 0.65 mm Hg respectively compared to a low fat diet [113].
In a 2-year study investigating the effect of a Mediterranean-style diet on endothelial
function and inflammatory markers in 180 patients with metabolic syndrome, a
Mediterranean-style diet that included consumption of 25-50 g of walnuts per day
significantly reduced SBP by 3 mm Hg and DBP by 2 mm Hg compared to a control
prudent diet [114].
The various dietary patterns that have been identified to lower blood pressure consist
of different food combinations. Some food components are common across multiple
dietary patterns while others are unique to a particular dietary pattern. For example,
the Brazilian diet incorporating DASH-Sodium principles is composed of foods of
low to moderate glycaemic index (GI<70) that are produced locally and adapted to
the local eating habits [106]. However, the DASH diet [24], the OZDASH diet [107],
the Brazilian diet, the Nordic diet [109] [115] [108], and the Mediterranean diet
[113] all comprise a high intake of fruit, vegetables, nuts and legumes. These diets
are high in nutrients such as potassium which has been associated with lowering
blood pressure [116]. The DASH diet and Brazilian DASH diet both incorporate
approximately 5 serves of fruit and 4 serves of vegetables per day. The Nordic diet
emphasizes locally grown foods such as strawberries, blackcurrants, bilberries,
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apples, pears and plums. The DASH, Brazilian and Nordic diets are rich in whole
grains and include approximately 2 to 3 serves of low-fat dairy per day. As
previously highlighted, consumption of dairy products has been associated with
reduced blood pressure [117].
Generally speaking, the dietary patterns identified as being beneficial emphasise
consumption of less red meat and more white meat as well as more than 3 serves per
week of fish. As a result of the diets being high in low-fat dairy and lean meat, they
are also low in total fat and saturated fat. The beneficial dietary patterns include
consumption of vegetable oils with the use of olive and soya bean oils in the
Brazilian diet, rapeseed oil in the Nordic diet and olive oil in the Mediterranean diet.
Alcohol is limited to less than 2 drinks per day in the DASH diet while the
Mediterranean diet allows consumption of more than 7 glasses of wine per week.
Wine is rich in polyphenols and has been linked to a reduction in blood pressure
although the results are inconsistent. For example, an open randomised cross-over
trial showed a 5.3 mm Hg reduction in postprandial blood pressure after
consumption of 250 ml of red wine with the noon meal [118] although the sample
size in this study was small (n = 13). On the other hand, another study did not show
any reduction in blood pressure after consumption of 560 mg of red wine
polyphenols for 4 weeks [119].
There is also limited consumption of sweet snacks and sweetened and carbonated
beverages in the four dietary patterns. However, salt intake differs across the four
dietary patterns. The DASH diet maintains an intake of 3,000 mg sodium per day
while the Brazilian diet has an intake of 2,400 mg sodium per day. The DASHSodium includes both low (1150 mg sodium per day) and high (3450 mg sodium per
day) sodium variations. The Nordic diet has an intake of 2,730 and 2,340 mg sodium
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in men and women respectively. The Brazilian diet uses spices such as garlic, bay
leaf, chive, coriander, oregano, parsley leaf and pepper in order to compensate for
the reduced salt and enhance flavour in the foods.
As described in this section, blood pressure is influenced by different foods,
consumed in combination as different dietary patterns, rather than by single foods. It
is therefore more important to focus on dietary patterns in blood pressure
management.
1.10 Role of weight loss and exercise in blood pressure

While a focus on dietary patterns and food groups is informative, there is also a body
of research on the effect of weight loss on blood pressure. In addition to dietary
changes, other behavioural interventions that are recommended for lowering blood
pressure include weight loss and increased physical activity [10]. Weight loss has
been found to normalize blood pressure levels in obese participants after controlling
for other factors such as age, sex, hypertensive drugs and degree of obesity [120]. In
addition, a meta-analysis of 3 randomised controlled trials that investigated the effect
of weight reducing diets in hypertensive people found that weight loss of about 4 kg
led to a reduction of 4.5 mm Hg and 3.2 mm Hg in SBP and DBP respectively [121].
Several studies have focused on the effect of weight loss and exercise, in
combination with diet, on blood pressure. An example is the Prospective Registry
Evaluating Myocardial Infarction: Events and Recovery (PREMIER) study which
investigated the effect of weight loss and exercise, in addition to inclusion of DASH
dietary principles in 810 free living subjects who were not on blood pressure
medication [122]. Intervention goals included weight loss of about 6.8 kg within the
intervention period, reducing sodium intake to 2,300 mg per day, incorporating 180
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minutes of moderate exercise per week and reducing daily alcohol intake to less than
2 drinks (28 g pure alcohol) for men and 1 drink (14 g pure alcohol) for women.
After 6 months, the behavioural intervention incorporating the DASH diet lowered
SBP and DBP by 4.3 mm Hg and 2.6 mm Hg respectively. In the PREMIER study,
there was no significant difference between the behavioural intervention group
incorporating the DASH diet and behavioural intervention only. Both groups had
increased exercise which resulted in weight loss, and both reduced sodium and
alcohol intake, which may have resulted in the lack of difference observed between
the groups.
In contrast, the 4-month Exercise and Nutrition interventions for CardiOvasculaR
hEalth (ENCORE) study found increased benefits of adding weight management
changes to the DASH diet [123]. Such interventions included consuming a
hypocaloric diet (-500 kcal/ day) and participating in supervised exercise sessions 3
times per week. Compared to the DASH diet only, the DASH diet plus weight loss
program significantly lowered SBP and DBP by 5 mm Hg and 3 mm Hg
respectively. There is therefore an added advantage of incorporating interventions
such as weight loss and exercise to the DASH dietary pattern in blood pressure
reduction.
It has been demonstrated that the DASH diet can be followed over the long term
[124] but motivation to exercise may decrease especially when supervised exercise
sessions are no longer being provided. This was demonstrated in an 8-month followup of the ENCORE study participants [125]. Ability to maintain changes in dietary
habits, exercise behaviour, weight loss and blood pressure reduction was assessed.
The two intervention groups had significant reductions of 6.7 mm Hg in SBP
compared to usual care. However, no significant differences were noted between
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DASH only and DASH diet plus weight loss groups. It was observed that the DASH
diet plus weight loss group had increased caloric intake and reduced energy
expenditure compared to DASH only, thus resulting in lack of significant differences
between the two intervention groups at follow up. Both DASH groups had lower
sodium intake and higher potassium, calcium and magnesium intake compared to the
usual care group. Behaviour change strategies including weight loss and exercise
may therefore reduce blood pressure in the short term, with longer term effects
requiring further investigation.
In this thesis, weight loss and physical activity are some of the lifestyle factors that
are controlled for in the analysis in chapters 4, 5 and 6 since they have been shown to
independently influence blood pressure.
1.11 Behaviour change in health care settings and blood pressure

Whilst most of the studies described above have been carried out in controlled
research settings with well-motivated volunteers, other studies have focused on
primary health care settings. The first contact between a patient and a health care
provider often occurs in healthcare practices. As a result, the health provider may be
required to provide dietary information to the client on the management of their
condition. The effect of such a health provider intervention was investigated in the
Hypertension Improvement Project (HIP), a 4-arm parallel design randomised
controlled trial involving 32 physicians in 8 primary care practices in central North
Carolina [41]. The study assessed the adherence of physicians to national guidelines
and of patients to behavioural recommendations for reducing blood pressure over a
period of 6 months, with further follow-up of patients for 12 months through
telephone counselling. The physician intervention included training of physicians on
60

blood pressure management and lifestyle modification, while the patient intervention
component included adherence to a DASH diet, increased physical activity, reduced
sodium intake and moderate alcohol intake. The results showed that both the
physician and patient interventions combined had the largest effect of lowering SBP
by 9.7 ± 12.7 mm Hg and DBP by 5.4 ± 4.6 mm Hg significantly compared to usual
care.
On the other hand, there was no effect on blood pressure when a brief 15-minute
educational intervention was provided by doctors in 33 general practitioner clinics in
Italy [126]. The randomised controlled clinical trial was carried out for 12 months.
The goals for the intervention group were to make the following dietary changes:
consume more than 5 servings of fruits and vegetables per day, 1 serving of fish per
week, use olive oil, consume less than 3 servings of red meat, and consume less
snacks and sweets. Control participants received a non-personalised information
session with no brochure. The study had a large number of participants (n = 3,186)
and the educational intervention was administered on the first visit only, with
participants being followed-up for one year without further counselling. This study
suggests that the number of contact hours that an individual has with the health
provider is an important determinant of behaviour change. More frequent contact
may lead to increased motivation for an individual to follow the intervention.
However, optimal health provider-patient interaction time, for management of blood
pressure has not been identified.
In this thesis, the effects of dietary patterns on blood pressure are examined in
clinical participants enrolled in a randomised controlled trial that is based on a
service delivery model. This is to establish the relevance of the context to study the
relationship between diet and blood pressure in terms of nutrients, foods and dietary
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patterns and how this might be implemented by healthcare professionals in clinical
practice.
1.12 Summary of evidence and gaps in literature

This review of the literature has identified that the problem of raised blood pressure
is of public health concern and therefore needs to be addressed. As has been
discussed throughout the chapter, blood pressure is influenced through diet at
various levels namely; nutrients, single foods and dietary patterns. However, the
results of the influence of diet on blood pressure are inconsistent with some foods
showing greater effects than others. There is therefore a need to investigate the
current state of evidence on how dietary patterns affect blood pressure in order to
inform both population level management of raised blood pressure and
individualised clinical practice.
Although various dietary patterns that affect blood pressure have been identified,
there is limited data on which dietary patterns have the most beneficial impact on
blood pressure in an intervention setting, especially with clinical groups such as
overweight adults. In addition, the relevance of dietary patterns to practice and their
usefulness in a clinical trial setting is yet to be established.
This chapter has identified the following gaps in the evidence base, which will be
addressed in this thesis:


There is a paucity of research evaluating the current evidence on the
relationship between dietary patterns and blood pressure.



There is little research on which dietary patterns are optimal for blood
pressure management in clinical settings.
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There is lack of research on how changes in dietary patterns influence change
in blood pressure in clinical settings.

1.13 Hypotheses

Dietary patterns characterised in terms of nutrients and foods, and changes in dietary
patterns over time, in a clinical setting significantly influence blood pressure in
adults.
1.14 Research questions

1. What is the current evidence on the relationship between dietary patterns and
blood pressure?
2. What is the association between sodium and potassium intakes and blood
pressure in a clinical sample of overweight adults?
3. What is the association between dietary patterns and blood pressure in a
clinical sample of overweight adults?
4. How do changes in dietary patterns affect changes in blood pressure under
weight loss conditions in a clinical setting?
1.15 Aims of the study
1. Study 1 – To assess the current level of evidence on the relationship between
dietary patterns and blood pressure by conducting a systematic review and
meta-analysis on studies examining the relationship between blood pressure
and dietary patterns in adults.
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2. Study 2 – To examine the association between sodium and potassium intake
and blood pressure in overweight and obese adults in the context of a lifestyle
intervention trial targeting weight loss.
3. Study 3 – To identify dietary patterns associated with blood pressure in
overweight adults in the context of a lifestyle intervention trial targeting
weight loss.
4. Study 4 – To assess how changes in dietary patterns as a result of more
specific dietary advice affect changes in blood pressure in the context of a
lifestyle intervention trial targeting weight loss.
1.16 Significance of research

The prevalence of hypertension and obesity in adults is increasing. This thesis will
expose new knowledge that is relevant to clinical practice by identifying dietary
patterns that influence blood pressure in the context of a clinical trial for weight loss.
By conducting analyses of changes in blood pressure, a defined secondary outcome
in the randomised controlled trial, new approaches for reducing blood pressure
concurrently with weight loss will be identified.
1.17 Theoretical framework

The theoretical framework utilised in this thesis is outlined below (Figure 1.3). Study
1 investigated the current level of evidence on the effect of dietary patterns and
blood pressure. Study 2 assessed the association between sodium and potassium
consumption and blood pressure in overweight adults enrolled in a randomised
controlled trial. Study 3 identified dietary patterns associated with blood pressure in
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overweight adults, while study 4 assessed the effect of changes in dietary patterns
after 3 months in a lifestyle intervention trial.

Study 1: What is the current
level of evidence of
relationship between blood
pressure and dietary patterns?

Study 2: What is the association
between sodium and potassium
intake and blood pressure in
overweight adults?

Study 4: What is the effect of
changes in dietary patterns in a
lifestyle intervention trial on
blood pressure?

Study 3: What is the
association between dietary
patterns and blood pressure in a
clinical setting?

Figure 1.3 Overview of thesis studies
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CHAPTER 2 – METHODOLOGY
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As discussed in Chapter 1, hypertension is a major public health problem and a risk
factor for developing cardiovascular disease, stroke and kidney disease [10]. Dietary
components that influence blood pressure including nutrients such as sodium and
potassium have been investigated however we do not consume single nutrients in
isolation but instead eat whole foods in different combinations that form dietary
patterns. In addition to single nutrients, this thesis hypothesizes that clinical settings
may be effectively used to intervene upon dietary patterns for hypertension
prevention and management. To test this hypothesis, various approaches were used.
First, the current body of evidence on the diet-blood pressure relationship was
examined applying the methodology of systematic literature review and metaanalysis. Second, a number of studies were conducted involving secondary analysis
of data from a randomised controlled trial reflecting the clinical practice setting.
Relationships between intakes of nutrients (sodium and potassium), foods or dietary
patterns, and blood pressure were examined. These issues are discussed below.
2.1 Systematic reviews and meta-analyses

In order to integrate evidence in nutritional research for translation in clinical
practice, systematic reviews and meta-analyses are conducted. Systematic reviews
are useful as they enable compilation and synthesis of results from different studies
[127]. In the rating of scientific evidence by the Australian health and medical
bodies, evidence obtained from systematic reviews of relevant randomised controlled
trials is regarded as the highest form (Level I) [128]. These follow established
protocols by various expert bodies and groups [129]. The first step in conducting a
review is to formulate a research question based on the identified problem. In
addition, the Preferred Reporting Items for Systematic Reviews and Meta-analyses
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(PRISMA) guidelines [130] offers a checklist and a flow diagram to ensure
consistency in reporting systematic reviews and meta-analyses. The protocol details
of reviews and meta-analyses are registered on the International Prospective Register
of Systematic Reviews (PROSPERO) [131].
In meta-analysis, results from different studies are pooled together and statistically
analysed to produce a single effect of an intervention [127]. The importance of
conducting a meta-analysis is that there is increased power to detect results as well as
increased precision in assessing the effects. In this thesis, results from all relevant
randomised controlled trials that met the inclusion criteria were pooled together
using computer analysis software, Cochrane Review Manager Software, RevMan
[132]. Quality rating for each of the studies included in the meta-analysis is assessed
using the “Risk of bias” assessment tool indicating the risk as low, unclear or high
[127]. Assessment of risk of bias is important as it can aid in explaining the results of
the meta-analysis especially the variation or heterogeneity of results. In clinical
practice, systematic reviews and meta-analyses are valuable in offering the evidence
that is required for implementation of clinical guidelines.
Meta-analyses can be a valuable component of systematic reviews by increasing
statistical power and allowing for the estimation of the effects of interventions
[127]. However, there are some limitations to their use. For example, conducting
meta-analyses on studies using different techniques in measuring outcome variables
or different populations, or combining studies with high levels of bias may lead to
misleading results [127] [133]. In addition, publication bias may exist whereby
significant results are more likely to be published than non-significant results. These
limitations can be minimised through searching through a wide range of literature

68

including un-published papers, dissertations, and findings in books and professional
meetings [133].
In this thesis, a systematic review and meta-analysis was undertaken to investigate
the current level of evidence of the relationship between blood pressure and dietary
patterns (Chapter 3).
2.2 Secondary analysis of a randomised controlled trial

Randomised controlled trials in nutrition research investigate the cause and effect of
relationships that have been identified from research in cross-sectional, case-control
and observational cohort studies [134]. Randomised clinical trials are important due
to the fact that participants are allocated randomly to intervention groups and also
blinded to minimise bias [135]. However, the trials can be expensive and time
consuming and may have limitations due to ethical and feasibility concerns [135].
The National Health and Medical Research Council (NHMRC) states that the highest
level of evidence in clinical practice including nutrition research should be obtained
from systematic review of all relevant randomised controlled trials followed by the
evidence from at least one properly designed randomised controlled trial [128].
Randomised controlled trials generate large amount of data which may not all be
utilised in the primary analysis. This may therefore necessitate secondary analysis of
the trial data in order to answer further questions that may not have been addressed
in the primary analysis [136] [137]. Secondary analysis involves using existing data
to answer various research questions. The strengths of secondary analysis include the
fact that the analysis can reveal important new findings after examining subgroups
and relationships not previously analysed [138]. In addition, secondary analysis
consumes less time to conduct, can be sourced at minimal cost since the data is
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readily available, and is of minimal risk to participants. On the other hand, various
limitations of secondary analysis may exist. These include, researchers need to
assess whether the data is able to answer the proposed research questions, dealing
with incomplete data sets as a result of missing data, variables not measured
correctly, and out of date data due to time lag between data collection and data
analysis [138].
2.2.1 The HealthTrack study
The results that are reported in this thesis were derived from secondary analysis of
data from the HealthTrack study. The study was a single blind randomised controlled
trial that was conducted in the Illawarra region, south of Sydney, Australia [139].
The study recruited adults 25-54 years of age through advertisements in local
newspapers (Figure 2.1). The sample size was calculated using SAS PROC POWER.
One hundred and twenty participants per group were deemed adequate to detect a
significant weight loss difference of 2.7 kg between groups. Inclusion criteria were
people living in the Illawarra region with a BMI of 25-40 kg/m2. Participants were
not excluded if they had chronic disease risk factors such as family history of
coronary heart disease, elevated low-density lipoprotein cholesterol and low highdensity lipoprotein cholesterol. Individuals who could not communicate in English,
had severe medical conditions that limited their ability to participate in the study,
immunodeficiency, had medical conditions that could limit survival to 1 year,
reported excessive alcohol intakes (greater than 50 grams of alcohol per day) or
illegal drug use, or had difficulties in participating in some parts of the study were
excluded.
Participants were randomised to one of three groups:
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1. Intervention (interdisciplinary intervention with individualised dietary
advice)
2. Intervention + walnut (interdisciplinary intervention with individualised
dietary advice plus a supplement of 30 grams of walnuts per day)
3. Control (usual care/ general advice)
Dietary advice in both intervention groups was provided in an individualised manner
according to the targeted requirements and usual food habits of the participants. A
number of food choices were prescribed from the food groups defined in the
Australian Guide to Healthy Eating [140]. This Guide was also used for the controls
but advice was given in a general manner. In the intervention + walnut group, walnut
supplementation was integrated into diets so as not to provide extra energy but to
increase the specificity of the intervention to consume healthy food. The control
group received general advice on food choices that enabled them to adjust their usual
food patterns to the dietary guidelines [140]. The HealthTrack study was registered
with the Australian and New Zealand Clinical Trial Registry (ANZCTRN
12614000581662) (Appendix A) and was approved by the University of
Wollongong/Illawarra Shoalhaven Local Health District Human Research Ethics
Committee (HE13/189) (Appendix B) including the current analysis in this thesis.
All participants provided their informed written consent before participating in the
study.
In the HealthTrack study, blood pressure was assessed as a secondary outcome.
Details on blood pressure assessment in the trial and the assessment of sodium and
potassium dietary intake are discussed in subsequent sections of this chapter.
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Screening surveys sent out to those
interested in participating in the study
n=718

Surveys completed
n=620

First pass eligible
n=459

First pass ineligible
n=161

Withdrew n=19:
n=16 time constraints
n=3 personal reasons

Baseline assessment
n=440

Eligible
n=434

Reason for
ineligibility:
n=2 high BMI
n=2 nut allergy
n=1 nut aversion
n=1 other medical

Ineligible
n=6

Withdrew n=57:
n=30 time constraints
n= 24 didn’t
complete pathology
tests
n=2 unhappy with
GP clearance
n=1 moved away

Randomised
n=377

Intervention + walnut
n=126

Intervention
n=125

Figure 2.1 Flowchart of the HealthTrack study recruitment
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Reason for
ineligibility:
n=83 high BMI
n=24 partner in study
n=12 low BMI
n=11 previous study
n=10 GP clearance
not received
n=10 other medical
n=5 gastric banding
n=3 sleep apnea
n=2 out of area
n=1 age >54 years

Control
n=126

2.3 Dietary intake measurements

Dietary assessment was conducted as a central method in the HealthTrack study.
Nutritional epidemiology has progressed over the past years with major
contributions to various nutrition-related health problems. Accurate measurement of
exposure variables especially diet can however be challenging. As highlighted in
Chapter 1, diet can be complex since it is composed of different components and is
consumed in different amounts in varying combinations [141].
Different methods are used in nutritional epidemiology for the assessment of dietary
intake. These tools include 24-hour dietary recalls, food frequency questionnaires,
diet histories, and food records or food diaries. The choice of dietary assessment tool
depends on the research design, hypothesis, objectives, study population and
resources that are available [142]. Diet histories and food records were utilised in the
collection of dietary data that was analysed and reported in this thesis and thus will
be discussed in details.
2.3.1 Diet histories
Diet histories were utilised in the HealthTrack study for the assessment of dietary
intake. Diet histories are an assessment method that involves a detailed account of an
individual’s usual dietary intake collected through an in-depth interview with a
trained personnel such as a dietitian or nutritionist [142]. Detailed information is
collected from the participant such as amounts of food and drinks consumed at every
meal, frequency, preparation methods, and may also include a frequency checklist to
assist in probing for forgotten items [143]. Advantages of diet histories include the
detailed assessment of food consumption for a relatively longer period including
meal patterns [143]. However, diet histories have limitations including the fact that
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they require trained personnel to administer them and enter the data. They rely on the
respondents’ memory and may be influenced by recall bias. In addition, participants
may tend to underestimate energy, fat, saturated fat and sodium [144]. More details
on the appropriateness of diet histories in measuring sodium intake will be discussed
in the sections below on measurement of sodium and potassium intake.
2.3.2 Food records
Food records or dietary records were also utilised in the HealthTrack study. Food
records involves the participants recording all the foods and drinks consumed for
specified number of consecutive days usually 3-7 days including at least one
weekend day [143]. However, validity of recording decreases beyond four
consecutive days since reported intake reduces due to participants’ fatigue [143]. To
measure the amount of food and drinks consumed, weighing scales or household
items such as cups and spoons are used. Advantages of food records include the fact
that they reduce participant’s reliance on memory since data is collected at the time
of food intake, though the respondents may require being highly motivated due to
the burden that is passed on to them [142]. For conversion to nutrient estimates, the
information from food records is entered into nutrient analysis software programs
which can be time consuming and requires trained personnel [145]. A limitation of
food records is that they are usually focussed on short-term food intake and may not
be ideal to investigate chronic diseases which require long-term dietary exposure
[142]. To overcome this, multiple food records at different time points may be
utilised.
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2.3.3 Dietary data collection in the HealthTrack study

In the HealthTrack study, the 4-day food records were recorded over four
consecutive days, including one weekend day. Participants were instructed by trained
health practitioners to record all foods and drinks consumed including amounts and
recipes. Quantities of food intakes were determined using common household
measures such as cups and spoons that were provided. Information on dietary
supplement use was not collected. The records were reviewed for completeness by
nutrition trained personnel upon return. In addition, Accredited Practising Dietitians
assessed participants’ dietary intake through a self-reported diet history interview
[146]. Dietary data were entered into the FoodWorks nutrient analysis software
program (Xyris software, FoodWorks. 2012: Brisbane, Australia).
2.4 Food composition database

In order to be able to convert food intake data to nutrients, food composition
databases are required. In Australia, the Food Standards Australia New Zealand
(FSANZ) creates and publishes food and nutrient databases for use by researchers,
food manufacturers and by consumers [147]. Two published databases developed by
FSANZ include the reference database, NUTrient TABles for use in Australia
(NUTTAB), and the survey specific database, AUStralian Food and NUTrient
Database (AUSNUT), which contains complete nutrient information for all foods.
For this thesis, dietary data was originally analysed using AUSNUT 2007 [148],
which was the most recent survey-specific food composition database available at
the time of data collection. Due to the subsequent release of AUSNUT 2011-13
[149], dietary data was categorized according to the AUSNUT 2011-13 food groups.
A matching file was created to convert the data from AUSNUT 2007 foods to
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AUSNUT 2011-13 equivalents using a systematic process which has been published
[150].
2.5 Measurement of sodium and potassium intake

Sodium and potassium dietary intake was assessed in the HealthTrack study. The
dietary intake can be estimated from dietary intake data. However, studies have
shown that individuals tend to under-report and over-report sodium and potassium
respectively [151] and the estimates are also subject to recall and recording bias
[143]. Furthermore, patients with hypertension have been found to underestimate
their sodium intake through dietary recall by 30% to 50% [152]. In addition, dietary
assessment methods may not take into account discretionary salt or other sources of
sodium such as antacids or sodium containing supplements and medications [153]. A
more reliable biomarker of sodium and potassium intake is 24-hour urine excretion
since about 90% of the sodium or potassium consumed is excreted in the urine [154].
However, a complete 24-hour sample has to be collected to avoid bias of results due
to under- or over collection. Due to the day to day variability in sodium excretion,
repeated 24-hour collections are the gold standard but may not be practical as they
are labour intensive for participants [154].
To ensure accurate urine collection, detailed verbal and written instructions can be
provided to participants, and research personnel can supervise the beginning and end
of the collection period [155]. Post collection, various methods can be used for
ascertaining completeness such as the use of para-aminobenzoic acid (PABA) and
urinary creatinine excretion. In the use of PABA, the participant is required to
consume one tablet of 80 mg PABA three times a day with meals during the
collection period [156]. About 93% of PABA is excreted in urine with completeness
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assumed in samples containing above 85% of recovered PABA [157]. Since the
timing and subject’s age can affect urine excretion [157], an improved method with a
high performance liquid chromatography has replaced the calorimetric method
allowing the effect of different drugs such as paracetamol to be reduced [158]. In
cases where PABA recovery is between 50% and 85%, linear regression equations
have been suggested in order to adjust for urinary sodium and potassium [156].
Another method of ascertaining completeness of 24-hour urine samples is use of
urinary creatinine excretion. Creatinine excretion models based on an individual’s
age, sex, weight, and protein intake have been developed, though with low
sensitivity, to detect incomplete 24-hour sample collections [159]. Two equations
that have been developed include Joosen’s equation [160] which considers an
individual’s sex only and Mage’s equation which accounts for age, sex, weight,
height and BMI [161]. Other strategies that can be used to ascertain completeness
include low urine volume collections, whereby samples with a total volume of less
than 500 mL and/or creatinine levels less than 6.0 mmol/d in volumes less than 1000
mL are deemed as incomplete [162]. The use of a single 24-hour urinary sample may
however be considered a limitation because of the large day-to-day variability. As a
result, greater accuracy of sodium and potassium habitual intake would be obtained
from repeated 24-hour urinary collections [163].
In the HealthTrack study, sodium and potassium intake was ascertained via a single
24-hour urine excretion obtained at various time points. Detailed instructions were
provided whereby participants discarded the first urine of the day and collected the
rest over the 24 hours in standard plastic containers that were provided. The
collected samples were delivered to Southern IML pathology and were stored upon
receipt at 2-8 degrees. The total volume of urine was measured and recorded.
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Sodium and potassium concentrations were determined by indirect ion-specific
electrodes whilst the creatinine concentration was determined using the Jaffe
reaction colorimetric method [164]. Samples that had a total volume of less than 500
ml and/or creatinine levels less than 6.0 mmol/d, in volumes less than 1,000 ml were
excluded as they were classified as incomplete [162].
2.6 Dietary patterns analysis

In dietary pattern analysis, two different approaches are commonly used to derive
specific dietary patterns; a priori or hypothesis-oriented approaches, for example diet
quality scores; and exploratory or posteriori methods that derive dietary patterns
from the data at hand, such as principal component analysis (PCA), exploratory
factor analysis, or cluster analysis [165]. In this thesis, PCA was utilised to derive
dietary patterns since it had been previously demonstrated that the PCA method can
reveal dietary patterns associated with blood pressure in clinical cohorts participating
in weight loss trials [166]. As a result, the PCA method will be discussed here
including its strengths and limitations.
PCA utilises available dietary data and reduces it into smaller interrelated
components (principal components) such as sets of foods or food groups, therefore
revealing interrelationships between food components and the dietary habits of a
given population [167] [168]. Limitations of PCA include the subjective nature of
some of the crucial decisions such as the variables to include, the number of factors
to extract, the rotation method and description of the components extracted [169].
However, the use of eigenvalues and examination of the scree plots are helpful in
determining the best number of components to extract.
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2.7 Blood pressure measurement

Appropriate diagnosis and treatment of blood pressure depends on accurate
measurement, using devices that undergo regular calibration and maintenance, and
minimization of human errors such as use of inappropriate cuff and incorrect cuff
positioning, lack of appropriate rest period prior to taking the measurement, low
concentration, digital bias and lack of repeated measurements [170]. Measuring
blood pressure in a clinical setting may be challenging due to the ‘white coat
syndrome’ - which refers to blood pressure becoming more elevated than usual in the
presence of medical personnel [171]. However, use of automated blood pressure
measurement instead of manual office blood pressure in primary care setting has
been shown to reduce the ‘white coat effect’ in hypertensive patients [172].
Moreover, the use of 30-minute office blood pressure measurement, whereby the
patient is left alone in a room for thirty minutes and the readings are taken
automatically, was shown to further reduce the ‘white coat effect’ compared to the
standard office blood pressure measurement [173]. This may however be challenging
to implement in daily primary care practice since additional rooms and more time
may be required.
Out of office blood pressure measurement, which includes home blood pressure
monitoring and ambulatory blood pressure monitoring is recommended as a more
accurate method of measuring blood pressure due to the larger number of readings
taken to calculate the average blood pressure [174]. In addition, out of office blood
pressure is better at detecting masked hypertension, which refers to a lower blood
pressure reading observed in the health care environment [174].
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In the HealthTrack study, office SBP and DBP were measured using automatic blood
pressure monitor (OMRON BP-203RPE III, OMRON Health Care Co. Ltd, Kyoto,
Japan). A test blood pressure reading was taken after participants had rested in the
supine position for 5 minutes and a confirmatory reading was taken 10 seconds after
the first which was the reading used for the analysis. All blood pressure
measurements were performed by trained health practitioners.
2.8 Anthropometric and physical activity measurements

Anthropometric measurements enable assessment of important variables that are
used to describe participants’ characteristics. In the Healthtrack study,
anthropometric measurements were conducted by trained health practitioners.
Lightly clad body weight was measured on digital scales [Tanita scales, Tanita
Corporation, Tokyo, Japan, UM0703581(1)] to the closest 0.1 kg and percent body
fat via bioelectrical impedance recorded to the closest 0.1 %. Height was measured
using a wall-mounted stadiometer rounded to the nearest millimetre in accordance
with the established anthropometric protocols [175]. Widest part of hip and
narrowest waist circumference were measured in accordance with the reported
acceptable protocols [175]. BMI was calculated as body weight in kilograms divided
by the square of the height in metres.
The International Physical Activity Questionnaire (IPAQ) was used to assess
physical activity through the survey’s short form questions [176]. IPAQ was deemed
appropriate in measuring physical activity due to its acceptable reliability and
validity in both developed and developing countries, especially in urban population.
However, its application is limited to middle-aged adults (18 to 65 years) and not
adolescents or older adults [176].
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This chapter has established the methods utilised in this thesis to address the various
research questions/ hypotheses of the thesis. A systematic review and meta-analysis
was carried out in Chapter 3 to assess the current level of evidence on the
relationship between dietary patterns and blood pressure. Measurement of 24-hour
urinary sodium and potassium excretion was used in Chapter 4 and dietary pattern
analysis was utilised to identify dietary patterns associated with blood pressure in
Chapter 5. In each chapter, further details of the specific application of methods used
in the specific studies will be provided.
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CHAPTER 3 - DIETARY PATTERNS AND BLOOD PRESSURE IN
ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF
RANDOMISED CONTROLLED TRIALS
The majority of this chapter is the substantative content of the published work:
Ndanuko, R.N., Tapsell, L. C., Charlton, K. E., Neale, E. P., Batterham, M. J., Dietary
patterns and blood pressure in adults: A systematic review and meta-analysis of randomized
controlled trials. Advances In Nutrition. 2016;7:76-89; doi:10.3945/an.115.009753.
The findings of this section were also presented in an oral presentation:
Ndanuko R, Tapsell L & Charlton K (2015). Identifying the effects of dietary patterns on
blood pressure: A systematic review. Dietitians Association of Australia, National
Conference, Perth, Australia, Nutrition & Dietetics; 72(S1): p32.

Pages 83-100 removed for copyright reasons. Please refer to citation:
Ndanuko, RN, Tapsell, LC, Charlton, KE, Neale, EP, & Batterham,
MJ 2016, 'Dietary Patterns and Blood Pressure in Adults: A
Systematic Review and Meta-Analysis of Randomized Controlled
Trials', Advances in Nutrition, vol. 7, no. 1, pp. 76-89. Available from:
10.3945/an.115.009753
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CHAPTER 4 – THE RELATIONSHIP BETWEEN SODIUM AND
POTASSIUM INTAKE AND BLOOD PRESSURE IN A SAMPLE OF
OVERWEIGHT ADULTS
The majority of this chapter is the substantative content of the published work:
Ndanuko, R.N., Tapsell, L. C., Charlton, K. E., Neale, E. P., O’Donnell, K. M., Batterham,
M. J. Relationship between sodium and potassium intake and blood pressure in a sample of
overweight adults. Nutrition. 2017;33:285-290: doi: 10.1016/j.nut.2016.07.011.
The findings of this section were also presented in poster presentations:
Ndanuko, R.N., Tapsell, L. C., Charlton, E. K., Neale, E. P., Batterham, M. J. Association
between urinary sodium intake, sodium-to-potassium ratio and blood pressure in adults.
Nutrition Society of Australia. Annual Scientific Meeting, Wellington, New Zealand. 1st-4th
December 2015.
Ndanuko R., Tapsell L, Charlton K & Neale E (2016). Diet history and food records as
predictors to urinary sodium, urinary potassium and blood pressure. Dietitians Association
of Australia National Conference, Melbourne, Australia. Nutrition & Dietetics; 73(S1):p80.
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4.1 Introduction

As discussed in Chapter 1, from a preventive health perspective, lifestyle changes
such as reducing dietary sodium, following a healthy diet such as the Dietary
Approaches to Stop Hypertension diet and engaging in regular physical activity have
been recommended to lower blood pressure [10]. Evidence supporting dietary
approaches is provided in meta-analyses that have assessed the effect of sodium and
potassium intake on blood pressure [45] [55]. In addition, the ratio of sodium to
potassium may better reflect desirable food choices for lowering blood pressure
across various geographical regions and cultures [64] but food patterns that reflect an
optimal ratio have not been adequately identified.
Despite the recommendations by the World Health Organization for a population
sodium intake of 2000 mg of sodium and 3510 mg of potassium per day [54] and
Suggested Dietary Target of 1600 mg of sodium for chronic disease prevention
recommendations by NHMRC [69] excessive sodium consumption and low
potassium intakes have been previously reported [209]. Food sources of sodium may
vary according to the dietary habits of different cultures. In the INTERMAP study,
major food sources of sodium included bread, grains and cereals in the United States
and United Kingdom; added salt in China; and soy sauce, processed fish/ seafood
and salted soups in Japan [210].
In the previous chapter, the association between dietary patterns and blood pressure
in the published research has been examined. There is need to explore relationships
between sodium and potassium intake with blood pressure in a clinical sample.
There are few studies examining the relationship between sodium and potassium
intakes and blood pressure specifically in clinical overweight populations, whereby
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exposing the details of dietary-blood pressure relationships may be informative for
primary healthcare practice. The aim of this study was to examine the association
between sodium and potassium intakes and blood pressure at baseline in a sample of
overweight and obese adults volunteering for a weight loss trial. To address issues of
translating dietary advice to practice, sodium and potassium intake is reported, as
well as major food sources of these nutrients, in the context of the clinical trial.
4.2 Methods

This chapter utilised baseline data from the 12-month HealthTrack randomised
controlled trial. The baseline data was utilised in order to assess the relationship
between sodium and potassium intake and blood pressure, consequently leading to
analysis of change in nutrients and foods and relationship with blood pressure after 3
months in Chapter 6. The HealthTrack study has been discussed in detail in Chapter
2. Sodium and potassium excretion was estimated from the 24-hour urine. Dietary
intake was assessed using 4-day food records (including one weekend day).
Participants recorded all foods and drinks consumed including amounts and recipes.
In addition, dietary intake was assessed using a self-reported diet history interview
administered by accredited practising dietitians. For this analysis, the primary
outcomes were SBP and DBP.
4.2.1 Statistical analysis
For this secondary analysis of the Healthtrack data, statistical analysis was
performed using the Statistical Package for the Social Sciences (IBM Corp., SPSS
for Windows Version 21. 2012: New York, USA). Normality testing was conducted
using Shapiro-Wilk test and data was log transformed where possible. For sodium
and potassium intake, medians were used as they are less influenced by extreme
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values and skewness compared to means. The number and percentage of participants
meeting the recommended amounts according to various guidelines was calculated.
The percentage contribution of sodium and potassium by AUSNUT 2011-13 major
food groups was also determined. Multiple linear regression was used to assess the
relationship between urinary sodium and potassium and dietary intake assessed via
4-day food records and via diet histories.
Spearman’s rank order correlation was performed to assess the relationship between
urinary sodium and potassium excretion and sodium-to-potassium ratio with blood
pressure. Stepwise forward multiple linear regression was performed to assess
prediction of blood pressure by sodium intake, potassium intake and sodium-topotassium ratio and prediction of urinary sodium and potassium by dietary sodium
and potassium. Covariates that were controlled for include age, sex, BMI and
antihypertensive medication. Initial analysis to ensure no violations of the
assumptions of normality, linearity, multicollinearity and homoscedasticity were
conducted. Data are expressed as mean (standard deviation) unless otherwise stated
and as a percentage for the food group contribution of sodium and potassium. Data
was considered statistically significant when P<0.05.
4.3 Results
4.3.1 Baseline characteristics
A total of 377 participants, predominantly Australian born (82%), were randomised
to the HealthTrack study. For the present analysis we included data from 328
participants who had complete dietary data, blood pressure data and 24-hour urine
collections at baseline. The main characteristics of the participants are reported in
Table 4.1. 26% of the participants (n=85) were hypertensive and of this n=46 were
taking antihypertensive medication. Participants were diagnosed as hypertensive if
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blood pressure was ≥140/90 mm Hg and/or taking antihypertensives. Median urinary
sodium concentrations indicated that dietary intakes were above the recommended
targets set by the NHMRC [69] and World Health Organization [54]. Table 4.2
illustrates the number of participants who were compliant with the NHMRC and
World Health Organization guidelines for sodium and potassium intake.
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Table 4.1 Baseline characteristics of the analysis sample (n=328)
Characteristic

Mean (SD)1

Male/ female, % (n)

27/73 (89/239)

Age, years

43.6 (8.0)

BMI, kg/m2

32.4 (4.2)

Blood pressure
Systolic, mmHg

124.9 (14.5)

Diastolic, mmHg

73.3 (9.9)

Urinary excretion
Creatinine, mmol/day

8.2 (4.5)

Median sodium, mg/day, (IQR)2

3197 (2282-4140)

Median potassium, mg/day, (IQR)

2886 (2223-3549)

Median sodium-to-potassium ratio, (IQR)

1.9 (1.5-2.4)

Median salt intake, g/day (IQR)

8.2 (5.9-10.6)

Dietary intake (4-d food records)
Median energy, kcal/day, (IQR)

2088 (1745-2500)

Median sodium, mg/day, (IQR)

2682 (2084-3439)

Median potassium, mg/day, (IQR)

3124 (2680-3825)

Medium calcium, mg/day, (IQR)

915 (695-1139)

Medium magnesium, mg/day, (IQR)

370 (304-473)

1

Data are presented as mean (standard deviation), unless otherwise stated; 2IQR,

Interquartile range.
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Table 4.2 Number (%) meeting sodium and potassium urinary excretion targets
defined in NHMRC and WHO guidelines
Target value1

Number (%)

24-h sodium excretion
≤6 g salt/day (2300 mg Na/day)a

86 (26.2)

≤5 g salt/day (2000 mg Na/day)b

50 (15.2)

≤4 g salt/day (1600 mg Na/day)c

14 (4.3)

24-h potassium excretion
≥ 97 mmol/day, men (n = 89)e

32 (36.0)

≥ 72 mmol/day, women (n = 239)f

111 (46.4)

≥ 90 mmol/dayb

90 (27.4)

1

Data presented for n = 328 unless otherwise stated; NHMRC, National Health and

Medical Research Council; WHO, World Health Organization. aNHMRC upper
level; bWHO population target; cNHMRC suggested dietary target; eNHMRC target
for men; fNHMRC target for women.
4.3.2 Food group contributions to total dietary sodium and potassium intake
Percentage contributions of sodium and potassium by the AUSNUT 2011-13 major
food groups from the 4-day food records data were determined (Appendix G).
Overall, cereal based products and dishes; cereal and cereal products; meat, poultry
and game products and dishes; and milk products and dishes were the major
contributors for dietary sodium. On the other hand, vegetable products and dishes;
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meat, poultry and game products and dishes; and milk products and dishes were the
major contributors for dietary potassium intake.
4.3.3 Prediction of urinary sodium and potassium by dietary intake
A multiple linear regression model established that reported dietary sodium via the
4-day food records significantly predicted urinary sodium excretion adjusted for
energy and BMI. The overall model was significant, F (21.8, 3df) P < 0.01
accounting for 16.0% of the explained variability in urinary sodium (Figure 4.1).
Dietary sodium was a significant predictor, B = 0.334, t = 4.032, P <0.01. Likewise,
the overall model for predicting urinary potassium from dietary potassium adjusted
for energy and BMI was significant, F (29.1, 3df), p < 0.01 accounting for 20.5% of
the explained variability in urinary potassium (Figure 4.2). Dietary potassium was a
significant predictor, B = 0.67, t = 8.537, P < 0.01. In both sodium and potassium
analysis, there was no evidence of multicollinearity and the residual diagnostics
indicated the models were a good fit. Dietary intake assessed via 4-day food records
showed a stronger relationship with urinary sodium and potassium compared to diet
histories (data not shown).
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Figure 4.1 Relationship between dietary sodium and urinary sodium excretion. The
solid line represents the regression best of line of fit while the dotted lines indicate
the 95% confidence limits for mean predicted values.
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Figure 4.2 Relationship between dietary potassium and urinary potassium excretion.
The solid line represents the regression best of line of fit while the dotted lines
indicate the 95% confidence limits for mean predicted values.
4.3.4 Relationship between sodium, potassium and sodium-potassium-ratio and
blood pressure
Urinary sodium was positively correlated with SBP (r = 0.176, P = 0.001) and DBP
(r = 0.150, P = 0.003). Sodium-to-potassium ratio was positively correlated with
SBP (r = 0.1, P = 0.035). In multiple linear stepwise regression, urinary sodium [(F
(4,323) = 20.381, P < 0.0005; adjusted R2 = 0.231)] and sodium-to-potassium ratio
[(F (4,323) = 25.008, P < 0.0005; adjusted R2 = 0.227)] were identified as significant
predictors of SBP after controlling for age, sex, BMI and hypertension medication
use. Likewise, dietary potassium was a significant predictor of DBP [(F (4,323) =
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28.059, P < 0.0005; adjusted R2 = 0.249)] (Table 4.3). No statistically significant
associations were observed between urinary potassium and SBP, urinary sodium and
sodium-to-potassium ratio and DBP, dietary sodium and dietary potassium and SBP,
and dietary sodium and DBP.
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Table 4.3 Stepwise regression analyses using SBP and DBP as the dependent
variables and age, sex, BMI, urinary sodium, dietary potassium and Na:K ratio as
independent variables
B1

SE B

Standardized B

P value

Age

0.002

0.0003

0.367

<0.001

BMI

0.003

0.001

0.242

<0.001

Urinary sodium

0.037

0.014

0.118

0.02

Na:K ratio

0.033

0.014

0.118

0.02

Age

0.003

0.0004

0.358

<0.001

Sex

-0.031

0.006

-0.232

<0.001

BMI

0.003

0.001

0.230

<0.001

Dietary potassium

-0.051

0.024

-0.104

0.035

Variable
SBP:

DBP:

1

Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; Na:K,

sodium-to-potassium ratio; SBP, systolic blood pressure; B, β standardized
coefficient. Only statistically significant variables are shown; variables excluded
include urinary potassium and dietary sodium.
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4.4 Discussion

This secondary analysis of baseline data from a weight loss clinical trial confirmed
that the relationship between dietary sodium intake and sodium-to-potassium ratio as
analysed using the 24h sodium excretion, and SBP can be observed within an
overweight clinical sample. In addition, age and BMI significantly predicted SBP,
while age, sex and BMI significantly predicted DBP. Dietary potassium as measured
using food records was also significantly associated with DBP. There was a marked
difference between urinary and dietary sodium and potassium intakes. It has been
shown that there is a tendency for subjects with a higher BMI to under-report their
dietary sodium intake and over-report dietary potassium intake [151]. Moreover, the
discrepancy between estimations of reported dietary intake and urinary excretion of
sodium in our sample may be an indication of discretionary salt intake.
This study focused on a clinical obese population that was participating in a weight
loss trial. About 26% of the participants were hypertensive with more than half
taking anti-hypertensive medication. Lifestyle interventions such as consuming a
healthy diet (such as the DASH diet and reduced sodium intake), weight loss and
regular physical activity, are some of the strategies recommended for blood pressure
management [10]. In the present study, we observed a significant association
between sodium intake, sodium-to-potassium ratio and SBP. This is in line with
findings from a previous Australian study whereby sodium intake (3567 mg/d) and
sodium-to-potassium ratio (1.99) were both positively associated with SBP [211]
though the sample population was older (mean age: 64 y) and less overweight (mean
BMI: 28 kg/m2) in comparison to our relatively young study population. Although
dietary potassium was significantly associated with DBP in the present study, no
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association was found with urinary potassium. The higher dietary potassium could
have been due to over-reporting of fruit and vegetable intake which has been
observed in epidemiological studies [212]. In this study, the sodium-to-potassium
ratio (1.9) exceeded the World Health Organization recommendation of a sodium-topotassium molar ratio of 1:1 [65]. A recent review demonstrated that in various
randomised controlled trials the sodium-to-potassium ratio had a stronger association
with BP than sodium or potassium alone [63]. In the development of hypertension,
excessive sodium and insufficient potassium intake are both shown to play a role
since they result in vascular smooth muscle cell contraction which leads to increased
peripheral vascular resistance thus causing high BP [62].
The major food sources of sodium that were identified in this study included cerealbased products and dishes; cereal and cereal products; meat, poultry and game
products and dishes; and milk products and dishes. These four food groups provided
more than 60% of the total sodium intake. This is comparable to the recent 20112012 population based cross-sectional Australian Health Survey (AHS) which found
that cereal-based products and dishes (25%), cereal and cereal products (18%) and
meat and poultry (18%) were the major sources of sodium [213]. Similar results
have been found in other studies in Finland [162] and South Africa [214]. In
contrast, sources of sodium may vary in other countries depending on the major
foods consumed and cultural context. For instance, in Japan, most of the dietary
sodium is derived from soy sauce, salted soups, processed fish/ seafood and
preserved vegetables [210]. While meal patterns and their sodium contribution to the
total daily intake were not analysed, a previous Australian study found that lunch had
the highest sodium density compared to dinner and breakfast [215]. This study did
not assess the use of discretionary salt, but in low and low-middle income countries,
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this has been found to be a significant source of sodium which may account for up to
76% of total intake in China [210]. Commercially processed foods are a major
source of sodium in most high income countries. In Australia, 54% of processed
food products have been reported to exceed maximum sodium level voluntary targets
recommended by the UK Food Standards Agency (FSA) [216]. Similarly, in the US
more than half of the commercially packaged food products exceed maximum upper
limits recommended by the Food and Drug Administration [217].
There are a limited number of studies that have assessed food sources of potassium.
In this study, vegetable products and dishes; meat, poultry and game products and
dishes; and milk products and dishes were identified as major contributors,
accounting for half of total potassium intake. These results are similar to the
nationally representative Australian Health Survey whereby vegetable products and
dishes accounted for 17.5% of total potassium intake [213].
Nutrient intakes, including sodium and potassium, are contributed from
combinations of food groups that are consumed within the context of dietary patterns
and cuisines. In a recent meta-analysis as described in Chapter 3, it was
demonstrated that consumption of diets that are rich in fruit, vegetables, wholegrains,
legumes, seeds, nuts, fish and dairy, and that are low in meat, sweets and alcohol,
significantly lowered SBP and DBP by 4.26 mm Hg and 2.38 mm Hg, respectively
[218]. In addition, specific dietary patterns that are related to blood pressure in
another clinical trial datasets were identified in an entirely different population of
obese adults attending for weight loss. Dietary patterns that included larger amounts
of fruits & nuts and/or seafood were associated with lower blood pressure at
baseline, while patterns that were characterised by yeast extract & seasonings were
associated with higher blood pressure [166]. Hence, diets that are high in potassium
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and low in sodium are shown to be beneficial in lowering blood pressure in clinical
populations.
While large cohort studies have provided in principle evidence of the relationship
between dietary sodium and potassium with blood pressure [219], the current
analysis of data from a clinical trial provides a novel confirmation that the
relationship between dietary sodium and SBP can still be observed in a relatively
small sample of an at risk group. Importantly, the analysis identifies the food sources
of sodium and potassium that would form the basis of dietary counselling in these
settings.
The major strength of this study includes the use of 24-hour urine excretion to
estimate sodium and potassium intake given the recognised problems with
underreporting and over-reporting of sodium and potassium respectively [151].
Dietary assessment remains important as it assists in identifying food sources of
sodium and potassium which may be useful in making recommendations in health
education [154]. A limitation of this study is that the dataset was not large enough to
group participants according to their level of sodium and potassium intake, though
the number of participants meeting the sodium and potassium targets is reported.
4.5 Conclusions
This study has confirmed that the relationship between dietary sodium and sodiumto-potassium ratio and SBP can be observed in a clinical sample of overweight
adults. In addition, dietary potassium as measured through food records was
associated with DBP. While much of the evidence for this relationship is translated
into population health messages, the analysis suggests there is good reason to
translate this advice to clinical practice for patient groups such as overweight adults.
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Importantly, the identification of food sources of sodium and potassium in the usual
diet enables a direct pathway to practice, with food based dietary advice specifically
targeting changes for improved blood pressure regulation.
In addition to individual nutrients, consideration of the combinations of foods which
can influence blood pressure in the context of a clinical sample is required. The
association between dietary patterns and blood pressure in the HealthTrack study
clinical sample will be investigated in the next chapter, utilising dietary pattern
analysis methodology discussed in Chapter 2.
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CHAPTER 5 – ASSOCIATIONS BETWEEN DIETARY PATTERNS AND
BLOOD PRESSURE IN A CLINICAL SAMPLE OF OVERWEIGHT
ADULTS
The majority of this chapter is the substantative content of the published work:
Ndanuko, R.N., Tapsell, L. C., Charlton, K. E., Neale, E. P., Batterham, M. J. Associations
between dietary patterns and blood pressure in a clinical sample of overweight adults.
Journal of Academy of Nutrition and Dietetics. 2017;117:228-239:
doi:10.1016/j.jand.2016.07.019.
The findings of this section were also presented in poster presentations:
Ndanuko, R.N., Tapsell, L. C., Charlton, E. K., Neale, E. P., Batterham, M. J. Dietary
patterns associated with blood pressure in a clinical sample of overweight adults
volunteering for a weight loss trial. International Congress of Dietetics, Granada, Spain. 7th –
9th September 2016.
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5.1 Introduction

As discussed in Chapter 1, research on dietary management of hypertension has
mainly focussed on single nutrients such as sodium and potassium or single foods.
Also highlighted previously is the fact that diets are complex and may result in
multiple nutrient interactions thus making it difficult to isolate the role of individual
foods or nutrients in relation to specific health and disease outcomes [103].
Inconsistencies in the findings for single foods, and possible differences in
population sub-groups suggest a need for more research to better understand dietblood pressure associations, particularly in at risk groups such as obese and
overweight adults.
Dietary pattern analysis has been recommended in nutritional epidemiology as an
additional method to better understand relationships between diet and chronic
diseases [104]. Various beneficial dietary patterns for blood pressure regulation as
identified in Chapter 3 include the DASH diet [24], the Nordic diet [108] and the
Mediterranean diet [113]. These dietary patterns are characterized by a diet that is
high in fruit and vegetables, whole grains, legumes, seeds and nuts, fish and dairy
and has a low consumption of meat and sweets and moderate alcohol intake. In
dietary pattern analysis, two different approaches are commonly used to derive
specific dietary patterns; a priori or hypothesis-oriented approaches, for example diet
quality scores; and exploratory or posteriori methods that derive dietary patterns
from the data at hand, such as principal component analysis, exploratory factor
analysis, or cluster analysis [165].
Previously, the principal component analysis method has been demonstrated that it
can reveal dietary patterns associated with blood pressure in clinical cohorts
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participating in weight loss trials [166]. In these food based dietary trials, significant
associations were found between blood pressure and dietary patterns, namely those
characterised by fruit and nuts (inversely associated with SBP), seafood (inversely
associated with DBP), or a yeast extract and seasonings (positively associated with
both SBP and DBP). These results need to be confirmed by further studies in broader
lifestyle interventions with at risk populations to add to the evidence base. The aim
of this study was to examine the association between dietary patterns and blood
pressure in a sample of overweight adults volunteering for a lifestyle intervention
trial targeting weight loss. A secondary aim was to identify the association between
dietary patterns and 24-hour sodium and potassium excretion.
5.2 Methods

The current study is an analysis of baseline data from the 12-month HealthTrack
randomised controlled trial which has been described in detail in Chapter 2.
Estimation of sodium and potassium excretion was done through 24-hour urine.
Dietary intake was estimated via 4-day food records taken over 4 consecutive days,
including 1 weekend day.
5.2.1 Statistical analysis
To derive dietary patterns, principal component analysis was performed based on
consumption of the 24 AUSNUT 2011-13 major food groups (grams/day) estimated
from the 4-day food records data. The suitability of principal component analysis
was assessed prior to analysis. Sampling adequacy was supported by a KaiserMeyer-Olkin (KMO) measure of 0.55 and Bartlett’s test of sphericity < 0.0005,
indicating that the data was likely factorizable. Inspection of the Anti-image
Matrices was performed in order to determine the food groups to retain for principal
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component analysis. To determine the number of components to retain, eigenvalues
> 1.0 were considered along with examination of the Scree Plot [220]. To simplify
the structure and improve interpretability, an orthogonal (varimax) rotation was
applied. Calculation of the factor scores for each component was performed using
the regression method. Food groups with positive loadings signify direct relationship
with that pattern while those with negative loadings indicate an inverse relationship.
Multiple regression analysis was performed to assess the association between the
extracted dietary patterns and blood pressure, controlling for age, sex, BMI, blood
pressure medication, energy intake and physical activity in the model. As alcohol
intake was collected in the four day food records and included in the principal
component analysis as a food group, it was not included as a covariate in the
analysis. Similarly due to the low number of smokers in the sample (4%), smoking
was also not included as a covariate. The difference in macronutrient and
micronutrient intakes between individuals adhering or not adhering with specific
dietary patterns was analysed using independent t-test. Chi square test was
performed to determine the association between the dietary patterns and
hypertension status. All statistical analyses were performed using the Statistical
Package for the Social Sciences (Version 21, 2012, IBM Corp. New York, USA).
Statistical significance was considered at P < 0.05.
5.3 Results

5.3.1 Baseline characteristics
A total of 377 participants were randomised to the HealthTrack study. For the
present analysis, data was included from 328 participants (89 men and 239 women)
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who had complete dietary intake, blood pressure and 24-hour urine collections data.
The main characteristics of the participants are presented in Chapter 4, Table 4.1.
5.3.2 Dietary pattern analysis
Due to a lack of participants consuming foods from the AUSNUT 2011-13
categories labelled Infant formulae and foods, Reptiles, amphibia and insects, and
Dietary supplements, these food groups were excluded, leaving n = 21 AUSNUT
2011-13 food groups categorized for this analysis (Appendix H).
Six principal components (dietary patterns) were derived, explaining 46% of the total
variance (Appendix I). Food groups with factor loadings of more than 0.4 were
considered as significant contributors to the dietary pattern. The “nuts, seeds, fruit
and fish” dietary pattern was characterized by the consumption of seeds/nuts, fruit,
fish and seafood products, and confectionery (including cereal/nut/fruit/seed bars);
“milk and meat” dietary pattern by consumption of non-alcoholic beverages, milk
products and dishes, and meat, poultry and game products and dishes; “breads,
cereals and snacks”, dietary pattern by intake of cereal based products and dishes,
confectionery and snack foods; “cereal based products, fats and oils” dietary pattern
by intake of cereals and cereal products, fats and oils; “alcohol, eggs and legumes”
dietary pattern by consumption of alcoholic beverages, eggs products and dishes, and
legumes; and “savoury sauces, condiments and meat” dietary pattern by intake of
savoury sauces and condiments and meat.
After adjusting for age, sex, BMI, hypertension medication, physical activity and
energy intake, multiple linear regression found the “nuts, seeds, fruit and fish”
dietary pattern was significantly and inversely associated with SBP (F (7,320) =
15.248, P < 0.0005; adjusted R2 = 0.234), DBP (F (7,320) = 17.351, P < 0.0005;
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adjusted R2 = 0.259) and sodium-to-potassium ratio (F (7,320) = 6.210, P < 0.0005;
adjusted R2 = 0.100). On the other hand, the association between SBP and DBP with
the other dietary patterns was not significant. The “alcohol, eggs and legumes” and
“savoury sauces, condiments and meat” dietary patterns were significantly and
positively associated with sodium excretion while the, “milk and meat”, and “breads,
cereals and snacks” dietary patterns were significantly and positively associated with
potassium excretion. The “savoury sauces, condiments and meat” dietary pattern was
significantly and positively associated with urinary sodium-to-potassium ratio (Table
5.1).
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Table 5.1 Regression coefficients (confidence intervals) showing associations between the six dietary patterns with blood pressure,
urinary sodium, urinary potassium and sodium-to-potassium ratio among participants of the HealthTrack study (n=328)
Nuts, seeds, fruit

Milk and meat

and fish

Breads, cereals

Cereal based

Alcohol, eggs

Savoury sauces,

and snacks

products, fats and

and legumes

condiments and

oils
SBPb

-0.005 (-0.010, -

-0.001(-0.005, 0.004)

0.000)*
DBPc

-0.003 (-0.008,

0.003 (-0.002, 0.008)

0.002)

meat
0.005 (0.000,

0.003 (-0.002, 0.008)

0.010)
0.006 (0.000, 0.012)

0.004 (-0.002,

0.003 (-0.003, 0.009)

-0.007 (-0.013, -

-0.003 (-0.009,

0.001 (-0.005,

0.001)*

0.002)

0.007)

Urinary

-4.001 (-10.543,

1.541 (-4.767,

-4.652 (-11.418,

-0.438 (-7.175,

9.575 (3.161,

9.865 (3.485,

sodium

2.540)

7.850)

2.14)

6.300)

15.989)**

16.245)**

Urinary

2.165 (-

3.589 (0.390,

-4.960 (-8.377, -

0.297 (-3.137, 3.732) 3.269 (-0.031,

Potassium

1.169,5.499)

6.789)*

1.544)**

Sodium-to-

-0.128 (-0.215, -

-0.076 (-0.161,

0.057 (-0.035,

potassium

0.040)**

0.010)

0.149)

0.010)

-0.903 (-4.199, 2.393)

6.570)
0.014 (-0.077, 0.106) 0.014 (-0.074,
0.103)

0.123 (0.036,
0.209)**

ratio

Model adjusted for age, sex, BMI, antihypertensive medication, energy intake and physical activity; bSBP, systolic blood pressure;
c

DBP, diastolic blood pressure; *P < 0.05, **P < 0.01.
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Mean energy intake between participants whose diet aligned and those not aligned
with “milk and meat”, “breads, cereals and snacks”, “cereal based products, fats and
oils”, “alcohol, eggs and legumes” and “savoury sauces, condiments and meat”
dietary patterns were significantly different (P < 0.05) (Appendix J). There was a
significant difference in percentage protein intake between participants that aligned
to the “milk and meat”, “breads, cereals and snacks”, “cereal based products, fats
and oils” and “savoury sauces, condiments and meat” dietary patterns and those not
aligned to the specific dietary patterns. Dietary sodium intake was not significantly
different in participants aligned with “nuts, seeds, fruit and fish” dietary pattern
compared to those not aligned with this pattern. Dietary potassium between
participants whose diets aligned and those not aligned to all the dietary patterns was
significantly different (P < 0.05). There was no association between hypertension
status and whether participants were aligned or not aligned with a dietary pattern in
all patterns identified (P > 0.05) (data not shown).
5.4 Discussion

Findings from this study reveal dietary patterns associated with blood pressure in a
defined clinical cohort. In this study, a dietary pattern characterised by a high intake
of nuts and seeds, fruit, and fish was inversely associated with both SBP and DBP.
Whilst this pattern also included confectionery items but as that also meant muesli
bars and snack bars, some of which contain seeds and nuts, the inclusion was not
considered noteworthy. This combination of foods provides nutrients and food
components that have been shown to be protective for blood pressure such as
potassium [55], magnesium [74], polyphenols [221], and long chain omega-3 fatty
acids [222]. The pattern is consistent with a previous analysis from a different
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clinical cohort that found dietary patterns characterised by fruit and nuts or by
seafood were inversely associated with SBP and DBP, respectively [166]. The larger
sample size in the study reported here (n=328 vs n=118) may account for the
stronger ability to cluster all these foods and to show associations with both SBP and
DBP. In addition, the present study included younger participants (mean age = 43.6
vs 45.1 years) that had higher BMI (32.4 vs 31.2 kg/m2) compared to the previous
cohort and also did not exclude participants with diabetes and chronic disease risk
factors such as elevated LDL (low density lipoproteins) and low HDL (high density
lipoproteins) cholesterol.
The association between dietary patterns and blood pressure has been investigated in
large population-based cohort studies in different countries. In middle-aged Chinese
men, a dietary pattern characterized by fruits and milk was inversely associated with
SBP and DBP (P < 0.001) [223]. In the Netherlands, a “cosmopolitan” dietary
pattern that was high in vegetables and vegetable oil, pasta, rice, fish, chicken and
wine was significantly associated with lower SBP while a “traditional” dietary
pattern that was higher in intake of red meat, coffee, potatoes, beer and high
saturated added fat and low in fruit, tea, breakfast cereals and low-fat dairy was
associated with higher SBP in adults aged 20-65 years [224]. Likewise, in Japan, a
high intake of the “vegetable” pattern in women was significantly associated with
lower SBP and DBP [225]. There is however a paucity of data on the association
between dietary patterns and blood pressure in clinical populations.
The dietary patterns inversely associated with blood pressure emphasise plant based
foods. Plant-based diets that include consumption of fruit, vegetables, nuts, and
whole grains have been associated with lower risk of cardiovascular disease [226]. In
the Framingham Study, an inverse association was observed between fruit and
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vegetable intake and development of stoke in middle-aged men after 20 years of
follow-up [227]. Likewise, consumption of nuts was significantly inversely
associated with hypertension (RR: 0.66; 95% CI: 0.44, 1.00; P = 0.049) in a recent
meta-analysis of four prospective studies [87]. Dietary patterns such as the DASH
diet [24], the Mediterranean diet [113] and the Nordic diet [115] have been shown to
reduce blood pressure. In addition, a dietary pattern that was rich in fruits,
vegetables, wholegrains, legumes, nuts, seeds, dairy and fish and low in processed
foods and red meat was shown to reduce blood pressure in Chapter 3. In the current
study, a diet that was high in nuts, seeds, fruit and fish was associated with lower
blood pressure and therefore these findings are consistent with previous research.
In the analysis reported here, there was no significant difference between the
reported dietary sodium intakes in participants who aligned and those not aligned
with the “nuts, seeds, fruit and fish” dietary pattern which was significantly
associated with blood pressure. However, the “nuts, seeds, fruit and fish” and the
“savoury sauces, condiments and meat” dietary patterns were associated with the
urinary sodium-to-potassium ratio. Previous studies have reported a positive
correlation between sodium-to-potassium ratio and high blood pressure [228] with
the ratio showing a stronger association with blood pressure compared to sodium or
potassium alone [229]. Many blood pressure-lowering intervention studies focus on
reduction of dietary sodium, with or without an increase in potassium intake [207]
[230]. This approach may not be useful for translation of dietary advice into practice,
where consideration of the whole of diet within the context of the population cuisine
appears to be more important.
There are a number of potential synergistic mechanisms at play between sodium and
potassium that could explain the findings of this study as outlined in Chapter 1. In
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addition, other dietary constituents and diets that have been found to improve
endothelial function include polyunsaturated fats [231], polyphenols [232], dealcoholized red wine [233] and the Mediterranean diet [234]. Vegetables are a rich
source of nitric oxide [235] and ingestion of dietary nitrate load has been shown to
reduce blood pressure in acute studies [236]. This highlights that blood pressure
regulation may be achieved via a combination of various dietary constituents present
in different foods.
A major strength of this study is the use of 24-hour urinary sodium and potassium
excretion which is considered as the “gold standard” [154] to assess dietary sodium
and potassium intake, given that under-reporting of energy intake has been shown to
occur in overweight and obese participants [237]. This is therefore a novel approach
in dietary patterns research as it allows for the evaluation of the relationship between
dietary patterns and urinary sodium, potassium and sodium-to-potassium ratio.
There are limitations to this study including the subjective nature of the PCA method
to extract dietary components. Some subjective but crucial decisions include the
number of factors to extract and description of the components for each of the
dietary patterns identified. However, the use of eigenvalues and examination of the
scree plots guided determination of the best number of components to extract. The
food grouping classifications used were done a priori by Australian Bureau of
Statistics and Food Standards Australia and New Zealand to group similar foods
together and to examine trends in food consumption and not necessarily to
investigate food-health relationships. However, these groupings have been designed
to classify similar foods together in order to reflect the current food supply in
Australia, thus warranting their use in this study. Information on the use of dietary
supplements was not collected in this study and this could be a potential study
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limitation. The use of discretionary salt was included in the 4-day food records
although it has been shown to be poorly reported [154].
5.5 Conclusions

This analysis demonstrated that for participants in a weight loss clinical trial,
consumption of a dietary pattern rich in nuts, seeds, fruit and fish was inversely
associated with blood pressure and with urinary sodium-to-potassium ratio. Other
dietary patterns shown to be associated with either urinary sodium or potassium
excretion or sodium-to-potassium ratio were not predictive of blood pressure. In
clinical weight loss settings, these findings could be integrated with other wellstudied dietary patterns that have been shown to reduce blood pressure such as the
DASH diet, the Nordic diet and the Mediterranean diet for blood pressure regulation.
The findings also align with current dietary guidelines and highlight the importance
of considering the whole dietary pattern when exploring the diet-disease relationship.
As highlighted in this and previous chapters, it is important to consider the role of
nutrients, foods and dietary patterns in blood pressure management. While the role of
nutrients is well established, nutrients are consumed in foods, and in different food
combinations or dietary patterns. The types of foods that individuals consume can be
influenced by various interventions in clinical care settings. In the following chapter,
the effect of individualised dietary advice in the context of a randomised clinical trial
will be explored. The change in nutrients and food intake and dietary patterns after 3
months will be investigated.
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CHAPTER 6 – MORE SPECIFIC DIETARY ADVICE FOR WEIGHT LOSS
SUPPLEMENTED WITH WALNUTS PRODUCED GREATER
REDUCTIONS IN BLOOD PRESSURE THAN GENERAL ADVICE
The majority of this chapter is the substantative content of the published work:
Ndanuko, R.N., Tapsell, L. C., Charlton, K. E., Neale, E. P., Batterham, M. J. Effect of
individualised dietary advice for weight loss supplemented with walnuts on blood pressure:
The HealthTrack study. European Journal of Clinical Nutrition. (under review).
The findings of this chapter have also been presented as conference poster presentations:
Ndanuko, R.N., Tapsell, L. C., Charlton, E. K., Neale, E. P. Changes in blood pressure,
urinary sodium and sodium-to-potassium ratio in a clinical sample of overweight adults.
Nutrition Society of Australia. Annual Scientific Meeting, Melbourne, Australia. 29th
November – 2nd December 2016.
Ndanuko, R.N., Tapsell, L. C., Charlton, E. K., Neale, E. P., Batterham, M. J. Effect of
specific dietary advice on change in blood pressure, dietary patterns, food and nutrients in
the HealthTrack study. Australian Society for Medical Research. NSW scientific meeting,
Sydney, Australia. 2nd June 2017.
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6.1 Introduction

As discussed in Chapter 1, dietary trials for blood pressure-lowering have primarily
focused on interventions that result in reductions in sodium intake, either with or
without a concomitant increase in potassium intake [45] [81]. However, Chapters 3
and 4 of this thesis have identified dietary patterns that influence blood pressure,
especially in the context of a clinical sample of overweight adults.
Given that weight loss itself helps to reduce blood pressure [238], adding knowledge
of healthful food patterns over and above the benefits of energy restriction alone may
be beneficial in managing obesity and its related disorders such as hypertension. The
relationship between obesity and hypertension is well established [239]. As a result,
weight loss is recommended as a strategy to lower blood pressure in overweight and
obese individuals [71]. An average of 5 kg weight loss resulted in blood pressure
reduction of 4.4 mm Hg and 3.6 mm Hg in SBP and DBP respectively in a metaanalysis of 25 randomised controlled trials [238].
While weight loss is dependent on total food intake, investigations into the effects of
individual foods on blood pressure have been conducted through randomised clinical
trials and observational studies as discussed in Chapter 1. Research that focuses on
individual nutrients or single foods may not consider the complexity of the
interactions between nutrients and foods and their relationship with disease outcomes
[103]. In nutritional epidemiology, research on dietary patterns may present a
broader view of the impact of nutrient and food intakes and enable a better
understanding of the association between diet and chronic disease risk [104]. Given
that improved dietary choices is a goal of dietary advice in practice, the aim of this
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study was to examine the impact of more specific dietary advice, on blood pressure
during a weight loss trial.
6.2 Methods

The current study is a secondary analysis using baseline and 3 month data from the
12 month HealthTrack randomised controlled trial. The 3 months data was utilised
since this was the intensive period of the trial. The HealthTrack study has been
discussed in detail in Chapter 3. Participants were randomised to one of three groups:
intervention [(I) (interdisciplinary intervention with individualised dietary advice],
intervention + walnut [(IW) (interdisciplinary intervention with individualised
dietary advice plus a supplement of 30 grams of walnuts per day], or control [(C)
(usual care].
For the analysis in this chapter, dietary intake data from self-reported diet history
interviews was utilised. Specifically, intakes of the AUSNUT 2011-13 major food
groups seed and nut products and dishes, fruit products and dishes, and seafood
products and dishes were determined. These food groups were selected as they were
significantly associated with blood pressure in a previous baseline analysis in this
sample in Chapter 5. For the analysis reported here, SBP and DBP were the
outcomes of interest.
6.2.1 Statistical analysis
In this secondary analysis of the HealthTrack study data, baseline characteristics
were presented as means and standard deviation for normally distributed data and
median and interquartile range for data that was not normally distributed. To assess
differences between study groups at baseline, one-way analysis of variance was
conducted for normally distributed data such as age, height, weight, BMI and waist
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circumference. Kruskal-Wallis H test was conducted for data that was not normally
distributed such as dietary intake, and urinary excretion. A chi square test was
performed to compare difference in the proportion of participants with hypertension
(participants were categorised as hypertensive if blood pressure was ≥140/90 mm Hg
and/or taking antihypertensives) between study groups. To determine change from
baseline to 3 months in blood pressure, urinary excretion and intake of key food
groups (seed and nut products and dishes, fruit products and dishes, and seafood
products and dishes), the Wilcoxon signed-rank test was used to assess the
difference between baseline and 3 months in each study group. The Kruskal-Wallis
H test was used to determine the difference between groups at each time point, and
significant results were explored via post-hoc Mann Whitney U tests with Bonferroni
adjustment. These analyses were repeated after excluding participants who were
taking diuretics at baseline and/ or 3 months, as diuretics have been shown to
increase sodium and potassium excretion [240]. Multiple linear regression was
performed to assess the association between change in blood pressure from baseline
and (1) change in urinary excretion and (2) consumption of key food groups, while
controlling for age, sex, blood pressure medication, weight loss, change in physical
activity, and smoking. All analyses were performed in accordance with an as-treated
analysis approach. Statistical analysis was performed using the Statistical Package
for the Social Sciences (IBM Corp., SPSS for Windows Version 21, Armonk, New
York, USA). Significance level was considered at P value <0.05.
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6.3 Results

6.3.1 Baseline characteristics
A total of 377 participants were randomised to one of the 3 groups; intervention +
walnut (IW), intervention (I) or control (C). For this study, data were analysed from
211 participants (60 men and 151 women) who had complete blood pressure, urinary
excretion data and dietary intake data at baseline and 3 months. Appendix K shows
the baseline characteristics of the 3 groups.
6.3.2 Change from baseline to 3 months
SBP reduced significantly in all the three groups from baseline to 3 months (P <
0.001 in IW and I groups, P = 0.002 in C group). The greatest reduction in SBP was
observed in the IW group (Appendix L). The change in SBP was significantly
greater in the IW and I groups compared to the control group (P = 0.022 and P =
0.041, respectively). There was no significant difference in change in SBP between
IW and I groups (P = 0.692). DBP significantly reduced in both IW and I groups (P
< 0.001). The decrease in urinary sodium excretion was larger in the IW and C group
compared to the I group (P = 0.007 and P = 0.018 respectively). The decrease in
urinary sodium-to-potassium ratio was larger in the IW group compared to the I
group (P = 0.012). At 3 months there was greater consumption of seed and nut
products and dishes by the IW group compared to the I group (P < 0.001), and C
group (P = 0.024). From baseline to 3 months the IW group increased intakes of seed
and nut products and dishes more than the I group (P < 0.001) and the C group (P <
0.001). Intake of fruit products and dishes also increased from baseline to 3 months
in both the IW (P < 0.001) and I (P = 0.005) groups. Results were similar when
participants on diuretics were excluded from the analysis (data not shown).
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In multiple linear regression, an increase in urinary potassium and decrease in
urinary sodium-to-potassium ratio was significantly associated with SBP reduction
in the IW group (Appendix M). On the other hand, a reduction in urinary sodium
was significantly associated with a reduction in DBP in the C group. In the IW
group, an increase in the consumption of seed and nut products and dishes was
significantly associated with a reduction in SBP while increased intake of seafood
products and dishes was significantly associated with decreased DBP. The results
did not change after excluding participants who were taking diuretics at baseline and
3 months (data not shown).
6.4 Discussion

This secondary analysis of data from a weight loss trial provided further insights into
the impact of changes in dietary patterns, foods and nutrients on blood pressure.
Dietary patterns [24], key foods such as nuts [88] and dietary levels of nutrients such
as sodium [45] and potassium [81] can all affect blood pressure, but these effects are
also inter-related [40]. The present analysis showed that highly specified dietary
advice, strengthened by a daily supplement of a healthy food (30 g walnuts) resulted
in a greater reduction in SBP than general advice referencing the dietary guidelines.
The effect was supported by a greater decrease in urinary sodium-to-potassium ratio,
a parameter associated with lower blood pressure [63]. After adjusting for weight
loss, the study found the decrease in sodium-to-potassium ratio and concomitant
increase in intakes of the “nuts and seeds” and “seafood” food categories were
significantly associated with blood pressure reduction, confirming the effect of diet
composition.
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The first observation was a greater significant reduction in sodium-to-potassium ratio
in the IW group compared to the other groups. Diets with a lower sodium-topotassium ratio have been negatively associated with hypertension in
epidemiological studies [219] and have been found to reduce blood pressure in
randomised controlled trials [200]. Sodium and potassium play an interdependent
role in affecting blood pressure, whereby consumption of excessive sodium and
insufficient potassium cause the vascular smooth muscle cell to contract and as a
result lead to an increase in the peripheral vascular resistance which increases blood
pressure [62].
The results of the current study build on the analysis from Chapter 5 that identified
an inverse association between blood pressure and a dietary pattern that was rich in
“nuts, seeds, fruit and fish”. In addition, significant inverse associations between
SBP and dietary patterns characterized by fruit and nuts, and between DBP and
dietary patterns characterized by seafood were found in previously conducted
analyses of food-based dietary trials [166]. Previously reported randomised
controlled trials show beneficial effects of walnut consumption on blood pressure. In
a 2-year study investigating the effect of a Mediterranean-style diet on endothelial
function and inflammation markers in 180 patients with metabolic syndrome, a
Mediterranean-style diet that included consumption of 25-50 g of walnuts per day
significantly reduced SBP by 3 mm Hg and DBP by 2 mm Hg compared to a control
prudent diet [114]. Likewise, in the PREDIMED study, the group following a
Mediterranean diet which contained a daily supplement of 30 g mixed nuts including
15 g of walnuts showed greater reductions in ambulatory SBP and DBP (-2.4 mm Hg
and -1.0 mm Hg respectively) after one year compared to the control diet [206]. In a
recent meta-analysis of 21 randomised controlled trials, total nut consumption was
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shown to lower SBP by 1.29 mm Hg in participants without type 2 diabetes [88].
Nuts contain high amounts of mono- and polyunsaturated fats, magnesium,
potassium and fibre and are low in sodium and saturated fats and thus may elicit a
blood pressure lowering response [86]. Consumption of nuts may also be associated
with improved diet quality [241] which in turn may lead to adoption of healthier
dietary patterns.
In this study, we found that an increase in seafood consumption was associated with
a decrease in DBP in the IW group. The effect of fish consumption on blood pressure
has also been assessed in previous studies. For example, moderate consumption of
fatty fish (150 g of salmon three times per week) led to greater reductions in DBP in
an 8 week weight-loss study compared to lean fish, fish oil capsules or placebo
capsules [242]. While various studies have shown a blood pressure lowering effect
through supplementation with omega-3 polyunsaturated fatty acids [243], conclusive
evidence on the effect of dietary fish intake on blood pressure is lacking. This is
possibly due to other factors that may attenuate the protective effects such as the
method of preparation, consumption of salted fish or presence of other contaminants
such as mercury and pesticides [244].
Compared to individual foods, however, dietary pattern analysis may better
demonstrate diet- blood pressure relationships since foods are not consumed in
isolation but as part of a total diet. In addition, the concept of food synergy proposes
that investigation of patterns of food consumption may be more informative than
focussing on individual food components such as nutrients or single foods [39]. This
study has demonstrated that under weight-loss conditions, an increase in nuts, seeds
and seafood was associated with reductions in blood pressure. Further investigations
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are warranted on the effect of change in dietary patterns on change in BP especially
in different cultural contexts and cuisines.
6.5 Conclusions

This secondary analysis from a weight-loss trial found greater reductions in SBP for
the group provided with individualised dietary advice supplemented with walnuts
and this was associated with increased intake of seeds and nuts, and seafood, and
reduced Na and sodium-to-potassium excretion. Identification of a dietary pattern
that includes these foods could be helpful in the development of food based dietary
recommendations in clinical practice that not only address weight loss but also blood
pressure.
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CHAPTER 7 – CONCLUSIONS AND RECOMMENDATIONS
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In the context of a lifestyle intervention trial targeting weight loss, this thesis has
confirmed the central hypothesis that dietary patterns characterised in terms of
nutrients and foods significantly influence blood pressure in adults, as confirmed by
associations at baseline and changes in the proposed direction with dietary
intervention in a clinical setting.
7.1 Introduction

While much of the diet-blood pressure research has been conducted in larger
populations, the implications for dietetic practice in smaller clinical cohorts are not
known. In addition, people are more likely to present for dietetic management for
conditions such as weight loss rather than blood pressure alone [245]. This thesis
addressed the question of how dietary factors might influence blood pressure in the
context of an overweight adult clinical population by providing novel evidence for
the relationship between consumption of nutrients, foods, and dietary patterns, and
blood pressure in this setting. The results from the analyses conducted in this thesis
have implications for clinical practice, where dietary advice is a central strategy.
Furthermore, it is important to investigate dietary interventions in a pragmatic way
because patients with high blood pressure present with other risk factors for chronic
disease such as obesity, unhealthy diet, physical inactivity and risky alcohol
consumption [16]. In terms of total cardiovascular disease risk, the absolute
cardiovascular disease risk scores used by general practitioners in primary care
setting assist in the management of multiple individual risk factors [17]. The
modifiable risk factors that are considered include blood pressure, diet, smoking,
physical activity level, alcohol consumption, lipids, waist circumference and BMI.
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Blood pressure control is therefore seen in the context of total cardiovascular disease
risk.
7.2 Diet and blood pressure

As highlighted in Chapter 1, the problem of high blood pressure (hypertension) is of
major public health concern globally [7] and is a major risk factor for developing
cardiovascular disease, stroke and kidney disease [5]. Lowering blood pressure
would therefore result in numerous health benefits such as reduced risk of stroke,
coronary heart disease and cardiovascular events [21] [22]. Previously, research to
address the problem of high blood pressure has mainly focussed on the nutrient level
specifically on dietary intake of sodium (high intake associated with increased blood
pressure) [45] and potassium (high intake associated with lower blood pressure) [55]
[56]. In addition, the sodium-to-potassium ratio has been implicated in influencing
blood pressure [63] [64] as opposed to sodium and potassium alone. However, from
a translation perspective, it is well known that humans do not consume single
nutrients in isolation, but rather as whole foods. Additionally, as sodium and
potassium come from distinct foods, the ratio may be a reflection of certain food
choices or dietary patterns. Investigations on the effect of single foods on blood
pressure have nevertheless yielded conflicting results. Moreover, single foods go to
make up whole diets or dietary patterns. As these dietary patterns may also be
characterised by nutrient composition, the ability to truly separate out effects of
nutrients, foods and whole diets remain problematic [40] [41]. Indeed, an
understanding of the interdependence between nutrients, foods and dietary patterns is
required to translate dietary advice in clinical practice especially in food-based
recommendations for blood pressure reduction.
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In the sections ahead, the effect of nutrients, foods and dietary patterns on blood
pressure are outlined with respect to the results obtained from this thesis and
implications for clinical practice will be highlighted.
7.3 Current level of evidence on dietary patterns and blood pressure

To evaluate the current level of evidence on the effect of dietary patterns on blood
pressure, the thesis began with a systematic review and meta-analysis of randomised
controlled trials. This published analysis found that a dietary pattern characterised by
high consumption of fruit, vegetables, whole grains, legumes, seeds, nuts, fish and
low-fat dairy and low consumption of meat, sweets and alcohol resulted in
significant reductions in SBP by 4.26 mm Hg and DBP by 2.38 mm Hg compared to
comparator or usual diet.
This was the first systematic review and meta-analysis to examine the effect of
dietary patterns on blood pressure in adults. The magnitude of blood pressure
reduction is of clinical significance. For instance, reducing DBP in the population by
2.0 mm Hg would result in reduction of stroke by 17% and reduction in the risk of
coronary heart disease decrease by 6% [246]. In addition, lowering SBP and DBP by
5.0 and 3.0 mm Hg respectively has been shown to result in a 15% reduction in the
incidence of coronary heart disease and 27% reduction in stroke incidence [24].
Whether this would still relate to a clinical sample of overweight adults is an
important question for practice which was addressed in subsequent secondary
analysis of clinical trial data from a 12 month lifestyle intervention trial (the
HealthTrack study).
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7.4 Sodium and potassium intake and blood pressure

The first stage in the analysis of the trial data started with the nutrient aspects of the
diet-blood pressure relationship. The results confirmed that the relationship between
sodium intake and sodium-to-potassium ratio and blood pressure seen in large
epidemiological studies can still be present in smaller clinical samples of overweight
adults. Among the sample from the HealthTrack study, only 15% and 27% of the
participants were meeting the World Health Organization recommended targets for
sodium and potassium intakes, respectively, based on urinary sodium and potassium
excretion values [54]. This data was established using the ‘gold standard’ biomarker
of intake of the 24-hour urine excretion.
The baseline results clearly showed that majority of the participants had high sodium
and low potassium dietary intakes, reflective of the general Australian population
[211]. The dietary sodium-to-potassium ratio was shown to be positively correlated
with SBP while both urinary sodium and sodium-to-potassium ratio were identified
as significant predictors of SBP after controlling for age, sex, BMI and hypertension
medication use. Again, this may reflect certain food choices or dietary patterns.
Establishing the types of foods or dietary patterns consumed by this clinical sample
would enable appropriate food based dietary advice especially within the context of
clinical practice.
7.5 Food sources of sodium and potassium

Identification of food sources of sodium and potassium then enabled translation from
the nutrient level of understanding to that of foods. This is important since it allows
food based dietary recommendations to be implemented in clinical practice. The
major food sources of sodium that were identified were cereal based products and
143

dishes; cereal and cereal products; meat, poultry and game products and dishes; and
milk products and dishes. On the other hand, vegetable products and dishes; meat,
poultry and game products and dishes; and milk products and dishes were the major
contributors for dietary potassium intake. Thus, while relationships could be seen
with nutrient intakes, the consumption of specific foods was also implicated in this
relationship.
The results were comparable to results from the recent Australian Health Survey
[213] as well as with results from other countries with similar food supply and
hypertension prevalence such as the United States [247] and Finland [162]. Various
plant-based foods have been shown to influence blood pressure due to their high
potassium content. These foods include fruits and vegetables [77] [75], nuts [87] and
pulses [92]. For example, in the PREDIMED randomised controlled trial,
supplementation of the Mediterranean diet with mixed nuts or olive oil was shown to
significantly reduce blood pressure in comparison to a low-fat diet [113]. When
analysing data from the HealthTrack study, the research in this thesis confirmed the
influence of food supplementation reported in other research [248].
7.6 Dietary patterns and blood pressure

The regular consumption of specific foods constitutes a dietary pattern, so dietary
patterns drove the next level of analysis for the thesis. This analysis of data from the
HealthTrack study investigated the association between dietary patterns and blood
pressure. Six dietary patterns were derived using the principal component analysis
from 21 food groups. These include; the “nuts, seeds, fruit and fish”; “milk and
meat”; “breads, cereals and snacks”; “cereal based products, fats and oils”; “alcohol,
eggs and legumes”; and “savoury sauces, condiments and meat” dietary patterns.
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Multiple regression analysis showed that a dietary pattern characterised by nuts,
seeds, fruit and fish was significantly and inversely associated with SBP and sodiumto-potassium ratio. In addition, there was no difference in mean energy intake
between participants whose diet aligned with the nuts, seeds, fruit and fish pattern
and those not aligned with this pattern. Thus a dietary pattern that is dominated by
specific foods: nuts, seeds, fruit and fish appeared protective. These foods are
naturally low in sodium and the plant foods are all high in potassium. In addition,
these foods have been associated with reduced blood pressure in previous
randomised controlled trials [88] [166] and prospective studies [77] [87]. In the
“nuts, seeds, fruit and fish” dietary pattern, the aspect of food synergy – whereby the
combination of nutrients provided through different food matrices may have greater
benefits compared to individual nutrients in individual foods themselves, seems to
play a role in its protective nature [39].
It is important to determine the effect of change in consumption of nutrients, foods
and dietary patterns over time especially in clinical populations undergoing lifestyle
intervention. Furthermore, interventions are higher level of evidence than
observational (baseline analyses) studies. As a result, this led to the second stage in
the analysis of the HealthTrack trial data. After 3 months it was found that
participants who received individualised dietary advice that was strengthened by a
daily supplement of a heathy food, (30 g walnuts) had greater reduction in SBP than
those receiving generalized advice that referenced the Australian dietary guidelines.
In addition, the effect was supported by a greater decrease in urinary sodium-topotassium ratio, a biological parameter associated with lower blood pressure [63].
This clearly shows that in addition to the effects seen with nutrients, reductions in
blood pressure can also be seen with consumption of whole foods. After adjusting
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for weight loss, an increase in intakes of the seed and nut products and dishes and
seafood products and dishes food categories were significantly associated with blood
pressure reduction, confirming the effect of diet composition, namely combination of
different foods which forms dietary patterns. These greater effects on blood pressure
were observed in participants receiving specific individualised dietary advice as
opposed to those receiving general advice based on dietary guidelines and it
highlights the importance of such advice being offered in clinical practice to
overweight patients with high blood pressure. On the other hand, no significant
associations were observed between change in intakes of fruit products and dishes or
seafood products and dishes and blood pressure.
7.7 Limitations of this thesis

The major limitations in this thesis relate to the secondary analysis of HealthTrack
study data. Firstly, the HealthTrack study being a randomised controlled trial testing
the effects of forms of intervention on weight loss, there is a likelihood the analysis
would be underpowered, particularly in relation to the analysis of changes in dietary
patterns which carry a high degree of variability. The participants were an
overweight clinical population from a regional area of New South Wales, Australia,
who had volunteered to participate in the 12-month weight loss trial. The results may
therefore not be generalizable to the wider adult population. In addition, the study
participants were about 70% female. It has been shown that females are more likely
to seek primary care services compared to males especially in the age group between
20 and 44 years [249].
In terms of dietary intake, participants may have under-reported dietary sodium
intake and over-reported dietary potassium intake, especially since it has been shown
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to occur in individuals with higher BMI [151]. However, a strength of the study was
the assessment of sodium and potassium intake by the gold standard of 24-hour urine
excretion [154], with completeness of urine samples being determined by the use of
urinary creatinine concentrations. However due to the large day-to-day variability of
sodium and potassium intake, repeated 24-hour urinary collections would have
provided greater accuracy [163].
In terms of potential bias, about a quarter of the participants were already
hypertensive and may have made dietary changes as a result of receiving previous
dietary advice from a health professional [250]. The use of office blood pressure is
another potential source of bias. Ambulatory blood pressure has been shown to
eliminate “white coat hypertension” and has increased precision over office blood
pressure [251]. Repeated measurements of ambulatory blood pressure provide an
even more accurate indication of usual blood pressure than a single 24-hour
measurement [206]. However, automated office blood pressure measurement is
recommended for use in primary care settings as it has been shown to be comparable
with awake ambulatory blood pressure [252], and was thus deemed appropriate in
this research context.
7.8 Conclusions

The combination of studies conducted for this thesis has confirmed the central
hypothesis that dietary patterns characterised in terms of nutrients, foods and dietary
patterns significantly influence blood pressure in adults. It was also confirmed that in
the context of clinical practice for weight loss, specific food choices and nutrient
intakes that align with beneficial dietary patterns may also assist in reducing blood
pressure. Despite this thesis utilising a secondary analysis of trial data, the results
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demonstrated that blood pressure effects can nonetheless be seen in small clinical
samples and where weight loss is the primary outcome. This has important
translational implications for the delivery of dietary advice for blood pressure
management. In clinical practice, dietary advice based on specific food choices and
attention to sodium and potassium intakes could be helpful in not only addressing
weight loss but also high blood pressure associated with being overweight. Further
trials to test this hypothesis in practice would strengthen these findings.
7.9 Future research and recommendations

Based on the findings of this thesis, the following recommendations are proposed:
1. Clinical settings:
In clinical settings, in addition to messages on salt (sodium) reduction or
increased potassium intake, providing food based dietary advice for the
management of high blood pressure would also be beneficial and especially
in patients undergoing weight loss. This includes advice on increased
consumption of foods that were found to be associated with lower blood
pressure in this thesis such as nuts, seeds, fruit and fish; and also foods
associated with a lower sodium-to-potassium ratio such as increased fruit and
vegetables. Apart from health practitioners, the management and
administration of clinical settings also needs to be aware of these data and be
champions to advocate for diet interventions in clinical settings.
2. Public health programs:
In public health programs, the messages that are provided to the population
for lowering blood pressure should not only address salt reduction but also
include food based strategies. This includes promoting consumption of
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healthy dietary patterns that consist of foods that are high in potassium such
as fruit, vegetables, nuts, seeds and legumes. In addition, consumption of
seafood should be encouraged since it was identified to be significantly
associated with reduced blood pressure.
3. Energy intake:
The energy value of food is an important factor that needs to be addressed
through dietary advice both in the public health and clinical settings, since
weight loss is one of the strategies recommended for lowering blood
pressure.
4. Healthcare service delivery and clinical level relevance:
In the healthcare setting, dietitians are the health professionals trained and
qualified to deliver nutrition education and counselling as was demonstrated
in the HealthTrack study. They play a major role in the delivery of healthcare
interventions in clinical settings. However, in primary healthcare, the first
contact for most patients with a clinician is with a general practitioner.
Ensuring general practitioners are aware of the value of dietary intervention
would therefore enable them to plan more effective nutrition management
strategies for hypertension especially in at risk populations such as
overweight individuals.
Further randomised controlled trials on the effects of dietary patterns on blood
pressure would strengthen the findings for this thesis. These can be carried out in the
context of primary health care and for a longer duration to establish the role of
nutrients, foods and dietary patterns especially in overweight populations.
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APPENDIX C
Hypertension guidelines and recommendations

Guideline

Management guidelines for different populations and BP goals
(mm Hg)

ESH/ESC, 2013 [8]

General non-elderly:


SBP 130-139 or DBP 85-89: no BP intervention



SBP ≥140 or DBP ≥90: lifestyle changes and BP drugs with
goal BP of <140/90

General elderly <80 years:


Goal BP of <150/90

General elderly >80 years:


Goal SBP of <150 if in good mental and physical condition

Diabetes:


Goal BP of <140/85

CKD and no proteinuria:


Goal BP of <140/90

CKD and proteinuria:

JNC 8, 2014 [5]

Goal BP of <130/90

General population:

197

(includes JNC 7



SBP<120 and DBP<80: Encourage lifestyle modification

recommendations



SBP 120-139 or DBP 80-89: Lifestyle changes, no

[10])

hypertensive drugs indicated


In adults aged <60 years, SBP≥ 140/90: Lifestyle changes and
initiate antihypertensive drugs with goal BP of <140/90



In adults ≥60 years, SBP≥150/90: Lifestyle changes and
initiate antihypertensive drugs with goal BP of <150/90

CKD and diabetes:

CHEP, 2015 [12]

Lifestyle changes and goal BP of <140/90

Lifestyle changes for all hypertensive individuals including:


30-40 minutes of moderate physical activity on most days of
the week



Reduce weight if overweight or obese



Reduce alcohol intake to less than 2 standard drinks per day,
not exceeding 14 and 9 standard drinks for men and women
per week respectively (1 standard drink = 13.6 g Ethanol, 44
mL of 80-proof spirits, 355 mL of 5% beer or 148 mL of 12%
wine)



Consume a diet rich in fruits, vegetables, whole grains, low
fat dairy, dietary fibre, plant protein, reduced saturated fat and
low cholesterol



Reduce sodium intake to 2000 mg/day (5.2 g salt per day)



Stress management using appropriate relaxation techniques

198

BP targets:


General population <80 years with no other risk factors: Goal
BP <140/90



General population >80 years with no other risk factors: Goal
SBP <150



Diabetes: Goal BP <130/80



Cardiovascular disease and nondiabetic CKD: Goal BP
<140/90

Abbreviations: BP, blood pressure; ESH, European Society of Hypertension; ESC,
European Society of Cardiology; CKD, chronic kidney disease; JNC, Joint National
Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood
Pressure (JNC 8); AHA, American Heart Association; ACC, American College of
cardiology; CHEP, Canadian Hypertension Education Program.
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APPENDIX D
Completed PRISMA checklist for the systematic review and meta-analysis publication (Chapter 3)
Section/topic

#

Reported
on page #

Checklist item

TITLE: Dietary patterns and blood pressure in adults: A systematic review and meta-analysis of randomized controlled trials
Title

1

Identify the report as a systematic review, meta-analysis, or both.

1

2

Provide a structured summary including, as applicable: background; objectives; data sources; study
eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results;
limitations; conclusions and implications of key findings; systematic review registration number.

2

Rationale

3

Describe the rationale for the review in the context of what is already known.

3-4

Objectives

4

Provide an explicit statement of questions being addressed with reference to participants, interventions,
comparisons, outcomes, and study design (PICOS).

5

ABSTRACT

Structured summary
INTRODUCTION

METHODS

200

Protocol and registration

5

Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available,
provide registration information including registration number.

5

Eligibility criteria

6

Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years
considered, language, publication status) used as criteria for eligibility, giving rationale.

5

Information sources

7

Describe all information sources (e.g., databases with dates of coverage, contact with study authors to
identify additional studies) in the search and date last searched.

5

Search

8

Present full electronic search strategy for at least one database, including any limits used, such that it could
be repeated.

5

Study selection

9

State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if
applicable, included in the meta-analysis).

5

Data collection process

10

Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any
processes for obtaining and confirming data from investigators.

6

Data items

11

List and define all variables for which data were sought (e.g., PICOS, funding sources) and any
assumptions and simplifications made.

5

Risk of bias in individual
studies

12

Describe methods used for assessing risk of bias of individual studies (including specification of whether
this was done at the study or outcome level), and how this information is to be used in any data synthesis.

6

Summary measures

13

State the principal summary measures (e.g., risk ratio, difference in means).

6

Synthesis of results

14

Describe the methods of handling data and combining results of studies, if done, including measures of
consistency (e.g., I2) for each meta-analysis.

6
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From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and MetaAnalyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097.
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APPENDIX E
Characteristics of the randomised controlled trials on dietary patterns and blood pressure
Author,
country,
duration

Subjects, inclusion
and exclusion
criteria

Intervention2

Control2

Nature of
intervention
(Sodium
restriction/
weight loss/
exercise)

Office or
24-h ABP

Change in
SBP, mm
Hg

Change in
DBP, mm
Hg

Sodium/
potassium
excretion

Moore et
al 1999
[187]

354 Adults

Fruit and vegetable
(F&V) diet:

Typical
American diet:

All kept
constant

24-h ABP

DASH diet:
-4.5 (-6.2, 2.8)3
P=0.0001

DASH diet:
-2.7 (-4.0, 1.4)
P=0.0001

24h urine sodium
change:

fruit~5 servings/d,
vegetables~3
servings/d, whole
grains~7
servings/d, low fat
dairy~0, nuts, seeds
and legumes~1
serving/d, snacks
and sweets~1
serving/d,
fats/oils~5
servings/d,
sodium~ 3000mg/d

fruit~2
servings/d,
vegetables~2
servings/d,
refined
grains~8
servings/d,
low fat
dairy~0,
meat~1.5
servings, nuts,
seeds,
legumes~0,
snacks and
sweets~4

Inclusion:
United
States

>22y, not taking BP1
medication,

8 wk

BP < 160/80 to 95
mm Hg , BMI<35
kg/m2

Exclusion:
Serious health
problems, conditions
that may affect
nutrient metabolism

DASH diet
-73±1499 mg

F&V diet:
-3.1 (-4.8 to
-1.4)
P=0.001

F&V diet:

F&V

-2.0 (-3.3, 0.8)
P=0.002

-232±1365 mg
Control
+142±1427 mg

24 hr potassium
change:

203

or BP
DASH diet:

servings/d,
fats/oils~6
servings/d,
sodium~
3000mg/d

DASH diet
+1500±1105 mg

fruit~5 servings/d,
vegetable~4
servings/d, whole
grains~8
servings/d, low fat
dairy~2 servings/d,
nuts, seeds and
legumes~1
serving/d, snacks
and sweets~1
serving/d, reduced
fat/oils~3
servings/d,
sodium~ 3000mg/d
Sacks et
al. 2001
[105]

United
States

412 adults

DASH diet with

Inclusion:

3 sodium amounts
for both
intervention and
control:

>22yrs

F&V
+1298±1104 mg
Control
+146 ±608 mg

Typical
American diet

Sodium
restriction

Office BP

High
sodium:

High
sodium:

-5.9 (-8.0, 3.7)

-2.9 (4.3, 1.5)
P<0.001)

High Na level

Intermediat
e sodium:

Intermediate Na
level

P<0.001

24hr urine sodium:

~142 mmol/d

BP 120-159/
80-95 mmHg

High:
Intermediat
150 mmol/d
204

90 days

(3500mg Na)

e sodium:

Exclusion:

Intermediate:

heart disease,

100 mmol/d (2300
mg Na)

-5.0 (-7.6, 2.5)
P<0.001

-2.5 (-4.1, 0.8) P<0.01

~105 mmol/d

Low Na level

renal disease,

~65 mmol/d
Low:

poorly controlled
diabetes or
hyperlipidaemia,

Low
sodium:

50 mmol/d (1150
mg Na)

-2.2 (-4.4, 0.1)

insulin dependent
diabetes mellitus,

P<0.05
special dietary
requirements,
>14 alcoholic
drinks/week,
use of antihypertensives or
other medication
affecting BP
Appel et
al. 2003

810 Adults

Established
behavioural
intervention:

[122]
Inclusion:
>25 years
United

weight loss,
reduced sodium
intake ~
2300mg/day,

Advised on
factors
affecting BP
such as
weight,
sodium
reduction,

Weight loss,
exercise,
sodium
restriction

Office BP

Established
vs advice:

Established
vs advice

Established vs
advice:

-3.7

1.7

(-5.3, -2.1)

(-2.8, -0.6)

Significant change
in Na excretion
after 6 months.
-11mEq/24h

205

States

BMI 18.5-45.0
Kg/m2

6 mo
BP 120-159/ 80-95
mmHg

Not on BP
medication

Exclusion:

increased exercise,
limited alcohol
intake, no goal for
fruit, vegetable or
dairy

Established plus
DASH diet:

physical
activity and
DASH diet.

(P<0.001

P=0.002

(P=0.01)

Established plus

-4.3

Established
plus DASH
vs advice

(-5.9, -2.8)

-2.6

advice:

P<0.001

(-3.7, -1.5)
P<0.001

Sign change in K
excretion

Established
plus DASH
vs advice

No behaviour
change
counselling

Above goals plus
fruit and vegetables
~9-12 servings/d,
low fat dairy ~2-3
servings/d

+20.6mEq/24h
(P<0.001)

Diabetes, drugs that
affect BP, weight
loss medication,
prior cardiovascular
disease event,
congestive heart
failure, angina,
cancer in the past 2
years, >21 alcoholic
drinks/week,
pregnancy/ lactation
Blumenth
al et al.
2010

144 Adults

DASH vs

Established plus
DASH vs
Established:
K excretion
+18.4mEq/24h
(P<0.001)

DASH diet alone
(DASH-A) and
DASH diet plus
weight

Usual care
(Typical
American diet)

Weight loss,
exercise

206

Office BP
and 24-h
ABP

DASHWM vs
usual care

DASHWM vs
usual care

Urinary sodium
excretion:

[123]

Inclusion:

management

>35 years, BMI 2540 kg/m2

(DASH-WM)

-no exercise
recommended

-12.7±4.54

-6.1±2.2

DASH-WM

P<0.001

P<0.001

114 mmol/L (95%
CI: 97,130)

DASH-A
vs usual
care

DASH-A
vs usual
care

United
States
Both interventions:
BP 130-159/85-99
mmHg,

-DASH diet

4 months
not on BP
medication,
sedentary

-reduced total
fat~27%

-7.8±4.5
P<0.001

-3.7±2.4

DASH-A
125 mmol/L (95%
CI: 108,142)

P<0.001
-saturated fat~6%
Control
-protein ~18%

Exclusion:

-high fibre

Diabetes, CKD,
serious medical
condition, use of
medications that
would affect

-Na
2400mg/d/2000Kca
l

cardiovascular
disease system

DASHWM vs
DASH-A

DASHWM vs
DASH-A

145 mmol/l (95%
CI: 129,161)

-4.9±4.3
-2.4±2.4
P=0.02
P<0.048

Change in both
interventions vs
control: P=0.01

DASH-WM
-500 calories less

Urinary potassium
excretion:

-exercise sessions 3
times /week

DASH-WM
71.1mmol/L (95%
CI: 64,79)
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DASH-A
74.9 mmol/L (95%
CI: 67,83)

Control
52.9 mmol/l (95%
CI: 46,60)

Change in both
interventions vs
control: P=0.001
Svetkey
et al.
2009

574 Adults

[41]

Inclusion:
≥25 years

United
States

6 months

Receiving primary
care from
participating
physicians,
hypertensive and on

Physician
intervention (MDI):

Physician
control (MDC)

On-line training
modules on
management of BP

Usual care

Patient intervention
(PI):

Patient control
(PC):

weight loss, DASH
diet, increased

usual care ~
written

Weight loss,
exercise,
sodium
restriction
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Office BP

MDI/PI

MDI/PI

-9.7±12.7
P=0.0006
compared
to MDI/PC

-5.4 ±4.6
P<0.05
compared
to MDI/PC

No significant
differences between
groups in the
urinary sodium and
potassium excretion

BP medications

Exclusion:
Chronic kidney
disease,

physical activity,
reduced sodium
intake, moderate
alcohol intake,
adherence to BP
medication

materials on
lifestyle
modification
according to
guidelines

Intervention:

Usual care:
salt reduction,
BP control

cardiovascular
disease event last 6
months, pregnant,
lactating
Lima et
al. 2013
[106]

206 Adults

Inclusion:
Brazil

>20 years, BP>140/
>90 mmHg,

6 months

all on BP medication

Exclusion:
Diabetes, chronic
renal disease, cancer,
pregnancy

Low glycaemic
index Brazilian diet
incorporating
DASH-Na
principles: reduced
salt, low fat dairy~3
servings/d, fruit~35 servings/d,
vegetable~4-5
servings/d,
legumes~1
serving/d, grains,
roots and tubers~59 servings/d, meat
mainly fish~1-2
servings/d

Sodium
restriction

Office BP

-9.2 (SD
not
provided)

-6.2 (SD
not
provided)

Urinary sodium:

P=0.02

P=0.04

Intervention:
Reduced by 43.4
mmol/L (1000 mg)
(P<0.01)

No significant
change in the
control group
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Brader et
al. 2014
[108]

37 adults

Inclusion:
Iceland,
Sweden,
Denmark
and
Finland

30-65 years,
metabolic syndrome,
BP <160/100 mm Hg
with or without BP
medications, BMI
27-38 kg/m2

Nordic diet: whole
grains (rye, barley,
oats), nuts,
rapeseed oil, fruits/
berries ≥150g/d,
vegetables

Control diet

≥500g/day,
fish≥300g/week,
low-fat dairy 2
servings/d, salt
intake <7g/d men,
<6g/d women

wheat
products, dairy
fat-based
spreads, fruit,
vegetables
≤250g/d, fish
≤100g/week,
salt intake
<10g/d

DASH diet:

Low fat diet

12 weeks
Exclusion:

Sodium
restriction

24-h ABP

No
significant
change

-4.4 (-6.9, 2.0)
P=0.001

No difference in
urinary sodium and
potassium excretion
between groups

Weight loss,
exercise,
sodium
restriction

Home BP

-5.2 ± 1.8

-4.8 ± 1.3

Urinary sodium
analysis not done

(P=0.006)

(P=0.001)

(Mean nutrient
intake in
Nordic
countries):

Poor compliance,
chronic liver, kidney
or thyroid disease,
diabetes
Nowson
et al.
2005
[191]

Australia

63 men

Inclusion:
>25 years, BMI 2535 kg/m2, BP
≥120/≥80 mm Hg

fruit ≥4 servings/d,
vegetables ≥4
servings/d, low-fat
dairy ≥3 servings/d,
fish ≥3
serves/week,
legumes~1 cup /

Advised to
reduce high
energy food
and drinks,
choose plant
based foods,
choose low fat
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12 weeks
Exclusion:

cardiovascular
disease event in the
past 6mo, insulin
dependent diabetes
mellitus, medication
such as warfarin or
phenytoin, consumed
meals outside home
>twice/week, >30
standard drinks/
week, use of dietary
supplements
Burke et
al. 2005
[192]

241 adults

week, unsalted nuts
and seeds~30g 4
times/week, red
meat ≤2
serves/week, fat~ 4
servings/d

30 minutes
moderate physical
activity on most
days

Lifestyle
programme (4
months):

Inclusion:
Australia

40-70 years, BMI
>25 kg/m2,could be
on blood pressure
medication

4
and 12
months

Exclusion:
BP >160/90 mmHg,

DASH diet:
high in fruits and
vegetables, low salt
and sugar, 4 fish
meals/ week,
alcohol < 2
standard drinks/
day for both men

dairy, limit
cheese and ice
cream to twice
per week, use
lean meat,
avoid frying
foods in fat

30 minutes
moderate
physical
activity on
most days

Usual care:

Provided with
information
from the
National Heart
Foundation
and Health
Department of
Western
Australia, no
behaviour
change

Weight loss,
exercise,
sodium
restriction

24-h ABP

-3.0 (-6.3,
0.1)

-1.8 (-3.4, 0.2)
P=0.006

Intervention group
reduced 24h
urinary sodium by

P=0.02
4.9 mmol/24h
compared to
control group at 4
months (P=0.007)
but no significant
difference at 12
months
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intake of >2 fish
meals per week or 4
fish oil capsules per
week, alcohol intake
>4 standard drinks/d
for women, >6
standard drinks/d for
men, drug or insulin
treated diabetes,
chronic renal failure,
symptomatic
cardiovascular
disease of less than 3
months duration,
other chronic
debilitating disease

and women

information

30 minutes
moderate intensity
physical activity on
most days, advice
on cessation of
smoking, social
support from
partners
encouraged

12 month follow-up
period:
telephone contact, 6
sessions for
measurements and
group workshops

Nowson
et al.
2009
[193]

Australia

111 women

Inclusion:

Vitality diet (low
acid load, low
sodium DASH
diet):

45-75 years, BMI 1835 kg/m2,
lean red meat 6

Reference
healthy diet

Sodium
restriction

(high acid
load, high
carbohydrate,
low fat diet):
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Home BP

Significant
reduction
only in
those
taking
antihyperte
nsives:

Significant
reduction
only in
those
taking
antihyperte
nsives:

Vitality diet group
reduced 24h
urinary sodium
excretion:
-38.6±6.9 mmol/d
(P<0.001)

menopausal or
postmenopausal
14 weeks
not on HRT

Office BP:
120-160/80-95
mmHg
Home BP:
SBP ≥116/
≥78 mmHg

Exclusion criteria:
Menopause before 43
years, taking
warfarin,
diphenylhydantoin,
medications for
osteoporosis
treatment, treated for
cancer in the past 3
years,

servings/ week
(600g/wk), low fat
dairy ≥3 servings/d,
fruit ≥4 servings/d,
vegetables ≥4
servings/d, fats/ oils
≥4 tsp/d, whole
grain breads/
cereals ≤4
servings/d, caffeine
drinks ≤4
servings/d,
alcoholic drinks ≤2
servings/d

Sodium intake =
69 mmol/d (1590
mg/d)

-5.5 (-11.0,
0.02)
P=0.05

lean red meat
≤2 servings/
week
(200g/wk),
low fat dairy
≥3 servings/d,
fruit 2
servings/d,
vegetables 2-3
servings/d,
fats/ oils ≥8
tsp/d, whole
grain or white
breads/ cereals
≥4 servings/d,
caffeine drinks
≤4 servings/d,
alcoholic
drinks ≤2
servings/d

-3.6 (-6.9, 0.3)
P=0.04

cardiovascular
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disease event in the
last 6 mo, insulin
dependent diabetes,
intake of >30
standard drinks/
week, consumed
meals outside the
home >2 times/ week
Miller et
al. 2002
[188]

45 adults

Inclusion:
United
States

9 weeks

22-70 years, on a
single
antihypertensive
medication, BP 130170/80-100 mmHg,
BMI>25 kg/m2

Exclusion:
Active or prior
cardiovascular
disease, medication
treated diabetes,
random glucose of
>180 mg/dL, renal
insufficiency, fasting

Comprehensive
lifestyle
intervention:

Control

DASH diet, alcohol
~2 drinks/day,
caffeinated
beverages~3 per
day, reduced
sodium intake: 100
mmol/d (2300
mg/d), supervised
moderate aerobic
exercise 3 times/
week, weight loss
of 0.6 kg/ week

No
intervention

Weight loss,
exercise,
sodium
restriction

24-h ABP

-9.5 (-14.5,
-4.5)
P<0.001

-5.3 (-8.5, 2.1)
P<0.002

24-h urinary
potassium excretion
significantly
increased in
intervention group
by 20 mmol/L
(95% CI: 5,35,
P=0.009)

No significant
change in urinary
sodium excretion
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cholesterol >260
mg/dL, pregnancy or
lactation,
consumption of >14
alcoholic drinks/
week, unwillingness
to stop supplements
intake
Toobert et
al. 2003
[189]

279 women

Mediterranean
Lifestyle Program:

Usual care

Weight loss,
exercise

Inclusion:
United
States

6 months

Post-menopausal
with type 2 diabetes,
living independently,
has a telephone and
able to read, not
developmentally
disabled, living
within 30miles

Increased amounts
of bread,
vegetables, fruits,
legumes, fish, less
red meat, avoid
cream and butter,
use of olive/ canola
oil or margarines

Exclusion:
>75 years, planning
to move from study
area
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Office BP

No
significant
change

No
significant
change

Urinary sodium and
potassium analysis
not done

Esposito
et al.
2004
[114]

180 adults

Mediterranean diet:

Prudent diet

Inclusion:

Increased
consumption of
whole rains (400
g/d), fruits (250300g/d), vegetables
(120-150g/d),
walnuts (25-30g
/d), olive oil (8g/d)

General
information on
healthy food
choices, no
individualized
plan

Italy

-three or more
features of metabolic
syndrome

24
months

Exclusion:

cardiovascular
disease disease,
psychiatric problems,
history of alcohol
abuse, smoking,
taking any
medication
Esposito
et al.
2003
[190]

Italy

Exercise for 30
minutes per day

Office BP

-3.0 (-5.0, 1.0),
P=0.01

-2.0 (-3.5,
-0.5),
P=0.03

Urinary sodium and
potassium analysis
not done

Weight loss,
exercise

Office BP

-2.0 (-3.5, 0.5),
P=0.009

-1.7 (-3.0 0.4)
P<0.001

Urinary sodium and
potassium analysis
not done

Exercise for
30 minutes per
day

120 women

Mediterranean diet

Control diet

Inclusion:

Information on
calorie restriction
to achieve weight
loss of 10% or
more, use of food

Information
about healthy
food choices
and exercise

20-46 years, BMI
≥30 kg/m2, sedentary

Exercise
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24
months

Exclusion:

diaries, behavioural
and psychological
counselling

Diabetes or impaired
glucose tolerance,
hypertension,

cardiovascular
disease, psychiatric
problems, history of
alcohol abuse
(≥500g/week),
smoking, any
medication use
VincentBaudry et
al. 2005
[194]

212 adults

Mediterranean diet
recommended:

Low fat diet
recommended
foods:

All kept
constant

Inclusion:
18-70 years

France

One of the following:

3 months

-BP 140-190/90-105
mmHg
-cholesterol 6.5-7.7
mmol/L
-glucose 6.1-6.9
mmol/L

Nuts, whole meal
bread and cereals,
fresh or dried fruit,
vegetables,
legumes, olive oil,
fish 4 times/week,
red meat once per
week, sheep and
poultry as main
source of meat,
cheese from sheep
and goats, red

Consume more
poultry, avoid
offal and
saturated fat
rich animal
products, fish
2-3 times per
week, fruit and
vegetables,
low fat dairy
products, use
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Office BP

No
significant
change

No
significant
change

Urinary sodium and
potassium analysis
not done

-BMI>27 kg/m2
-smoking

wine: 2 glasses/d
men, 1 glass/d
women

of vegetable
oils

Interventions:

Control:

-sedentary
-family history of

cardiovascular
disease

Exclusion:
Treatment with
hypolipemic or
hypoglycemic drugs

Domenec
h et al.
2014
[206]

Spain

1 year

284 adults

All kept
constant

Low fat diet
Inclusion:
Men 55-80 years,
women 60-80 years,
type 2 diabetes or
with ≥3

cardiovascular

Mediterranean diet
and extra virgin
olive oil (provided
1 litre/week)

ABP

Mediterran
ean diet
and extra
virgin olive
oil: -4.0 (6.4, -1.6)

Mediterran
ean diet
and extra
virgin olive
oil
-1.9

P<0.001
(-3.4, -0.4)
P<0.001

Mediterranean diet

Mediterran
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Urinary sodium and
potassium analysis
not done

disease risk factors

Exclusion:

and mixed nuts ~
provided 30g/d
(15g walnuts, 7.5g
almonds, 7.5g
hazelnuts)

ean diet
and nuts
-4.3 (-6.7, 1.9)
P<0.001

History of

-1.9 (-3.4, 0.4)
P<0.001

cardiovascular
disease, severe
chronic illness,
immunodeficiency or
HIV, illegal drug or
alcohol misuse,
allergy to nuts or
olive oil, unwilling to
change dietary habits

Mediterran
ean diet
and nuts

Mediterranean diet
amounts used to
assess adherence:
olive oil
consumption
≥4tbs/d, vegetables
≥2 servings/d, fruit
≥3 servings/d, red
meat, hamburger or
meat products e.g.
ham, sausage <1
serving/d, butter,
margarine, cream
<1 serving/d (1
serving=12g),
sweet and
carbonated drinks
<1/d, wine ≥7
glasses/week,
legumes ≥3
servings/week, fish
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≥3 servings/week,
commercial sweets/
pastries < 3times
/week, nuts
≥30g/week,
vegetables, pasta,
rice or other dishes
seasoned with
sofrito (sauce made
with tomato and
onion, leek or
garlic and
simmered with
olive oil) ≥2 times/
week, consumption
of chicken, turkey
or rabbit meat
instead of veal,
pork, hamburger or
sausage
Adamsso
n et al.
2011
[109]

Sweden

88 adults

Nordic diet:

Inclusion:

Foods supplied to
participants except
beverages:

25-65yrs, BP
<145/85 mm Hg,
BMI 20-31 kg/m2

Fruits, berries,
vegetables,
legumes, low-fat
dairy, fatty fish,

Control diet
(Usual
Western diet)

All kept
constant

No foods
provided
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Office BP

-7.2 (-12.3,
-1.9)
P=0.008

No
significant
change

Urinary sodium and
potassium analysis
not done

6 weeks

Hb >120g/L
(women), >130g/L
(men)

oats, barley, soy
protein, almonds,
psyllium seeds

LDL-C >3.5mmol/L
Diet provided ad
libitum
Exclusion:
Use of lipid lowering
drugs, Triglycerides
>4.5 mmol/L,
Allergy to certain
foods, weight-loss
diets or drugs,
special diets eg
vegan, pregnancy/
lactation
Poulsen et
al. 2014
[110]

Denmark

26 weeks

181 adults

New Nordic diet:

Inclusion:

Vegetables 400g/d,
fruit 300g/d

18-65 years, BP >
130/85 mm Hg, waist
circumference
>80(w), >94(m), BP
>130/85 mm Hg,
metabolic syndrome

(berries 75g/d),
potatoes 150g/d, no
limit on fresh
herbs,
wild plants and

Control Average
Danish diet:

All kept
constant

Vegetables
180g/d, fruit
200g/d
(berries 4g/d),
potatoes
100g/d, no
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Office BP

-5.2 (-8.0, 2.4)
P=0.001

No
significant
change

No significant
difference between
24-h sodium
excretion between
intervention and
control

Exclusion:
Diabetes, food
allergies,
hypercholesterolemia
, pregnant and
lactating

mushrooms 5g/d,
nuts 30g/d, dairy
products 500g
milk/d, 25g
cheese/d, eggs
25g/d,

Foods are
organically grown
and consumed ad
libitum

Von
Haehling
et al.
2013
[196]

Germany

524 adults

Traditional Tibetan
diet:

Inclusion:
>18 years, coronary
artery disease, any 2
of metabolic
syndrome traits, BMI
>25 kg/m2

12
months
Exclusion:

Adapted to food
availability in the
Western world,
cooked and warm
foods.
Barley, wheat, rye,
corn, rice, oat,
buckwheat, beef,
mutton, hare,

wild plants
and
mushrooms,
fresh herbs ≤1,
nuts
≤1serving/d,
refined grains,
sweets,
imported fruit

Usual care
(western diet),
guidelines by
American
heart
association
and German
academy and
society of
nutritional
medicine

Weight loss,
exercise

Cereals; whole
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Office BP

No
significant
change

No
significant
change

Urinary sodium and
potassium analysis
not done

Pregnancy, end stage
renal disease,
infectious diseases,
malignancy

chicken, venison;
Vegetables -onion,
garlic, radish,
fennel, leek, onion,
carrot, soy beans,
dried dark beans.
Fruit pomegranate,
banana, pineapple,
mango, bramble,
apricot, nectarine.

Eat in a relaxed
atmosphere with
warm colours,
avoid psychological
stress, moderate
physical activity,
sufficient sleep

Azadbakh
t et al.
2011
[195]

44 adults

DASH diet:

Inclusion:

Fruit ~5 servings/d,

grain rice and
noodles and
grains
Meat; chicken,
turkey, veal,
rabbit. All
vegetables and
fruits

Avoid
psychological
stress,
moderate
physical
activity, obtain
sufficient
sleep, avoid
sudden
changes in
temperature
e.g. sauna and
cold water
diving
Usual diabetic
diet:

Sodium
restriction
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Office BP

-10.5 (19.2, -1.8)
P=0.02

-8.8 (-17.1,
-0.6)
P=0.04

Urinary sodium and
potassium analysis
not done

44-70 years, type 2
diabetes
Iran

Exclusion:

vegetables ~6.8
servings/d, dairy~3
servings/d, whole
grains~ 4.5
servings/d

8 weeks
Any secondary cause
of hyperglycaemia,
hepatic or kidney
disorders, cancer,
oestrogen therapy,
untreated
hypothyroidism,
smoking

1

Sodium = 2300
mg/d

Fruit~3
servings/d,
vegetables~ 4
servings/d,
dairy~2
servings/d,
whole
grains~2.5
servings/d

Sodium =
3000 mg/d

Abbreviations: ABP, ambulatory blood pressure; BP, blood pressure; DASH, Dietary Approaches to Stop Hypertension; DBP, diastolic

blood pressure; MD, Mediterranean diet; MDC, physician intervention; MDI, physician control; Na, sodium; PC, patient control; PI,
patient intervention; wk, week
2

Serves per day unless otherwise stated, glass in terms of mL, 3Mean; 95% CI in parenthesis, 4Mean ± SD (all such values).
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APPENDIX F
Characteristics of the observational studies on dietary patterns and blood pressure
Author,
country
,
duratio
n

Design/ aims

Subjects,
inclusion
and
exclusion
criteria

Dietary
assessment/
methods
defining
dietary pattern

Dietary
pattern(s)
identified

Outcomes

Statistical analysis/
confounders adjusted
for

Results

Dauchet
et al.
2007
[77]

Longitudinal
analysis

2341 adults

Repeated 24-h
dietary records
every 2 months.
Total of 6
records per year.

Fruit and
vegetables
(excluding potato
and legumes)

BP

Specific quartiles
calculated and P for
linear trend performed
with dietary intakes as
continuous variables.

High fruit and vegetable intake
(642g vs 228g) was associated with
smaller increase in BP:

35-63 years
1

France

5.4
years
(4.46.4y)

SU.VI.MAX
study originally a
randomised
controlled trial
of antioxidants
from 1994 to
2002

Aim:

Exclusion
criteria:
Hypertension
, use of
hypertensive
s

DASH diet
characteristics

Dairy products
including milk,
cheese, yoghurt
and other dairy
products

SBP -2.1 mm Hg (-3.6, -0.7)2
P<0.004
DBP -0.7 mm Hg (-1.7, 0.3) P<0.03

Confounders:

Healthy fat
(defined by Keys
score)

To investigate
the relationship
between BP
changes and
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Age, sex, group, total
energy intake
(excluding alcohol),
number of dietary
records completed,
tobacco use, alcohol,
physical activity,
educational level,
BMI, dietary sodium
intake (except table
salt), blood pressure at

High DASH score associated with
smaller increase in BP:
SBP -2.1mm Hg (-3.6, -0.7)
P<0.002
DBP -0.6 mm Hg (-1.6, 0.4) P<0.02

No significant associations found
with dairy products consumption or

dietary patterns.

McNaug
hton et
al. 2007
[180]

Longitudinal
study

1265 adults

5-day food diary

18 years
(19821999)

Umesaw
a et al.

BP

-ethnic foods and
alcohol
36-53 years

Factor analysis

1946 Birth
cohort study
United
Kingdo
m

Women:

Aim:
To determine
the association
between dietary
patterns and risk
factors for
chronic disease.

Longitudinal
Prospective

healthy fat.

Dietary patterns
assessed using Mplus
factor analysis.

Fruit, vegetable and dairy (P=0.02)
and ethnic foods and alcohol
(P=0.008) dietary patterns were
inversely associated with BP in
women.

BMI
-meat, potatoes
and sweet foods

Included
normotensive
s and
hypertensive
s

1st clinical
examination,
magnesium and
potassium intakes

-fruit, vegetables
and dairy

Waist
circumfere
nce

Longitudinal analysis
conducted using the
dietary data obtained
in 1982, 1989 and
1999.

Red cell
folate

Confounders:

Antioxidants intake was found to
have no effect on risk of
hypertension compared with
placebo.

Mixed pattern was significantly
associated with BP in men
(P=0.01).

Men:
-ethnic foods and
alcohol

Age, social class,
education, region,
alcohol, smoking,
physical activity,
supplement use

-mixed

3486 males

Questionnaire
containing 19

-dairy products

Incident of
hypertensio
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Logistic regression
models. Odds ratios

Increased risk of developing

2013
[96]

study

workers

Aim:

30-71 years

To determine
the association
between dietary
behaviour and
the risk of
hypertension.

(mean 42.9y)

items related to
dietary
behaviour

-meat

n

-eggs

(ORs) for risk of
hypertension
calculated.

hypertension in:

Confounders:

-those who did not consume dairy
every day

-noodle soup

-those who did not eat meat
frequently OR:1.26 (95% CI: 1.001.59)

Japan

Average
4.6
years

Age, BMI, alcohol
intake, job, smoking
habits, estimated
glomerular filtration
rate, SBP at baseline

Exclusion:
hypertension

OR 1.39 (95% CI: 1.13-1.71)
-those who started consuming all
noodle soup
OR: 1.32 (95% CI: 1.02-1.71)
-those not consuming eggs daily
OR: 1.33 (95% CI: 1.00-1.75)

Wang et
al. 2012
[78]

Longitudinal
prospective
study

United
States

Women’s
Health study
(WHS)

28,082
women

131-item semiquantitative
food frequency
questionnaire

Fruit and
vegetables

Incident of
hypertensio
n

39-89 years

12.9
years

Aim:

Cox models to
estimate hazard ratio
(HR) of hypertension
across levels of fruit
and vegetable intake.

Confounders:
Age, race, total energy
intake, BMI,
randomised treatment
group, smoking status,

Exclusion:
cardiovascul
ar disease,
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Fruit and vegetables:
Higher intake of fruits and
vegetables was significantly
associated with reduced risk of
hypertension after adjustment for
lifestyle factors; HR: 0.90 (0.82,
0.99), P<0.001 but the association
was not significant after adjustment
for dietary factors and BMI.

To assess the
association
between fruit
and vegetables
intake and the
risk of
hypertension.

hypertension
or cancer
(except nonmelanoma
cancer)

alcohol use, physical
activity,
postmenopausal status,
postmenopausal
hormone use,
supplement use,
history of diabetes and
hypercholesterolemia,
dietary risk factors
such as whole grains,
red meat, low-fat dairy
and nuts.

Total fruits:
Higher intake of fruits significantly
associated with reduced risk of
hypertension after adjusting for
lifestyle and dietary factors but not
BMI. HR: 0.89 (0.81-0.96),
p=0.0004

Total vegetables:
No significant association with risk
of hypertension.

Toledo
et al.
2010
[198]

Longitudinal
prospective
study

10,800 adults

Exclusion:
SUN project

136-item semiquantitative
food frequency
questionnaire

15 priori-defined
scores of
adherence to
healthy food
pattern

hypertension

Incident of
hypertensio
n

Cox regression models
to assess incidence of
hypertension.

Higher adherence to DASH diet
was associated with lower risk of
developing hypertension
HR: 0.48 (95% CI 0.21-1.09),
P=0.02

Confounders:

Spain

2-6
years
(median
4.6

(University
graduates
followed every
2 years
beginning
December 1999)

Age, sex, total energy
intake, BMI, family
history of
hypertension,
smoking, physical
activity

UMMDS (Updated modified
Mediterranean diet score) showed a
significant increased risk of
development of hypertension
HR: 1.34 (95% CI 1.04-1.73),
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years)

P=0.002
Aim:
To assess the
association
between
adherence to
several healthy
dietary patterns
and the risk of
hypertension.

Rumaw
as et al.
2009
[197]

United
States

7 years
mean
followup

Longitudinal
prospective
study

Other dietary scores did not show
significant results

2370 adults

Median age:
Framingham
Heart Study
Offspring
Cohort

Aim:
To assess the
association
between
Mediterranean
style dietary

126-item semiquantitative
food frequency
questionnaire

54 years

Exclusion:
diabetes,
metabolic
syndrome

Food groups
considered:

Metabolic
syndrome
biomarkers
including
SBP and
DBP

-whole grain
cereals
-fruit

Mediterranean
style dietary
pattern score
(MSDPS)

ANCOVA to assess
relationship between
MSDPS and metabolic
syndrome traits.

Confounders:
-vegetables
Age, sex, BMI, energy
intake, smoking dose,
change in BMI

-dairy
-wine
-fish
-poultry
-olives/ legumes/
nuts
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No association was found between
MSDPS score and BP

pattern and
metabolic
syndrome.

-potatoes
-eggs
-sweets
-meat
-olive oil

Steffen
et al.
2005
[93]

United
States

15 years

Longitudinal
prospective
study

4304 adults

Interviewer
administered
diet history

Food groups
considered:

Elevated
BP
incidence

18-30 years
CARDIA
(Coronary artery
risk
development in
young adults)
multi-centre
study

Aim:
To determine
the association
of dietary intake
with elevated
BP.

Exclusion:
Diabetes,
pregnant,
lactating,
extreme
caloric
intakes,
elevated BP

Plant – fruit,
vegetables, whole
and refined
grains, nuts,
legumes

Cox proportional
hazards regression
analysis to assess
association between
food group
consumption with 15-y
incidence of BP.

Plant food (whole grains, fruit and
nuts) intake was inversely
associated with elevated BP in the
highest compared with lowest
quintile.

Whole grains: HR 0.83 (95% CI:
0.67, 1.03), P=0.03
Confounders:

Dairy – milk,
yoghurt, cheese,
dairy desserts

Meat – red and
processed meat,
poultry, fish, eggs
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Age, sex, race, centre,
education, BMI,
energy intake,
smoking, physical
activity, alcohol
intake, vitamin
supplement use,
dietary intake, baseline
SBP, fasting insulin

Fruit: HR 0.75(95% CI: 0.60, 0.94),
P=0.02
Nuts: HR 0.85 (95% CI: 0.72,
0.99), P=0.04

Inverse association with milk, HR
0.87 (95% CI: 0.70, 1.08), P=0.03
and dairy desserts, HR 0.74 (95%
CI: 0.60, 0.92), P=0.01.

Egg intake was inversely associated
with elevated BP. HR 0.79 (95%
CI: 0.64, 0.98), P=0.05

Red and processed meat intake was
significantly positively associated
with elevated BP. HR 1.39 (95%
CI: 1.05, 1.82), P=0.006
Miura et
al. 2004
[178]

United
States

7 years

Longitudinal
prospective
study

The Chicago
Western Electric
Study (study of
coronary heart
disease and its
precursors)

1710 men

Food groups:

BP

-vegetables

(Measured
at the
beginning
of each
yearly
medical
examinatio
n)

41-57 years

-fruits

(mean 48.5y)

-fish
-beef/ veal/ lamb

Exclusion
criteria:

-pork/ ham/ bacon

Aim:

Confounders:
Age, weight, height,
education, total energy
intake, smoking,
alcohol intake, dietary
intake (food groups
and nutrients –
carbohydrate, protein,
saturated fatty acid,

To evaluate the
association
between food

prior
myocardial
infarction,
missing
blood
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Increased vegetable intake at 14-42
cups/month (0.5-1.5cups/day) was
associated with smaller BP increase
though the association weakened
after further adjustment for
nutrients.
SBP change: -2.8 mm Hg
(P=0.008)

-poultry
Diabetes
mellitus,

(19591966)

Generalized estimating
equation method for
longitudinal data to
assess relationship
between baseline
dietary factors and
average BP change.

DBP change: -1.19 mm Hg
(P=0.037)

Increased fruit intake at 14-42 cups/
months (0.5-1.5cups/day) led to a
decrease in BP even after adjusting
for nutrients.

intake and BP
change.

pressure or
dietary
assessment
data, fewer
than 3
follow-up
examinations

polyunsaturated fatty
acid, dietary
cholesterol, iron,
thiamine, riboflavin,
niacin, Vitamin C,
beta-carotene and
retinol)

SBP change: -2.2 mm Hg
(P=0.043)
DBP change: -1.5 mm Hg
(P=0.046)

Intake of 8-20 servings/ month and
>20 servings/ month of beef, veal
and lamb led to a greater rise in
SBP by 5.4 mm Hg and 6.0 mm Hg
respectively (P<0.05). DBP: >20
servings/ month led to a greater
increase by 2.9 mm Hg (P=0.022)
compared to <8 servings/month.

Pork intake: 4-8 servings/month led
to greater rise in SBP by 3.9 mm
Hg (P=0.002)

Poultry:
SBP: >8 servings/ month led to a
greater rise by 3.4 mm Hg
(P=0.012)
DBP: 4-8 servings/month compared
to <4 servings/month led to greater
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rise by 1.3 mm Hg (P=0.006), >8
servings/ month led to a greater
increase by 1.8 mm Hg (P=0.031)
NunezCordoba
et al.
2009
[184]

Longitudinal
prospective
study

9408 adults

Exclusion
criteria:
SUN study
Hypertension
,

Spain
Aim:
4.2
median
years
(19992005)

To determine
association
between
adherence to the
Mediterranean
diet and
incidence of
hypertension.

cardiovascu
lar disease,
cancer,
diabetes
mellitus,
extreme
caloric
intakes

136-item food
frequency
questionnaire

Mediterranean
diet (MD)

Incident of
hypertensio
n and BP
change

9-point MD score.
Include :

Linear regression to
assess relationship
between MD
adherence and relative
change in BP in nonhypertensive
participants.

MD not associated with incidence
of hypertension.

Cox proportional
hazard models to
estimate hazard ratios
(HR) for hypertension.

Direct association between alcohol
intake and incidence of
hypertension

Inverse association with intake of
legumes. HR:0.84 (95% CI: 0.701.00)

-vegetables
-legumes
-fruits and nuts
-cereals

HR: 1.25 (95% CI: 1.03-1.51)

-fish
-meat and meat
products

Confounders:
Age, sex, BMI, family
history of
hypertension,
hypercholesterolemia,
caffeine intake, total
energy intake,
smoking, physical
activity

-dairy products
-alcohol
-ratio of
MUFA:SFA
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MD associated with reduced
changes in SBP and DBP in those
without hypertension after 6 years.
SBP change (P=0.01) in
comparison with low adherence
score:
-3.1mm Hg (-5.4, -0.8) for the high
score

-2.4mm Hg (-4.0, -0.8) for the
moderate score
DBP change: (P=0.05)
-1.9 mm Hg (-3.6, -0.1) for high
score
-1.3 mm Hg (-2.5, -0.1) for
moderate score
Schulze
et al.
2003
[179]

German
y

2-4
years

Baseline
examina
tion
done
between
Aug

Longitudinal
prospective
study

8552 women

35-64 years
EPIC-Potsdam
multi-centre
cohort study

EPIC: European
Prospective
Investigation
into Cancer and
nutrition

Aim:
To determine

Exclusion
criteria:
Hypertension
, missing
data (on
dietary
intake,
anthropometr
y, physical
activity and
basal
metabolic
rate),

148-item selfadministered
food frequency
questionnaire

Dietary patterns
identified :

Incident of
hypertensio
n

Traditional
cooking - meat,
cooked
vegetables, sauce,
potatoes, poultry

Fruit and
vegetables fruits, raw
vegetables,
vegetable oil

DASH - fruits,
vegetables (raw
234

Cox regression models
to estimate relative
risks of hypertension.

DASH pattern: 3rd quartile had
significant inverse association with
incident of hypertension compared
to 1st quartile. HR: 0.51 (0.29-0.89)

Confounders:
BMI, alcohol intake, ,
smoking status, history
of cardiovascular
disease or diabetes,
physical activity, use
of mineral supplement,
employment status,
education, SBP, DBP,
waist to hip ratio, total
energy intake, dietary
change within the year
prior to baseline
examination

No association was found between
the traditional cooking and fruit and
vegetable dietary patterns with
incident of hypertension.

1994
and Sep
1998

the effect of
dietary patterns
on incidence of
hypertension.

1

pregnant or
lactating,
extreme
energy
intakes

and cooked), milk
products (milk,
yoghurt, cheese)

Abbreviations: BP, blood pressure; DASH, Dietary Approaches to Stop Hypertension; DBP, diastolic blood pressure; MD,

Mediterranean diet; SBP, systolic blood pressure; SU.VI.MAX, SUpplementation en VItamines et Mine´raux AntioXydants.
2

Mean; 95% CI in parenthesis.
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APPENDIX G
Percentage contribution of major food groups to sodium and potassium intake among clinically overweight adults
Food groupa

Sodium

Potassium

% Sodium

Median (IQR)b

% Potassium

Median (IQR)

intake

mg/day

intake

mg/day

Cereal based products and dishes (biscuits, cakes, pastries)

21.61

527 (247-878)

7.37

206(100-343)

Cereal and cereal products (breads, rice, pasta, breakfast

14.53

384 (251-529)

7.78

231 (149-326)

Meat, poultry and game products and dishes

17.57

393 (203-709)

15.58

456 (307-704)

Milk products and dishes (milk, yoghurt, cheese, custard)

10.59

247 (141-418)

12.74

356 (181-575)

Savoury sauces and condiments

8.69

176 (70-333)

1.68

26 (8-76)

Vegetable products and dishes

4.72

100 (46-181)

22.02

682 (426-930)

cereals)
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Soup

4.27

282 (179-563)

1.93

158 (87-282)

Fish and seafood products and dishes

4.01

134 (77-262)

2.69

128 (65-217)

Non-alcoholic beverages (tea, coffee, soft drinks, juices)

3.11

66 (31-117)

9.51

254 (109-444)

Miscellaneous (yeast, herbs, spices, seasonings)

3.02

76 (23-234)

0.85

16 (3-69)

Snack foods

1.89

76 (38-155)

1.62

58 (22-155)

Legume and pulse products and dishes

1.29

124 (56-201)

0.84

81 (52-129)

Fats and oils

1.13

22 (7-51)

0.04

1 (0.3-2)

Egg products and dishes

0.86

27 (14-54)

0.67

29 (16-50)

Confectionery and cereal/nut/fruit/seed bars

0.75

22(7-41)

1.88

62 (28-123)

Alcoholic beverages

0.65

27 (13-54)

2.08

102 (43-179)

Seed and nut products and dishes

0.60

6 (1-38)

2.00

71(37-147)
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Dairy & meat substitutes (soy based beverages and soups)

0.25

22 (3-69)

0.51

62 (26-238)

Special dietary foods

0.17

37 (24-59)

0.23

60(0-133)

Fruit products and dishes

0.15

3 (1-6)

7.74

231 (112-404)

Sugar products and dishes

0.14

1 (0.1-4)

0.24

4 (1-14)

a

Using AUSNUT 2011-13 major food groups; bIQR, interquartile range.
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APPENDIX H
AUSNUT 2011-13 major food groups and example foods used in the Principal
Component Analysis in the HealthTrack study
Major food group

Example food items

Alcoholic beverages

Beers, wines, spirits, cocktails and liqueurs

Cereal and cereal products

Bread, rice, noodles, pasta and breakfast cereals

Cereal based products and

Sweet and savoury biscuits, cakes, sweet and savoury pastry,

dishes

pizza, sandwiches and burgers

Confectionery and

Chocolate, muesli bars, fruit bars, lollies, chewing gum

cereal/nut/fruit/seed bars
Dairy & meat substitutes

Soy beverages, almond milk, tofu, quorn and tofu stirfry

Dietary supplements

Vitamins and mineral supplements, fish oil supplements, fibre
supplements

Egg products & dishes

Eggs, omelette, soufflé and frittata

Fats & Oils

Butter, margarine and oils

Fruit products and dishes

Apples, pears, berries, oranges, peaches, bananas, banana
split, melons, dried fruit, apple crumble

Infant formulae and foods

Toddler formula, rusks, infant cereals and fruit, infant custards
and fruit juices

Legumes and pulse products

Lentils, soy beans, chickpeas, kidney beans, falafel and dhal
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and dishes
Meat, poultry, game product

Beef, chicken, lamb, pork, veal, kangaroo, ham, dried meats,

and dishes

sausages, casseroles and curries

Milk products and dishes

Milk, yoghurt, cream, cheese, ice cream, dairy desserts, and
cheesecake

Miscellaneous

Yeast, salt, intense sweeteners, herbs, stock, essences, gelatine
and spreadable yeast extract

Non-alcoholic beverages

Coffee, tea, fruit juice, cordial, soft drink, water and
electrolyte drinks

Reptiles, amphibia and

Crocodile, turtle, goanna

insects
Savoury sauces and

Tomato sauce, chutney, salad dressings, mayonnaise, vinegar

condiments

and dips

Seafood products and dishes

Fish, prawns, canned tuna, fish with pasta or rice

Seed and nut products &

Peanuts, walnuts, almonds, peanut butter, pumpkin seeds,

dishes

coconut milk

Snack foods

Potato crisps, popcorn, corn chips, rice crisps and pretzels

Soup

Canned and homemade soup, dried soup mix

Special dietary foods

Liquid and powdered meal replacements, protein drinks and
powders, oral supplement powder and beverages
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Sugar products and dishes

Sugar, honey, jam, icing sugar, apple sauce and meringue

Vegetable products and

Potatoes, carrots, beans, tomato, lettuce, cucumber, corn,

dishes

salads, potato bake

Adapted from:
http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/4364.0.55.007Appendix22011-12;
Food groups labelled Infant formulae and foods, Reptiles, amphibia and insects, and
Dietary supplements were excluded from analysis due to a lack of participants
consuming foods from these categories.
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APPENDIX I
Factor loading matrix for the dietary patterns identified by factor analysis among the HealthTrack study participants (n=328)
Dietary
pattern
Food group

Nuts, seeds,

Milk

Breads,

Cereal

Alcohol,

Savoury

fruit and

and

cereals and

based

eggs and

sauces

fish

meat

snacks

products,

legumes

and

fats and

condimen

oils

ts and
meat

Seeds and nut products and dishes

0.626a

-0.096

-0.053

-0.071

0.024

0.115

Fruit products and dishes

0.574

0.146

-0.316

0.117

-0.133

-0.215

Confectionery and cereal/nut/fruit/seed bars

0.524

0.062

0.458

0.084

-0.064

-0.112

Fish and seafood products and dishes

0.427

0.013

0.030

-0.047

0.346

0.138
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Non-alcoholic beverages

0.166

0.693

-0.013

-0.055

0.155

-0.023

Milk products and dishes (milk, yoghurt, cheese, custard)

0.089

0.575

-0.021

0.294

-0.160

-0.159

Dairy and meat substitutes

0.388

-0.540

-0.002

0.021

0.072

-0.165

Meat, poultry and game products and dishes

-0.161

0.482

-0.121

-0.121

0.145

0.400

Snack foods

0.181

0.065

0.613

-0.079

-0.050

0.254

Cereal and cereal products (bread, rice, pasta, breakfast

-0.162

-0.124

0.612

0.061

0.134

-0.088

Vegetables products and dishes

0.164

0.064

-0.548

0.033

0.364

0.288

Sugar products and dishes

-0.117

0.249

0.262

0.221

0.059

-0.056

Cereal based products and dishes (biscuits, cakes, pastries)

0.047

-0.064

-0.043

0.669

-0.040

0.220

Fats and oils

-0.071

0.065

0.100

0.609

0.249

0.023

Special dietary foods

-0.010

-0.061

0.008

-0.535

0.167

0.043

Alcoholic beverages

-0.090

0.047

0.074

-0.106

0.673

0.201

Egg products and dishes

0.040

0.043

-0.033

0.020

0.584

-0.097

cereals)
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Legume and pulse products and dishes

0.104

-0.151

-0.143

0.313

0.438

-0.364

Savoury sauces and condiments

0.079

-0.049

-0.046

0.262

0.030

0.784

Variance explained (%)

9.46

8.69

7.99

7.21

6.71

5.97

a

Factor loadings represent the magnitude and direction of association with dietary patterns and can range from -1.0 to 1.0. Factor loadings are

interpreted similarly to the correlation coefficients. Bold font indicates factor loadings > ± 0.4 that were considered significant for inclusion of a
food group in the respective dietary pattern. Two food groups (Miscellaneous and soup) were excluded from analysis due to low Kaiser-MeyerOlkin measure (< 0.45) after inspection of the Anti-image Matrices.
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APPENDIX J
Reported macronutrient and micronutrient intakes per day showing alignment and non-alignment with each of the six dietary patterns among
participants of the HealthTrack study (n=328)
Nuts, seeds, fruit
and fish

Milk and meat

Breads, cereals
and snacks

Cereal based
products, fats
and oils

Alcohol, eggs
and legumes

Savoury sauces,
condiments and
meat

Aligne Not aligned
d

Aligned

Not

(n=119)

Aligne Not
d
aligned
(n=16
6)
(n=162)

Aligne Not
d
aligned
(n=17
3)
(n=155)

Aligne Not
d
aligned
(n=15
(n=175)
3)

Aligne Not
d
(n=18 aligned
1)
(n=147)

(n=209)

aligned

(n=16
0)

(n=168)

Energy, kcal

2236
(608)

2100 (582)

2224
(618)

2065
(547)*

2299
(661)

2030
2328
(490)*** (597)

1985
2303
(546)*** (640)

2047
2267
(531)*** (635)

2042
(523)***

Protein, g

105.4
(27.9)

103.2
(32.7)

108.6
(28.6)

96.7
(32.1)**

102.6
(30.1)

106.0
(30.6)

100.8
(30.6)

97.8
(27.9)**

94.4
(25.4)***

Macro
Nutrients
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107.3
(30.0)

111.7
(31.4)

112.3
(31.8)

*
Total fat, g

89.7
(30.2)

82.5
(30.2)*

88.1(31.
5)

82.3
(28.0)

93.0
(32.9)

78.9
(25.7)**
*

94.3
(30.3)

76.8
(27.7)**
*

92.3
(32.6)

80.5
(27.2)**
*

91.1
(33.0)

79.7
(25.5)***

Saturated fat,
g

33.9
(12.8)

34.6 (14.9)

35.5
(14.5)

32.1
(12.6)

38.2
(15.1)

30.2
(11.3)**
*

38.0
(14.5)

30.1
(12.0)**
*

36.4
(15.0)

32.4
(12.6)*

35.2
(14.6)

33.1
912.9)

Polyunsaturat
ed fat, g

15.1
(6.2)

11.4
(4.3)***

13.3
(5.6)

13.1
(5.7)

13.7
(5.7)

12.7
(5.3)

14.3
(5.6)

12.0
(5.4)***

14.2
(5.9)

12.3
(5.3)**

14.2
(6.1)

12.0
(4.8)***

Monounsatura
ted fat, g

34.2
(13.0)

30.6
(11.4)**

33.0
(12.6)

31.2
(11.7)

34.4
(12.9)

30.2
(11.3)**

35.2
(12.6)

29.2
(11.3)**
*

34.9
(13.2)

30.1
(11.0)**
*

35.1
(13.6)

28.9
(9.5)***

Cholesterol,
mg

309.5
(117.2
)

331.4
(142.6)

335.6
(122.8)

294.6
(141.3)*
*

318.5
(125.0
)

323.0
(137.5)

331.4
(131.6
)

308.9
(130.0)

372.5
(140.9
)

275.5
(102.7)*
**

339.3
(135.5
)

297.9
(122.2)**
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Carbohydrate,
g

230.1
(73.6)

212.9
(63.8)*

227.0
(73.8)

211.3
(59.1)*

242.2
(75.1)

199.8
(55.0)**
*

241.2
(70.7)

199.0
(60.3)**
*

222.1
(76.9)

220.5
(61.8)

223.7
(70.3)

218.3
(67.9)

Sugars, g

105.9
(41.9)

92.8
(39.5)**

106.9
(43.8)

85.8
(32.1)**
*

107.0
(45.5)

91.2
(34.5)**
*

106.3
(43.3)

91.3
(37.2)**

94.8
(42.0)

103.1
(40.1)

96.7
(39.8)

102.4
(42.7)

Starch, g

121.0
(44.8)

117.0
(36.3)

117.3
(41.1)

121.9
(39.9)

131.9
(42.2)

105.7
(34.4)**
*

131.9
(39.1)

104.5
(37.6)**
*

123.3
(45.1)

115.2
(36.1)

123.5
(41.3)

113.3
(39.3)**

Alcohol, g

6.1
(11.0)

8.5 (13.0)

7.1
(11.7)

7.7
(12.7)

7.1
(11.1)

7.6
(13.0)

6.4
(11.8)

8.4
(12.3)

13.5
(14.6)

1.9
(4.8)***

8.9
(13.2)

5.4
(10.2)**

Dietary fibre,
g

27.4
(8.8)

21.8
(7.4)***

24.4
(8.0)

24.7
(9.6)

23.2
(8.5)

25.9
(8.6)**

26.7
(8.6)

22.1
(7.9)***

25.7
(8.4)

23.5
(8.6)*

25.3
(8.5)

23.5 (8.6)

1.80
(0.67)

1.69 (0.88)

1.83
(0.83)

1.61
(0.69)*

1.77
(0.82)

1.72
(0.76)

1.94
(0.87)

1.53
(0.62)**
*

1.74
(0.75)

1.75
(0.82)

1.79
(0.80)

1.70
(0.77)

Micronutrien
ts
Thiamin, mg
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Riboflavin,
mg

2.54
(0.90)

2.40 (1.28)

2.65
(1.19)

2.15
(0.89)**

2.54
(1.15)

2.40
(1.07)

2.68
(1.13)

2.23
(1.04)**
*

2.38
(1.01)

2.55
(1.20)

2.53
(1.19)

2.40
(1.01)

Vitamin C,
mg

110.0
1
(63.15
)

88.84
(61.19)**

100.45
(57.53)

96.91
(71.70)

84.83
(55.05
)

113.86
(67.20)*
**

99.76
(59.65
)

98.51
(66.64)

105.9
7
(52.59
)

93.22
(70.40)

100.6
0
(62.33
)

97.41
(63.88)

Vitamin D, µg

3.65
(1.92)

3.14
(1.67)*

3.65
(1.86)

2.93
(1.64)**
*

3.39
(1.83)

3.40
(1.80)

3.59
(1.77)

3.17
(1.83)*

3.72
(1.86)

3.10
(1.72)**

3.50
(1.94)

3.25
(1.63)

Vitamin E, mg 11.07
(4.31)

8.47
(3.26)***

9.79
(3.90)

9.66
(4.23)

9.62
(3.86)

9.86
(4.18)

10.52
(4.33)

8.87
(3.46)**
*

10.45
(3.83)

9.11
(4.09)**

10.51
(4.45)

8.79
(3.17)***

Total folate,
µg

406.6
(154.1
)

366.2
(212.8)

399.6
(194.9)

361.9
(171.4)

378.6
(188.8
)

393.4
(186.0)

430.0
(196.6
)

336.7
(163.4)*
**

385.7
(168.6
)

386.1
(202.7)

379.2
(190.0
)

394.2
(184.2)

Total Vitamin
A equivalents,
µg

1008.
0
(487.2
)

923.2
(461.7)

981.2
(446.3)

935.4
(523.6)

877.5
(442.3
)

1053.8
(492.9)*
*

1058.
7
(493.1
)

859.5
(433.0)*
**

1049.
2
(503.0
)

890.6
(438.2)*
*

992.9
(498.8
)

929.7
(444.3)
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Retinol, µg

326.7
(161.4
)

Beta-carotene
equivalents,
µg
Sodium, mg

374.6
(195.7)*

369.3
(183.6)

319.4
(172.7)*

388.2
(200.4
)

4085
3291(2357)
(2846) **

3670
(2405)

3694
(3004)

2935
4441
3922
3407
(2140) (2870)** (2728) (2505)
*

2799
2926
(1129) (1077)

2953
(1166)

2709
(968)*

3052
2671
3073
2631
3057
2696
(1090) (1086)** (1178) (964)*** (1201) (982)**

3126
2542
(1202) (869)***

3112
(868)

Potassium, mg 3509
(913)

3064
(875)***

3398
(904)

3077
(915)**

Calcium, mg

986
(385)

908 (316)*

1001
(367)

Magnesium,
mg

437
(136)

354
(108)***

405
(129)

313.3
(150.3)*
**

404.8
(192.4
)

291.3
(146.3)*
**

375.6
(186.9
)

329.9
(173.6)*

4040
3363
(2695) (2545)*

351.5
(179.3
)

350.8
(183.8)

3848
3471
(2719) (2519)

3454
(941)**

3415
(857)

3132
(966)**

3470
(906)

3116
(902)**

3456
(939)

3067
(850)***

848
966
(304)*** (362)

925
(343)

1007
(329)

878
(367)**

938
(331)

953
(371)

955
(377)

934 (322)

375
(125)*

404
(128)

415
(122)

371
(132)**

418
(133)

374
(120)**

420
(133)

363
(115)***

385
(128)
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Phosphorus,
mg

1763
(424)

1627
(443)**

1763
(433)

1572
1689
(424)*** (453)

1698
(424)

1768
(408)

1610
(457)**

1765
(450)

1631
(420)**

1780
(454)

1587
(396)***

Iron, mg

13.41
(3.75)

11.77
(3.50)***

12.70
(3.51)

12.33
(4.06)

12.24
(3.82)

12.90
(3.58)

13.20
(3.66)

11.86
(3.66)**

13.18
(3.69)

12.04
(3.66)**

13.12
(3.74)

11.89
(3.57)**

Zinc, mg

13.40
(4.19)

12.74
(4.49)

13.67
(4.18)

11.97
(4.45)**

12.65
(4.04)

13.48
(4.62)

13.33
(4.03)

12.75
(4.68)

13.86
(4.52)

12.36
(4.09)**

13.89
(4.578
)

12.03
(3.82)***

Iodine, µg

127.6
0
(43.89
)

129.01
(54.14)

138.55
(49.66)

110.38
(43.47)*
**

131.5
6
(49.91
)

125.02
(48.68)

137.4
6
(49.84
)

118.14
(46.86)*
**

130.7
2
(48.92
)

126.23
(49.74)

131.1
8
(51.96
)

124.81
(45.83)

Percent of
total energy
from protein,
%

19.5
(3.8)

20.2 (4.3)

20.3(4.1
)

19.1
(4.1)*

18.3
(3.1)

21.4
(4.4)***

18.9
(3.3)

21.0
(4.6)***

20.0
(3.9)

19.7
(4.3)

20.4
(3.6)

19.2
(4.6)*

Percent of

35.2

34.2 (5.3)

34.6

34.8

35.4

34.0

35.6

33.7

35.1

34.4

35.1

34.2 (4.8)

% Energy
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total energy
from fat, %

(5.2)

Percent of
total energy
from
carbohydrate,
%

41.8
(6.3)

41.5 (7.5)

(5.3)

(5.2)

(4.9)

(5.6)*

(5.0)

(5.4)**

(5.2)

(5.3)

(5.6)

41.4
(6.5)

42.1
(7.7)

43.0
(6.3)

40.3
(7.3)***

42.2
(6.3)

41.1
(7.6)

39.2
(6.9)

43.9
(6.3)***

40.3
(7.1)

Data presented as mean (standard deviation); *P < 0.05, **P < 0.01, ***P < 0.001; P values represent significant differences between
participants who aligned or did not align with a specific dietary pattern.
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43.3(6.4)*
**

APPENDIX K
Baseline characteristics of the 211 participants with complete data on blood pressure, urinary sodium and potassium and dietary intake in the
HealthTrack study (n=211)
Characteristic

IW (n=82)

I (n=62)

C (n=67)

P value for group
difference2

Age, years

43.2 (8.7) 1

45.2 (7.1)

45.1 (7.2)

0.242

Height, m

1.7 (0.1)

1.7 (0.1)

1.7 (0.1)

0.397

Weight, kg

90.0 (14.6)

93.0 (16.1)

89.6 (15.4)

0.400

BMI, kg/m2

32.0 (4.1)

32.6 (4.4)

32.2 (4.2)

0.784

Waist circumference, cm

102.4 (11.4)

104.7 (11.8)

103.7 (13.3)

0.570

Hypertensives, % (n)3

31.7 (26)

32.3 (20)

26.9 (18)

0.755
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Dietary intaked
Median energy, kj/day (IQR)

8671 (7309-10350)

8618 (7701-10981)

9486 (8066-

0.165

11438)
Median sodium, mg/day (IQR)

2453 (1974-3037)

2260 (1682-3099)

2521 (2003-

0.452

3065)
Median potassium, mg/day (IQR)

3694 (3027-4211)

3519 (3044-4452)

3849 (3191-

0.123

4674)
Median magnesium, mg/day (IQR)

423 (329-542)

427 (331-522)

449 (349-570)

0.214

Median calcium, mg/day (IQR)

894 (663-1134)

985 (713-1234)

951 (731-1233)

0.334

2114 (962)

2048 (874)

2018 (838)

0.799

Urinary excretion4
Volume, mL/d
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Creatinine, mmol/d

13.6 (4.4)

14.2 (4.1)

13.8 (4.7)

0.758

Median sodium, mmol/day (IQR)

137 (108-191)

128 (97-170)

145 (99-181)

0.391

Median potassium, mmol/day (IQR)

72 (54-89)

77 (63-91)

75 (59-98)

0.319

Median sodium-to-potassium ratio

1.9 (1.4-2.7)

1.8 (1.3-2.1)

1.9 (1.4-2.1)

0.206

(IQR)
1

Values are expressed as means (standard deviation) unless otherwise stated; 2Group comparisons were made using analysis of variance for

normally distributed data; 3Group comparisons were made using Chi square test; 4Group comparisons were made using Kruskal-Wallis H test
for data that was not normally distributed; C, control (usual care); I, interdisciplinary intervention with individualised dietary advice; IQR,
interquartile range; IW, interdisciplinary intervention with individualised dietary advice plus a supplement of 30 grams of walnuts per day.
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APPENDIX L
Change in blood pressure, 24-hour urinary excretion and key food groups from baseline to 3 months in the HealthTrack study (n=211)
IW (n=82)

I (n=62)

C (n=67)

P value for
group
difference

Blood pressure
SBP (mmHg)

Baseline

128.5 (114.5-137.5)1

127.5 (113.8-133.3)

122.0 (112-131)

0.173

3 months

119.5 (110-127.3)

121.0 (107.8-130.3)

118.0 (108-130)

0.935

Change

-7.0 (-12 to 0)a

-6.0 (-11 to -1.8)a

-3.0 (-9 to 2)b

0.035

P value for difference between

<0.001

<0.001

0.002

Baseline

75.0 (66-80)

75.0 (65-83.3)

72.0 (66-78)

0.642

3 months

70.0 (63-76)

70.0 (60.8-80)

70.0 (64-77)

0.766

Change

-4.0 (-8 to 0.3)

-4.0 (-9 to 0)

-2.0 (-6 to 3)

0.059

baseline and 3m
DBP (mmHg)
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P value for difference between

<0.001

<0.001

0.069

Baseline

137.0 (108-190.5)

128.0 (96.5-170.3)

145.0 (99-181)

0.396

3 months

108.0 (83.8-140)

125.5 (89.5-183.5)

111.0 (81-158)

0.078

Change

-29.5 (-71.3 to 12.3)a

-2.5 (-43.3 to 46.5)b

-40.0 (-71 to 24)a

0.015

P value for difference between

<0.001

0.989

0.003

Baseline

72.0 (54-89.3)

76.5 (62.8-91.3)

75.0 (59-98)

0.398

3 months

70.0 (50-86)

75.0 (60-90.3)

70.0 (55-88)

0.377

Change

-3.0 (-24 to 13)

0.5 (-13.5 to 14)

-6.0 (-31 to 8)

0.085

P value for difference between

0.217

0.986

0.004

baseline and 3m
Urinary excretion
Urinary sodium
(mmol/d)

baseline and 3m
Urinary potassium
(mmol/d)
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baseline and 3m
Urinary Na:K ratio

Baseline

1.85 (1.43-2.68)

1.79 (1.26-2.11)

1.86 (1.40-2.14)

0.263

3 months

1.63 (1.25-2.21)

1.83 (1.15-2.49)

1.68 (1.23-2.23)

0.703

Change

-0.26 (-0.90 to 0.28)a

-0.05 (-0.50 to 0.69)b

-0.20 (-0.63 to

0.050

(mmol/mmol)

0.49)ab
P value for difference between

0.008

0.439

0.355

Baseline

13.4 (5.4-34.4)

16.2 (6.4-30.6)

18.2 (7.1-37.5)

0.560

3 months

30.0 (27.4-37.3)a

10.4 (4.2-19.1)b

20.4 (6.9-41.2)c

<0.001

Change

20.4 (4.9 to 30)a

-1.5 (-13.5 to 5.1)b

-1.8 (-18.5 to 11.6)bc

<0.001

baseline and 3m
Food groups
Seed and nut
products and
dishes (g/d)

257

P value for difference between

<0.001

0.008

0.766

Baseline

113.1 (57.7-224.7)

151.4 (81.0-258.8)

140.8 (69.9-231.6)

0.276

3 months

212.3 (146.7-270.9)ab

241.9 (149.6-301.4)a

160.9 (109.9-262.7)b

0.022

Change

62.5 (-10.8 to 169.1)

79.2 (-37.6 to 168.9)

37.0 (-51.6 to 107.2)

0.073

P value for difference between

<0.001

0.005

0.096

Baseline

35.0 (19.8-58.3)

35.4 (14.9-60.6)

32.9 (20.0-67.1)

0.957

3 months

35.1 (20.3-64.3)

45.4 (21.1-67.5)

40.1 (20.4-57.1)

0.404

Change

7.8 (-11.0 to 20.1)

2.9 (-15.8 to 29.6)

0.0 (-15.9 to 16.8)

0.641

P value for difference between

0.224

0.310

0.716

baseline and 3m
Fruit products and
dishes (g/d)

baseline and 3m
Seafood products
and dishes (g/d)

baseline and 3m
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1

Values are median (IQR); a,b,cGroups with different superscripts were significantly different after Bonferroni adjustment; change in blood

pressure unadjusted for weight loss; C, control (usual care); DBP, diastolic blood pressure; I, interdisciplinary intervention with individualised
dietary advice; IW, interdisciplinary intervention with individualised dietary advice plus a supplement of 30 grams of walnuts per day; Na:K.
sodium-to-potassium ratio; SBP, systolic blood pressure.
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APPENDIX M
Linear regression for association between change in blood pressure and change in urinary markers and key food groups in the HealthTrack study
(n=211)
IW (n=82)

I (n=62)

C (n=67)

B ± SE

P value

B ± SE

P value

B ± SE

P value

Change in urinary Na (mmol/d)

0.009 ± 0.021

0.687

0.010 ± 0.022

0.649

0.019 ± 0.013

0.154

Change in urinary K (mmol/d)

-0.101 ± 0.050

0.044

0.057 ± 0.074

0.445

0.022 ± 0.031

0.471

Change in Na:K ratio

2.446 ± 1.171

0.037

-1.107 ± 1.976

0.575

0.442 ± 1.041

0.671

Change in consumption of seed and nut

-0.108 ± 0.051

0.034

-0.002 ± 0.061

0.975

-0.011 ± 0.021

0.608

-0.002 ± 0.010

0.867

-0.007 ± 0.010

0.451

0.002 ± 0.006

0.785

Change in SBP1

products and dishes (g/d)
Change in consumption of fruit products and
dishes (g/d)
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Change in consumption of seafood products

-0.072 ± 0.041

0.083

-0.056 ± 0.032

0.077

-0.011 ± 0.030

0.720

Change in urinary Na (mmol/d)

0.007 ± 0.015

0.644

0.005 ± 0.017

0.751

0.024 ± 0.011

0.028

Change in urinary K (mmol/d)

-0.056 ± 0.034

0.103

0.070 ± 0.056

0.213

0.010 ± 0.025

0.697

Change in Na:K ratio

1.500 ± 0.808

0.063

-1.141 ± 1.497

0.446

0.856 ± 0.851

0.315

Change in seed and nut products and dishes

-0.046 ± 0.035

0.195

0.003 ± 0.047

0.946

-0.014 ± 0.017

0.925

Change in fruit products and dishes (g/d)

-0.004 ± 0.007

0.590

-0.003 ± 0.008

0.653

0.001 ± 0.005

0.672

Change in seafood products and dishes (g/d)

-0.063 ± 0.028

0.024

0.030 ± 0.025

0.231

-0.0002 ± 0.024

0.994

and dishes (g/d)
Change in DBP

(g/d)

1

Controlling for age, sex, BP medication, weight loss, change in physical activity, smoking; C, control (usual care); DBP, diastolic blood

pressure; I, interdisciplinary intervention with individualised dietary advice; IW, interdisciplinary intervention with individualised dietary advice
plus a supplement of 30 grams of walnuts per day; K, potassium; Na, sodium; Na:K. sodium-to-potassium ratio; SBP, systolic blood pressure.
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